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Samenvatting
Deel 1: Klinische achtergrond, hulpmiddelen en complicaties
Deel 1 biedt aan de lezer de nodige klinische achtergrond om de studies, die
later aan bod komen, te kunnen kaderen. Na een korte beschrijving van het
cardiovasculaire stelsel, de nieren en de bloedvaten in de bovenste ledema-
ten, wordt dieper ingegaan op nierfalen, de nood voor een vaattoegang en
tot slot de drie types vaattoegangen.
Van nierfalen tot de nood voor een vaattoegang
Wanneer een patiënt lijdt aan terminaal nierfalen, moeten de functies van de
nieren overgenomen worden. Het ontvangen van een nier via transplantatie
is de ideale vervangtherapie. Voor patiënten op de transplantatiewachtlijst,
of patiënten die niet geschikt zijn als orgaanontvanger, bestaan er twee op-
ties: peritoneaaldialyse of hemodialyse.
Bij peritoneaaldialyse wordt een dialysaat (electrolyten oplossing) gra-
vitair in de buikholte gebracht via een peritonale katheter en werkt het sterk
doorbloede buikvlies (peritoneum) als membraan om de afvalstoen uit het
bloed in het dialysaat te brengen. Na enkele uren laat men het ‘vuile’ dia-
lysaat gravitair wegstromen uit de buik. Dit gebeurt meerdere keren per
dag manueel of ’s nachts automatisch. Slechts 5-10% van de dialysepatiënten
maakt gebruik van die techniek.
De meest voorkomende vervangtherapie is hemodialyse, met ongeveer
een half miljoen patienten alleen al in Europa. Bij hemodialyse stroomt het
bloed van de patiënt extracorporeel door een kunstnier, een kunstmatig or-
gaan. In die kunstnier wordt het bloed gezuiverd (diusie en convectie) en
wordt het overtollig water uit de patiënt onttrokken (ultraltratie). Omdat
de patiënten niet 24u/24u zouden moeten verbonden blijven aan het he-
modialysetoestel, moet het lteren in de kunstnier eciënt gebeuren. Het
bloed van de patiënt moet daarom, tijdens de dialysesessie (meestal 3-4 u,
3x per week), met een relatief hoog debiet (300-400ml/min) uit het lichaam
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stromen, door de kunstnier en terug naar de patiënt. Er moet dus een vaat-
toegang gecreëerd worden die deze hoge debieten kan garanderen, die fre-
quent bruikbaar is en die zoweinigmogelijk complicaties veroorzaakt. Hier-
voor bestaan er drie mogelijkheden: een arterio-veneuze stel, een arterio-
veneuze gree en een centraal veneuze katheter.
Arterio-veneuze stel (AVF)
Een arterio-veneuze stel (AVF) is een directe verbinding tussen een arte-
rie (slagader) en een vene (ader). Hierbij naait een (vaat)chirurg het hoge-
druk-arteriële-systeem aan het lage-druk-veneuze-systeem. Die stel wordt
meestal in de arm, bij voorkeur in de onderarm, aangelegd, door de vene
op de zijkant van de arterie te naaien. De verbinding zelf noemt men de
anastomose. De stelcreatie zorgt dus voor een bypass van het haarvaten-
systeem in de hand (een soort kortsluiting) en voor een hoog debiet door
de arm. Waar in de arm normaalgezien debieten van maximaal 100ml/min
aanwezig zijn, kan dat postoperatief 10-20 keer hoger zijn.
Door de verhoging van druk en debiet in de vene, wordt die vene groter
en verstevigt de wand. Dat proces noemt men maturatie en is noodzakelijk
om ongeveer 6 weken na de operatie de vene te kunnen aanprikken met
een arteriële (aanzuig) en een veneuze (terugvoer) dialysenaald. In 25-45%
van de gevallen faalt dit maturatieproces echter. Eens de stel gematureerd
is, is de meest voorkomende complicatie het vernauwen van de bloedvaten.
Die stenosevorming vermindert het bloeddebiet door de stel, waardoor de
eciëntie van de hemodialysebehandeling sterk vermindert. Vooral deze
complicatie zorgt ervoor dat ongeveer 50% van de stels binnen het jaar een
radiologische of chirurgische interventie nodig hebben om hun werking te
garanderen.
Daarnaast is het ook mogelijk dat er een te groot debiet door de stel
anastomose stroomt en dat de drukval van arterie naar vene te laag is. Hier-
bij komt de doorbloeding van de distale delen (stroomafwaarts, meer speci-
ek, de hand) in het gedrang. Deze ischemie kan leiden tot necrose van het
weefsel. Ook een overload van het hart, dat het verhoogde debiet door de
arm, als surplus, moet aanleveren, is hierbij een ernstige complicatie.
Er is aangetoond dat een stel deminste complicaties teweegbrengt, ver-
geleken met de andere vaattoegangen. Daarom hoort dit type vaattoegang
de eerste keuze te zijn bij een hemodialysepatiënt.
Arterio-veneuze gree (AVG)
De arterio-veneuze gree (AVG) is een variant van de AVF. Bij een AVG
wordt onderhuids een kunstmatig textiel buisje genaaid tussen de arterie
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en de vene. Deze vaattoegang wordt meestal toegepast bij patiënten wiens
venen van een mindere kwaliteit zijn. In het geval van een gree, worden
de dialysenaalden dan ook in de gree zelf geprikt. De meest voorkomende
complicatie hierbij is stenosevorming aan de veneuze anastomose en in de
bloedafvoerende vene. Algemeen kan aangenomen worden dat er bij gree
meer interventies nodig zijn om de vaattoegang goed werkend te houden
dan bij een stel.
Centraal veneuze katheter (CVC)
Een centraal veneuze katheter (‘central venous catheter’, CVC) bestaat uit één
of twee lumens (buisjes) en wordt ingebracht in een vene die naar de vena
cava superior of de rechter voorkamer van het hart loopt. Deze katheter
wordt, meestal ter hoogte van het sleutelbeen, naar buiten geleid zodat hij
verbonden kan wordenmet het dialysetoestel. Het gebruik van katheters als
permanente vaattoegang wordt afgeraden door het veelvuldig voorkomen
van complicaties zoals infectie en thrombose. De CVC wordt echter wel ge-
bruikt bij hemodialyse tijdens het matureren van een stel of wanneer geen
enkele stel of gree meer kan aangelegd worden.
Er is een grote verscheidenheid aan beschikbare katheter designs. Van
het ‘shotgun’-ontwerp (terugvoer-lumen langer dan aanzuig-lumen), over
symmetrische ontwerpen, tot ontwerpen waar beide lumens los van elkaar
hangen (‘split’-ontwerp). Elk van die designs hee voor- en nadelen.
Deel 2: Ingenieurshulpmiddelen
Deel 2 behandelt enkele (ingenieur-)technische onderwerpen, ter verdui-
delijking van de gebruikte methodes in de uitgewerkte studies. Vooreerst
wordt het Europees ARCH-project kort toegelicht. Enkele studies die be-
schreven worden in dit manuscript maken deel uit van dat Europees pro-
ject. Enkele andere studies zijn gebaseerd op data uit het ARCH-onderzoek.
Daarna wordt de basis van de vloeistofmechanica beschreven: de algemene
vloeistofeigenschappen (dichtheid, viscositeit, . . . ), de behoudswetten en de
specieke karakteristieken van vloeistof in beweging. Om deze ingenieurs-
achtergrond te vervolledigen worden de gebruikte technieken, zowel com-
putationeel als experimenteel, ingeleid.
Computationele methodes
Vooreerst werd gebruik gemaakt van computational uid dynamics (CFD,
numerieke stromingsleer) berekeningen. Die techniek bestaat erin een vo-
lume eerst onder te verdelen in zeer kleine cellen (‘meshen’). Daarnaworden
vii
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de wetten van behoud van massa en momentum berekend in elke cel om zo
met een iteratief proces de stroming in het volledige volume te begroten en
visualiseren. Daarnaast laat deze techniek ook toe om schuifspanningen te
berekenen.
Een tweede computationele methode die in dit werk gebruikt werd, is
kinetischemodellering. Deze techniek verdeelt het lichaam in virtuele com-
partimenten om het inwendige massatransport te kwanticeren.
Experimentele methodes
In het experimenteel (in vitro) gedeelte van dit onderzoek werd gebruik ge-
maakt van siliconemodellen van de bloedvaten in de arm. Die modellen
werden aangesloten op gestuurde pompen en geconnecteerd met drukva-
ten, reservoirs en weerstanden stroomafwaarts. Nadat fysiologische druk-
en stromingsrandvoorwaarden gecreëerd werden, konden zowel de disten-
sie (diameter verandering ten gevolge van drukgolf) als de stromings- en
drukproelen nauwkeurig opgemeten worden. De bekomen data diende
deels als input van de computermodellen, en deels om de output van de
computermodellen te veriëren.
Voor het experimenteel gedeelte werd ook gebruik gemaakt van Particle
Image Velocimetry (PIV). Hierbij wordt op een perfect transparant model
een laser vlak aangebracht. Door het model stroomt een vloeistof waarin
kleine reecterende deeltjes, partikels, zijn aangebracht. Een camera regi-
streert de deeltjes die door het laser-verlichte gebied bewegen. Door verge-
lijking van opeenvolgende beelden kunnen dan lokale snelheden berekend
worden.
Deel 3: Studies over AVF’s
Computationele studie van stroming in een AVF anastomose
Tot op heden is er weinig interesse voor de geometrie van de anastomose
zelf, hoewel dit een cruciaal onderdeel is van het stromingspad en er tot 95%
van het bloed in de arm moet door stromen. In de studie beschreven in
hoofdstuk 10 gaan we dieper in op de stroming in de arterio-veneuze ana-
stomose en beschrijven we de invloed van de grootte van die verbinding
en van de hoek tussen arterie en vene op zowel het debiet als de drukver-
deling. We creëerden 11 verschillende computermodellen van een arterie,
waarop langs de zijkant een vene is geconnecteerd, en waarbij de anasto-
mose grootte varieerde tussen de 12.6 en 23.6mm2 en de anastomose hoek
tussen de 27○en 90○. Met CFD-berekeningen werd de stroming in deze ver-
eenvoudigde AVF-modellen geanalyseerd.
viii
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In een eerste luik hebben we een uitstroom debietsverdeling vastgelegd
en het instroom debiet gevarieerd tussen de 600-1200ml/min. We konden
aantonen dat de drukval over de anastomose (drukverschil tussen arteriële
en veneuze druk, de ‘weerstand’) kwadratisch stijgt met een groter wordend
debiet en dat de drukval kleiner wordt als de anastomose vergroot of als de
hoek wijder wordt dan 43○.
In een tweede luik hebben we de drukken aan in- en uitlaat vastgezet en
opnieuw de 11 verschillende modellen doorgerekend. Naar analogie met de
bevindingen uit het eerste deel, merkten we nu dat het instroomdebiet steeg
als de anastomose oppervlakte of hoek groter werden. Omdat de drukval
over de anastomose zodanig daalde, werd er zelfs bloed vanuit het distale
deel van de arterie (van de hand) aangezogen naar de vene. Dit laatste kan
klinisch leiden tot distale hypoperfusie of zelfs ischemie.
Deze studie toonde duidelijk aan dat de grootte en de hoek van de ana-
stomose zeer bepalend zijn voor de stroming in de stel. Omdat een te kleine
anastomose meestal maturatie verhindert, wordt snel overgeschakeld naar
een (te) grote anastomose. Het gebrek aan interesse voor de geometrie van
de anastomose lijkt echter onterecht. Een verandering van 2mm lengte bij-
voorbeeld kan leiden tot een verhoging van de drukval met 30%.
Experimentele validatie
Binnen het Europese project ARCH (hoofdstuk 7) werd een computerpro-
gramma ontwikkeld dat aan de hand van patiënt-specieke, preoperatieve,
medische beelden en gegevens, de direct postoperatieve debieten en druk-
ken in arteries en venen kan voorspellen. Hierbij kan reeds vóór de aanleg
van de stel, patiënt-speciek, de optimale stellocatie gekozen worden. Al-
vorens het computermodel in de klinische praktijk kan getest en geoptima-
liseerd worden, was het aangeraden om de nauwkeurigheid van het model
en de achterliggende fysica rigoureus te veriëren. Deze vericatie was mo-
gelijk aan de hand van experimentele validatiestudies (hoofdstuk 11). Hierbij
werd een model gebouwd dat gebaseerd is op patiënt-specieke data, werd
dit experimentele model met de computer nagebouwd en werden resultaten
van het experiment en het computermodel vergeleken.
De eerste experimentele setup, besproken in sectie 11.1, bestond uit een
pomp (cfr. het hart) gekoppeld aan een siliconen model van zowel de aorta,
de belangrijkste arteriën in de arm, een AVF ter hoogte van de pols, als en-
kele venen. De geometrie (lengtes en diameters) en de distensie werden
opgemeten en overgezet naar het numerieke pulse wave propagationmodel
(een 1D representatie van een vaatstructuur voor het berekenen van druk- en
ix
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debietsgolven). Wematen druk- en debietsgolven op 11 plaatsen experimen-
teel op en vergeleken deze met de computationele resultaten. Het was dui-
delijk dat het computermodel de gemiddelde druk en het gemiddelde debiet
accuraat kon simuleren. De golfvormen zelf waren echter minder gedempt
dan in het experimentele model. Dit laatste wellicht door het ontbreken van
visco-elasticiteit in het computermodel.
Verder voerden we een analyse uit rond de precisie van de outputwaar-
den, rekening houdend met de onnauwkeurigheden van de inputdata. Dit
werd uitgevoerd aan de hand vanMonte Carlo simulaties waarbij elke para-
meter, binnen een opgegeven nauwkeurigheid, 5000 keer werd veranderd.
Hieruit bleek duidelijk dat de onzekerheid op de gemeten waarden (vb. dia-
meter arterie ± 10%) sterk kon teruggevonden worden in een onzekerheid
op de gesimuleerde output. Dus het reduceren van de onzekerheid op de
inputdata, hee een grote invloed op de onzekerheid van de computer re-
sultaten. Deze kennismoet in rekening gebracht wordenwanneer hetmodel
klinisch geïmplementeerd wordt.
Een tweede validatiestudie, besproken in sectie 11.2, maakte gebruik van
een patiënt-speciek model van een arterio-veneuze stel. Hierbij werd de
stroming gevisualiseerd ter hoogte van de anastomose doormiddel van PIV-
metingen. Daarnaast hebben we de drukval over de anastomose (van arterie
tot vene) experimenteel opgemeten voor meer dan 200 verschillende debie-
ten. We vonden een goede overeenkomst tussen het stromingsbeeld gege-
nereerd door de PIV-metingen en dat gesimuleerd door het CFD-model.
Daarnaast vonden we opnieuw een kwadratisch verband tussen debiet en
drukval en kwam dit verband goed overeen met de resultaten van de com-
puterberekeningen.
Er kan dus gesteld worden dat, rekening houdend met een vastgestelde
onzekerheid, beide computermodellen betrouwbare resultaten geven en dus
kunnen ingezet worden om patiënt-specieke hemodynamica nauwkeurig
te simuleren.
Diagnose methodes
In hoofdstuk 12werden twee methodes bestudeerd die de arts kan helpen bij
de diagnostiek rond AV-stels.
Ten eerste hebben we in sectie 12.1 een methode uitgewerkt die in staat
is stenoses te detecteren met een diameterreductie van 25-50%. De hui-
dige methodes zijn meestal gebaseerd op drukvalverhoging of debietsver-
mindering en kunnen slechts vernauwingen detecteren van ongeveer 70%
diameterreductie (≈ 90% doorstroomoppervlakte reductie). De hier bestu-
deerde methode maakt echter geen gebruik van de gemiddelde druk maar
x
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van de pulsdruk (maximale minminimale druk tijdens een hartslag cyclus).
We toonden aan, via een silicone experimenteel model, dat stenoses in een
vroegtijdig stadium kunnen gedetecteerd worden aan de hand van drukgol-
ven geregistreerd aan de dialysenaald. Deze polsdruk analyse (pulse pressure
analysis (PPA)) bleek onafhankelijk van debiet en hartslag. Klinische stu-
dies moeten deze experimentele resultaten natuurlijk bevestigen, maar deze
lage-kostenmethode biedt goede perspectieven.
Een tweede diagnosemethode die onder de loep werd genomen is de
pulsed wave Doppler ultrasound (PWD-US) debietsmeting (sectie 12.2). Bij
PWD-US wordt de gemiddelde snelheid [m/s] in een doorsnede berekend
en vermenigvuldigd met de oppervlakte van de doorsnede [m2] om zo het
debiet [m3/s of ml/min] te bekomen. Deze methode kan bijvoorbeeld ge-
bruiktworden omdirect postoperatieve debietsmetingen uit te voeren. Deze
metingen blijken namelijk een voorspellend karakter te hebben rond het sla-
gen van de stelmaturatie. Een eciënte en betrouwbare methode om de-
bieten te meten is dus nodig.
Het bleek dat men met PWD-US (echograe) de bloedsnelheid, in het
centrum van een bloedvat, in de richting van de probe, nauwkeurig kan be-
palen. Wanneer echter wordt overgegaan naar debietvoorspellingen, blij-
ken er grote onnauwkeurigheden in de metingen te ontstaan. Een patiënt-
speciekCFD-modelwerd opgebouwd, en de ultrasone spectrawerden com-
putationeel gegenereerd. We analyseerden zowel een pre- als een postope-
ratief model, beiden ter hoogte van de elleboog en van de pols.
We toonden aan dat er, bij complexe stroming, reeds fouten worden ge-
ïntroduceerd wanneer de snelheid zoals opgepikt door de US-probe (in de
richting van de probe) wordt omgezet naar de snelheid in de lengterichting
van het bloedvat. Maar het werd vooral duidelijk dat de grootste onnauw-
keurigheid wordt geïntroduceerd wanneer de snelheid in een punt (vb. cen-
trum van het bloedvat, 0D) of op een lijn (over de volledige diameter van
het bloedvat, 1D) wordt omgezet naar de gemiddelde snelheid in de door-
stroomoppervlakte (2D). De vorm van het lokale snelheidsproel is name-
lijk volledig onbekend. We vergeleken aannames van parabolische proelen
(Poiseuille stroming), vlakke proelen (plug stroming) en tijdsafhankelijke
proelen (Womersley stroming).
Er kon geconcludeerd worden dat er geen enkele aanname werkt in elk
van de situaties en dat er bij gebruik van PWD-US debietsdata rekening
moet gehouden worden met zeer grote onnauwkeurigheden op de verkre-
gen debietswaarden.
xi
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Deel 4: Studies over AVG’s
Helicale gree designs
Zoals vermeld is stenosevorming een veel voorkomende complicatie bij gref-
fes. Deze vernauwingenworden veroorzaakt door neo-intimale hyperplasie.
Dit ongecontroleerd groeien van cellen uit de intimalaag van de bloedvat-
wand wordt gedreven door abnormale lokale stromingspatronen. In de li-
teratuur staat beschreven dat fenomenen als lage gemiddelde wandschuif-
spanning (lage time-averaged wall shear stress, TAWSS), sterk oscillerende
wandschuifspanning (hoge oscillatory shear index, OSI) en hoge verblijfstijd
(hoge relative residence time, RRT) deze neo-intimale hyperplasie induceren.
Daarnaast is er beschreven dat stroming met veel wervels deze ongunstige
hemodynamica reduceren.
In hoofdstuk 13 hebben we de beschreven stromingsfenomenen bestu-
deerd in greesmet een spiraalvormig (helix) design, aan de hand vanCFD-
simulaties. Er werden vijf verschillende helicale designs, parametrisch, ont-
worpen (met torsielengtes van 17,5 tot 6 keer de gree diameter) en verge-
leken met een rechte, conventionele gree. Uit de berekeningen, uitgevoerd
met hoge nauwkeurigheid, kon worden afgeleid dat het introduceren van
een spiraalvorm (swirl) in het design van een gree leidt tot een meer com-
plex stromingsbeeld en dat de zonesmet ongunstige hemodynamica geredu-
ceerd worden. De graad van reductie bleek echter niet proportioneel met de
ingebrachte heliciteit en we kunnen aannemen dat de eectiviteit van deze
grees dan ook casus per casus moet bekeken worden.
Deel 5: Studies over CVC’s
Computationele studie rond katheter met nieuw tipdesign
Bij het ontwerp van een katheter is het de bedoeling dat de recirculatie zo
laag mogelijk is (eventueel zelfs bij omgekeerde connectie van de aanslui-
tingen), dat het bloed niet stilstaat in de lumens (klontervorming) en dat
het bloed zo weinig mogelijk wrijving ondervindt (beschadiging van rode
bloedcellen, hemolyse).
In hoofdstuk 14werd het ontwerp van een nieuwe katheter, met een sym-
metrische tip, onder de loep genomen. Een uitgebreide CFD-analyse toonde
aan dat er een verwaarloosbare recirculatie optrad in de nieuwe VectorFlow
katheter. Dit werd zowel in een experimentele studie als in een studie op
een varkensmodel bevestigd. Daarnaast was het in de computationele stu-
die mogelijk de stromingspatronen rond de tip te bestuderen en parameters
xii
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rond klontervorming en hemolyse te analyseren en te vergelijken. De stro-
mingsfenomenen en parameters bleken voor het nieuwe design vergelijk-
baar met die bij reeds bestaande standaard ontwerpen. De studie toonde de
grote potentie van de VectorFlow katheter, door het uitblijven van recircu-
latie, en opent de deur voor verdere (pre-)klinische studies.
Computationele studie naar suboptimaal werkende katheters
Wanneer het gewenste dialysedebiet niet meer kan verkregen worden bij ge-
bruik van een katheter met twee lumens, wordt ofwel verder gedialyseerd
met het verlaagde bloeddebiet of worden de aanzuigzijde (arteriële lumen)
en de terugvoerzijde (veneuze lumen) omgekeerd geconnecteerd. Omdat de
meeste katheters ontworpen zijn om in gewone werking zo weinig mogelijk
gezuiverd bloed (uit veneuze lumen) terug aan te zuigen (via arteriële lu-
men), recirculatie genaamd, zorgt een omkering van de connecties meestal
wel voor een verhoogde recirculatie.
In sectie 15.1 hebben we eerst bij een groep van 22 patiënten onderzocht
hoe eciënt de hemodialyse is als de connecties omgekeerd worden. Hier-
uit bleek dat de eciëntie niet signicant verschilde bij gewone versus om-
gekeerde connectie voor ureum, creatinine, beta-2-microglobulin (β2M) en
fosfaat. Daarnaast werd een eerste mathematische model opgebouwd door
een 1-compartiment kinetisch model te koppelen aan een dialysemodel. De
studie rond de klaring (afvoer) van ureum tijdens dialyse toonde aan dat er
slechts een reductie van de eciëntie, op basis van de hoeveelheid verwij-
derde stof, van 9.2% optrad bij een recirculatie van 10%.
Om de vertraagde distributie van stoen in het lichaam beter te kunnen
modelleren werd in sectie 15.2 het meer volledige 2-compartimenten kine-
tisch model uitgewerkt. Hierbij werden vier verschillende opgeloste stoen
bestudeerd: ureum, methylguanidine, β2M en fosfaat. Hiermee werd aan-
getoond dat in een standaard dialysesessie (4 uur), een katheter met één
lumen zorgt voor een minder eciënte dialyse vergeleken met een katheter
met twee lumens. Daarnaast werd duidelijk dat het omkeren van de lijnen
bij een suboptimaal werkende katheter beter is dan het blijven dialyseren in
correcte connectie maar met verminderd debiet.
Vertrekkend van het 2-compartimenten kinetisch model, zijn we in sec-
tie 15.3 dieper ingegaan op een verlengde dialysesessie (8 uur), die vooral ’s
nachts, zowel in dialysecentrum als thuis, kan plaatsvinden. Daardoor heb-
ben ze vaak een lagere impact op het leven van de patiënt. Vooreerst vonden
we dat er in een 8 u dialyse, bij gelijke debieten, een verhoging van de dia-
lyseeciëntie plaatsvond ten opzichte van 4 u dialyse. De verwijdering van
de opgeloste stoen was, door het vertraagde transport in het lichaam, ech-
ter niet verdubbeld.
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Om de nachtrust van de patiënten te bewaren (minder opstaan om con-
centraatzakken te verwisselen en minder alarms) en de kost van water on-
der controle te houden, zou dialyse met een gehalveerd debiet aangewezen
kunnen zijn. Voor deze lange trage dialyse vonden we een eciëntie verge-
lijkbaar met standaard 4 u dialyse. Ten slotte werd nog de optie bestudeerd
waarbij de patiënt zichzelf met één naald aanprikt (in plaats van twee) in
een arterio-veneuze stel of waarbij er een katheter met enkel lumen ge-
bruikt werd. Hierbij vonden we een verhoogde eciëntie ten opzichte van
de standaard 4 u dialyse.
Deel 6: Algemene conclusies
Door het uitvoeren van de verschillende computationele en experimentele
studies, komen we tot volgende stellingen:
• Bij een AVF moet de grootste drukval over de anastomose liggen.
• Het gebruik van een helix vorm in het ontwerp van een AVG intro-
duceert een complexer stromingsveld en reduceert de zones met on-
gunstige hemodynamica, maar doet deze echter niet verdwijnen.
• De VectorFlow CVC is een veelbelovende katheter door de verwaar-
loosbare recirculatie.
• Het pulse wave propagation model en het numerieke stromingsleer-
pakket voor hoge debieten, ontwikkeld in het ARCH-project, zijn ex-
perimenteel gevalideerd en kunnen gebruikt worden voor implemen-
tatie in de klinische praktijk.
• Experimenteel onderzoek vereist ervaren onderzoekers.
• Het uitvoeren van polsdruk analyse aan de arteriële dialysenaald kan
leiden tot het vroegtijdig detecteren van stenoses.
• Standaard pulsed wave Doppler ultrasoundmetingen leveren geen be-
trouwbare waarde voor het bloeddebiet.
• Bij een slecht werkende dubbel lumen CVC tijdens standaard (4 u)
dialyse moet het omkeren van de katheter connecties en behoud van
voldoende debiet de voorkeur krijgen.
• Trage dialysemet een dubbel lumen CVC, of dialysemet een enkel lu-
men CVC ofmet één naald in de AVF, zijn goede alternatieven tijdens
dialyse met verlengde duur (8 h).
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Part 1: Clinical background, devices and complications
e rst part provides the reader with the necessary clinical background to
understand the conducted studies in this work. Aer a brief description of
the cardio-vascular system, the kidneys and the blood vessels in the upper
extremities, kidney failure, the need for a vascular access and the three types
of vascular access are discussed.
From a failing kidney to the need for a vascular access
If a patient suers from an end-stage renal disease (total kidney failure), the
functions of the kidneys must be reproduced. Receiving a kidney transplant
is the best replacement therapy. For patients on the transplant waiting list
or patients not suitable as organ recipient, there are however two options:
peritoneal dialysis or hemodialysis.
During peritoneal dialysis, a dialysate (electrolyte solution) is brought,
by gravity, in the abdominal cavity via a peritoneal catheter.e highly vas-
cularized peritoneum acts as amembrane, bringing waste products from the
blood into the dialysate. Aer a few hours, the spent dialysate is drained, by
gravity, from the abdomen to a waste bag. is sequence is repeated sev-
eral times a day manually or at night automatically. Only 5-10% of dialysis
patients make use of this technique.
emost common renal replacement therapy is hemodialysis, withmore
than half-a-million patients in Europe. Within this therapy, the patient’s
blood ows extracorporally through an articial kidney, an articial organ.
In an articial kidney, the blood is puried (convection and diusion) and
excess water is removed from the patient (ultraltration). To avoid that the
patient should remain connected to the dialyzer 24/7, the treatment should
happen as ecient as possible.e patient’s blood should therefore, during
the dialysis session (usually 3-4 h, 3/week), owwith a relative high ow rate
(300-400ml/min) through the articial kidney.erefore, there is the need
to create a vascular access which can provide these high ow rates, which
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is frequently usable and which has a low complication rate.ere are three
possibilities: an arterio-venous stula, an arterio-venous gra and a central
venous catheter.
Arterio-venous stula (AVF)
An arterio-venous stula (AVF) is a direct connection between an artery
and a vein. A (vascular) surgeon sews the high-pressure arterial system to
the low-pressure venous system. e stula is mostly created in the arm,
preferably in the lower arm, by connecting a vein to the side of an artery
(end-to-side). e connection itself is called the anastomosis. e stula
creation causes a bypass of the capillary system (sort of short circuit) and
an increase in blood ow through the arm. Normally, the ow in the arm
is around 100ml/min, but aer stula creation this can increase by a factor
ten to twenty.
Due to the increase in pressure and ow, the vein enlarges and the vein
wall reinforces.is process, called maturation, is required to puncture the
vein, mostly starting 6-8 weeks aer the surgery, with an arterial (suction)
and venous (return) dialysis needle. However, failure to mature occurs in
25-45% of the cases.
Once the stula matured, the narrowing of the vessels is the most com-
mon complication.is stenosis formation reduces the blood ow rate and
inhibits an ecient dialysis treatment.is complication in particular, is re-
sponsible for the fact that up to 50% of stulas need a surgical or radiological
intervention within the rst year.
In addition, a too high ow rate and/or to low pressure drop over the
arterio-venous anastomosis oen occur. Hereby, the blood circulation to
the distal part (downstream, more specically the hand) is inhibited. is
distal hypoperfusion syndrome can lead to ischemia and even necrosis of
the tissue. Furthermore, the heart has to deliver this elevated blood ow to
the arm and a cardiac overload can occur.
It has been shown that the complication rate in stulas is lower com-
pared to the other vascular access options.erefore, an AVF should be the
rst option as vascular access.
Arterio-venous gra (AVG)
An arterio-venous gra (AVG) is a variant on an AVF. With a gra, an ar-
ticial textile tube is sewn, subcutaneously, between an artery and a vein.
is vascular access is usually used in patients with low quality veins. In the
case of a gra, the dialysis needles are inserted in the gra itself. e most
common complication is stenosis formation at the venous anastomosis and
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in the draining vein. e number of vascular access interventions needed
to maintain the gra’s well functioning is higher compared to the necessary
interventions associated with a stula.
Central venous catheter (CVC)
A central venous catheter (CVC) consists of one or two lumens (tubes) and
is inserted into a vein leading to the vena cava superior or the right atrium.
e catheter is brought, usually at the height of the collar bone, to the outside
to be able to be connected with the dialysis machine. e use of catheters
as permanent vascular access is not recommended due to the frequent oc-
currence of complications such as infection and thrombosis. e CVC is
nonetheless used for hemodialysis during the maturation of a stula or if no
more stula or gra can be constructed.
ere is a great variety in available catheter designs. From the ‘shotgun’
design (return lumen longer than suction lumen), over symmetrical designs
to designs where both lumens are separated (‘split’ design), each with their
own advantages and disadvantages.
Part 2: Engineering tools
In the second part, some engineering background is provided. is should
make the methods, applied in the studies, more clear. First, the European
ARCH-project is briey explained.is is because some studies in this dis-
sertation were, on the one hand, part of this research project or, on the other
hand, rely on data from it. Next, the basic principles of uid mechanics are
described, starting from the overall liquid properties (density, viscosity, . . . ),
over the conservation laws, to specic characteristics of the uid in motion.
To complete this engineering background part, the used techniques, both
computational and experimental, are introduced.
Computational methods
Some computational studies were conducted based on computational uid
dynamics (CFD) calculations. In CFD, a volume has to be subdivided into a
large number small volume cells (‘meshing’).en, in each cell, an iterative
procedure is applied until the laws of conservation of mass and momentum
result in negligible residuals.is allows us to visualize and analyze the ow
in great detail. In addition, also shear stresses or blood residence times can
be calculated.
e second computational method that was used in this work is kinetic
modeling. is technique virtually divides the body into several compart-
ments to quantify the internal mass transport phenomena.
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Experimental methods
Silicone models of the blood vessels in the arm were used during the exper-
imental (in vitro) part of the research.ese were connected to (controlled)
pumps, (pressure) reservoirs and downstream resistances. When physiolog-
ical pressure and ow conditions were created, we couldmeasure distension
(change in diameter due to pressure changes) and ow and pressure proles
accurately. e obtained experimental data could partly serve as input for
computer models and partly to verify the output generated by the computer
models.
During the experimental studies, Particle Image Velocimetry (PIV) was
used as well. A thin laser sheet is applied on a transparent model and a liq-
uid, seeded with small tracer particles, ows through the model. A camera
records the particles owing through the illuminated region of interest.e
locations of the particles over consecutive images are compared to achieve
the local velocity eld.
Part 3: Studies on AVFs
Computational study on ow in a AVF anastomosis
Although the anastomosis is a crucial element in the blood ow path and
90-95% of the blood ow in the arm passes it, there is, in general, a signif-
icant absence of interest in the geometry of the anastomosis. In the study
described in chapter 10, the ow in the anastomosis region was assessed in
more detail and we described the impact of the size of the anastomosis, as
well as of the angle between vein and artery, on ow rates and pressure dis-
tribution.erefore, we created 11 dierent computational models of a vein
connected to the side of an artery with a varying anastomosis size (12.6-
23.6mm2) and anastomosis angle (27-90○).e ow in these simpliedAVF
models was analyzed based on CFD-calculations.
First, an outow distribution was xed, while the inow ow rate was
changed between 600 and 1200ml/min. We were able to show that the pres-
sure drop over the anastomosis (arterial minus venous pressure) changes
quadratically with the inow rate and decreases when the anastomosis size
increases or the angle gets wider then 43○.
Later, we xed the inlet and outlet pressures and recalculated all 11 CFD
models. In analogy with the conclusions from the rst part, we found an
increased ow rate when the anastomosis size or angle increased. Because
the decrease in pressure drop over the anastomosis was very high, blood
was ‘stolen’ by the vein from the distal artery (from the hand). is ‘steal
syndrome’ can clinically lead to distal hypoperfusion or even ischemia.
xviii
Part 3: Studies on AVFs
e study clearly showed that the anastomosis size and angle have a great
inuence on the oweld in the stula. Because a too small anastomosis can
inhibit the maturation process, physicians switch too fast to a (too) large
anastomosis.e lack of interest concerning the geometry of the anastomo-
sis seems, however, unfair. A change of, for example, 2mm in anastomosis
length can lead to a pressure drop increase of 30%.
Experimental validation
Within the context of the European ARCH project (chapter 7), a compu-
tational modeling framework was developed to predict direct postopera-
tive ow and pressure in both arteries and veins, based on patient-specic,
preoperative, medical images and functional data. e goal is to predict,
patient-specically, the optimal AVF anastomosis location. Before the test-
ing and optimization of the model framework in clinical practice, it was
recommended to rigorously verify the numerical model and the underly-
ing physics.is verication was performed using experimental validation
(chapter 11). First, an in vitromodel was built based on patient-specic data,
second, the experimental model was reconstructed in the computer model
and, nally, the experimental and computational results were compared.
e rst experimental setup we used, discussed in section 11.1, consists
of a pump (cf. the heart) coupled with a silicon model of the aorta, the most
important arteries in the arm, an AVF at the wrist and a basic venous circuit.
e geometry (lengths and diameters) and the distensibility were measured
and converted to the numerical pulse wave propagation model (a 1D rep-
resentation of the vessel topology for the calculation of pressure and ow
waveforms). We obtained experimentally pressure and ow waveforms on
11 dierent locations throughout the siliconmodel and compared these with
the computational results. It was clear that the computational model was
able to accurately simulate themean pressure and ow rates.e waveforms
themselves were however less attenuated compared to the experimental re-
sults. e latter is probably caused by the absence of visco-elasticity in the
computer model.
Furthermore, we studied the precision of the numerical output values,
taking into account the uncertainties of the input data. is analysis was
conducted using Monte-Carlo simulation in which every parameter was
changed 5000 times, within its predened uncertainty range. We showed
that the uncertainties of the measured values (e.g. diameter artery ±10%)
are clearly notable when analyzing the uncertainty of the simulated output.
us, reducing the uncertainty of the input data might signicantly increase
the accuracy of the computational results.is knowledge should be taken
into account when applying the model in clinical practice.
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Asecond validation study, discussed in section 11.2, used a patient-specic
model of an arterio-venous stula in which the ow eld was rstly visual-
ized, in the anastomosis region, by PIV measurements. Secondly, the pres-
sure drop over the anastomosis (artery to vein) was acquired experimen-
tally for more than 200 dierent ow rates. We found an excellent match
between the ow eld captured by the PIVmeasurements and the ow eld
simulated by the CFD model. Furthermore, we found a quadratic relation
between ow rate and pressure drop and, once again, an excellent match
between experimental and computational results.
We can state that, taking the dened uncertainties in consideration, both
computationalmodels are reliable tools and canbe used to simulated patient-
specic hemodynamics.
Diagnostic tools
In chapter 12, two methods were studied in order to help the physician with
the diagnosis of an AV stula’s patency.
First, we elaborated on a stenosis detection method, able to detect
stenoses with a 25-50% diameter reduction (section 12.1).e current meth-
ods aremost oen based on pressure drop increase or ow rate decrease and
can only detect sections with at least 70% diameter reduction (≈ 90% area re-
duction). Our studied method does not make use of the mean pressure but
of the pulse pressure (max minus min pressure over a cardiac cycle). We
showed, based on an in vitro study, that early detection of stenoses is pos-
sible, based on the pressure data gathered at the arterial needle. We found
that this pulse pressure analysis (PPA) method is independent of ow rate
and heart rate. Of course, clinical investigations have to conrm the exper-
imental results, but this low-cost method shows a great potential.
A second diagnostic method that was examined was pulsed wave
Doppler ultrasound (PWD-US) ow rate acquisition (section 12.2). Within
this PWD-USmethod, a cross-sectional averaged velocity [m/s] is estimated
and multiplied with the area of the cross-section [m2], to end up with the
ow rate [m3/s or ml/min].is method can, for example, be used to mea-
sure direct-postoperative ow rates.e outcome of the maturation process
seems to be predictive when looking at this ow rate data. e ow rate
should therefore be measured with an ecient and reliable method.
We found that PWD-US can determine the ow velocity, in the center of
the vessel lumen and in the direction of the US probe, accurately. However,
when this velocity data are transfered to ow rate data, large uncertainties
are introduced. We built a patient-specic CFD model and generated com-
putationally the ultrasound spectra. Both a pre- and a postoperative model,
both at the elbow and the wrist level, were studied.
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We showed that, for complex ow elds, errors are already introduced
when the velocity captured by the US probe (in the direction of the probe)
is converted to the velocity in the longitudinal direction of the vessel. It was
however clear that the major inaccuracies are introduced when the velocity
in a point (e.g. in the center of the vessel, 0D) or on a line (e.g. over the
full diameter of the vessel, 1D) are transferred to the cross-sectional aver-
aged velocity (2D).is is caused by the fact that the shape of the local ow
prole is totally unknown. We compared the assumption of a parabolic pro-
le (Poiseuille ow), a at prole (plug ow) and a time-dependent prole
(Womersley ow).
We can conclude that, in all cases, one should take into account that,
when using PWD-US ow rate data, a large uncertainty is present in the
ow rate output.
Part 4: Study on AVGs
Computational study of ow in helical AVGs
As mentioned, stenosis formation is a frequent occurring complication
within gras. is narrowing of the vessel is caused by neo-intimal hyper-
plasia.is uncontrolled growth of cells in the intimal layer of the vessel wall
is triggered by the local ow eld. In literature, we can nd that phenomena
like low time-averagedwall shear stress (TAWSS), high oscillatorywall shear
stress (high oscillatory shear index (OSI)) and high relative residence time
(RRT) induce neo-intimal hyperplasia. Furthermore, it is described that a
ow eld with strong vortices reduces the zones with unfavorable hemody-
namical conditions.
In chapter 13, we studied the discussed ow phenomena in gras with
a helical design, using CFD simulations. Five dierent helical gra designs
were, parametrically, constructed (pitch lengths from 17.5 to 6 times the di-
ameter of the gra) and compared with a conventional straight gra. From
the calculations, performed with great accuracy, we could conclude that in-
troducing helicity (‘swirl’) in the design leads to a more complex ow eld
and reduces zones with unfavorable hemodynamical conditions. However,
the rate of reduction seemed not fully proportional with the introduced he-
licity. We can presume that the eectiveness of such a gra has to be studied
case-by-case.
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Part 5: Studies on CVCs
Computational study of ow in a novel CVC
Whendesigning a catheter, onewants the catheter to have a low recirculation
(eventually even in reversed connection mode), no standstill of blood in the
lumens (clotting) and low levels of shear forces on the blood cells (damaging
of red blood cells, hemolysis).
In chapter 14, we assessed a new catheter, with a symmetrical tip de-
sign. An extensive CFD analysis on the new VectorFlow catheter revealed
that the recirculation was negligible.is nding was conrmed in both an
experimental (in vitro) study and in a study on a pig. e computational
model made it possible to study the ow eld around the tip and to analyze
parameters concerning clotting and hemolysis. e data representing the
ow phenomena in the new design were comparable with the values from
existing standard designs. Our study showed the potential of the Vector-
Flow catheter, due to the total absence of recirculation, and opens the way
for future (pre)clinical studies.
Computational study on malfunctioning CVCs
When the required dialysis ow can no longer be achieved during a dial-
ysis session with a double lumen catheter, either dialysis with the lowered
ow rate can be performed, or the connections of the suction side (arterial
lumen) and draining side (venous lumen) can be switched. Because most
catheters are designed to minimize recirculation (suction of cleansed blood
from venous lumen back in arterial lumen) when connected in the correct
sense, a connection reverse mostly induces an increased recirculation.
In section 15.1, we investigated the hemodialysis eciency, comparing
normal to reversed catheter connection in 22 patients. We found, for urea,
creatinine, beta-2-microglobulin (β2M) and phosphorus, that there was no
signicant dierence between the two types of connection. Next, we con-
structed a mathematical model by combining a 1-compartment kinetic mo-
del with a dialysis model. Our study of the clearance of urea showed that
there was only a 9.2% decrease in dialysis eciency, based on the the total
solute removal, when a 10% recirculation is present.
To be able to simulate the retarded distribution of solutes in the body
more accurately, a 2-compartment model was introduced in section 15.2. We
studied four dierent solutes: urea, methylguanidine, β2M and phospho-
rus. We showed that for a standard dialysis session (4 hours), dialysis with
a single lumen catheter reects in a less eective solute removal compared
to dialysis with a double lumen CVC. Furthermore, reversing the lines in
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suboptimal working catheters seemed a better option when compared to
dialysis in normal connection but with a lowered ow rate.
Starting from the 2-compartment kinetic model, we investigated in sec-
tion 15.3 the use of an extended dialysis session (8 hours), mostly taking place
during the night, in a dialysis center or at home.is can lower the impact of
the renal replacement therapy on the patient’s daily life. First, we found, for
8 h dialysis, an increase in eciency compared to the standard 4 h dialysis.
However, the total solute removal, for our studied solutes, was not doubled,
due to the retarded transport in the body.
To preserve the night’s rest of the patients (less frequent awakening to
change reservoirs and less alarms) and to keep the water cost under con-
trol, halving the ow rates during dialysis can be an option. We found for
this lowered-ow, extended (8 h), dialysis that the eciency was compara-
ble with the results of a standard 4 h dialysis session. Finally, we studied the
option of a patient puncturing his own AVF with a single needle and the use
of a single lumen catheter. An increased total solute removal was found in
both cases compared to standard 4 h dialysis.
Part 6: General conclusions
By conducting the dierent computational and experimental studies, we
could conclude with the following statements:
• e main pressure drop in the AVF circuit should be over the anasto-
mosis.
• Using a helical pattern in the design of an AVG introduces a more
complex ow eld and reduces, but does not delete, zones with unfa-
vorable hemodynamic conditions.
• e VectorFlow CVC outperforms standard catheters due to the neg-
ligible recirculation.
• e pulse wave propagation model and the high ow CFD solver, de-
veloped in the ARCH-project, are experimentally validated and can
be used for further clinical implementation.
• Experimental lab work needs experienced researchers.
• Pulse pressure analysis at the arterial needle can be used to detect
stenoses in early stage.
• Standard pulsed wave Doppler ultrasound measurements cannot es-
timate reliable blood ow rates.
• Reversing connection lines is the best alternative for a dysfunctional
double lumen CVC during standard (4 h) dialysis.
• Low-ow dialysis with double lumen CVC, or dialysis with single lu-
men CVC or single needle with an AVF, are considerable alternatives
during extended (8 h) dialysis.
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Introduction
Rationale
is dissertation gathers the research performed over the last six years all
relating to one of the three types of vascular access for hemodialysis: arterio-
venous stula (AVF), arterio-venous gra (AVG) and central venous catheter
(CVC).
e rationale of this dissertation was to broaden the knowledge on (the
design of) all three types of vascular access for hemodialysis, with the
goal to optimize vascular access patency and, with it, hemodialysis e-
ciency.
To be more specic, we tried to answer following research questions:
• Creating a too small arterio-venous stula anastomosis reduces the
chance of proper stula maturation. Should it not be preferable to
create, in all cases, a large (cross-sectional area) anastomosis?
• e ultimate aim of the pulse wave propagation model coupled with
results from the highowcomputational uid dynamics (CFD) solver,
established in the ARCH-consortium, is to assist the surgical decision
making in clinical practices. What can we learn from an in vitro vali-
dation?
• Can stenoses be detected by pulse pressure analysis and what are the
advantages of this method?
• Can blood ow be adequately estimated based on standard pulsed
wave Doppler ultrasound measurements?
• Does introducing a helical pattern in the design of an arterio-venous
gra reduces unfavorable hemodynamics?
• What are the improvements of the VectorFlow catheter compared to
standard designs?
• What are the alternatives for dysfunctional double lumen central ve-
nous catheters during standard (4 h) dialysis treatment?
• Which dialysis alternative(s) should be considered during extended
(8 h) dialysis?
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Introduction
Overview
is manuscript consists of six main parts. Part 1 provides the reader with
the necessary clinical background to understand the studies described in
this work. Part 2 deals with some engineering-technical topics: a general
description of uid and uid-mechanical principles and a discussion on the
used experimental and computational methods.
Next, all experimental and computational studies are addressed, grouped
by type of vascular access. Part 3, dealing with the arterio-venous stula,
starts with a computational study on the ow in AVF anastomoses, chang-
ing anastomosis size and angle. Next, two studies dealing with experimental
(in vitro) validation of computer models are described.e nal chapter of
this part deals with two diagnostic tools: stenosis detection by pulse pres-
sure analysis and ow rate estimation by pulsed wave Doppler ultrasound
acquisition. In part 4, arterio-venous gras with a helical design are stud-
ied. Part 5 gathers the studies on central venous catheters. First, the ow in a
novel catheter design, with a symmetrical tip, is studied. And second, three
studies, all based on the coupling of a kinetic model with a dialyzer model,
highlight the dierences in adequacy of dierent CVC dialysis treatments.
Finally, part 6 contains the general conclusions based on nine research
statements.
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Basic anatomy and physiology
1.1 Cardiovascular system
Figure 1.1: Cardio-
vascular system contain-
ing blood vessels and
heart.
e cardiovascular system includes the heart and
all blood vessels (Figure 1.1).e heart can be seen
as a pulsatile pump, pumping the blood to the or-
gans, tissues and cells and consisting of four cham-
bers. e le part of the heart contains the oxy-
genated (arterial) blood, the right part the deoxy-
genated (venous) blood. e blood is collected
from the systemic or pulmonary circulation in the
atria and is pumped into the arteries by the ventri-
cles. A schematic representation of the heart, with
arrows indicating the blood ow path is shown in
Figure 1.2.
e blood vessels can be split into ve major
types: arteries, arterioles, capillaries, venules and
veins. e arteries can be seen as muscled vessels
with a thickwall (≈ 1mm) andwith diameters from
2.5 cm (proximal aorta) to 1 cm (e.g. upper arm) or
even to about 0.3 cm (e.g. lower arm). e mean arterial pressure is most
oen around 100mmHg. e arterioles cover the vessels with a diameter
ranging from 0.3mm to 10 µm. e capillaries on the other hand are the
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Vena cava Inferior
Figure 1.2: Schematic representation of the heart.
smallest vessels in the body. ese have a diameter of around 8-10 µm, the
size of a red blood cell (Table 1.1).e capillaries can be seen as the driveways
which provide direct access to nearly every cell in the body. Furthermore,
they are ideally suited, because of their very thin wall (0.5 µm), for exchang-
ing gases, nutrients, hormones, etc. from the blood to the interstitial uid.
Venules are the venous counterpart of the arterioles with a diameter between
8 and 100 µm. When the venules join, they form veins. Veins are relatively
thin walled (0.5mm) with a transmural pressure around 5-10mmHg and up
to 65% of the total blood volume in the body [1].
Blood consists of mainly three dierent types of cells (see Table 1.1). It is
generally well accepted that the red blood cells (RBC) are the only ones to be
taken into account when explaining the macroscopic rheological properties
of the blood. Nevertheless, in the capillary bed, white blood cells (leuko-
cytes) and blood platelets (thrombocytes) may play an important role too.
Type of cell Volume fraction Dimension (µm) Number/mm3
Erythrocytes (RBC) 0.45 8 4 to 6 (106)
Leukocytes 0.01 7 to 22 4 to 11 (103)
Platelets 0.01 2 to 4 2.5 to 5 (105)
Table 1.1: Parameters of cell types in blood.
A red blood cell can be considered as a bi-concave, very exible disc,
see Figure 1.3 (le). e RBC can be deformed to a high extent. is de-
formation occurs when the cell is exposed to a shear stress (denition in
4
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Normal RBC
Deformed RBC
Figure 1.3: Deformation of red blood cells when exposed to an increasing shear
force [2].
Chapter 8), as seen in Figure 1.3 (right). In the case of high shear stress with
a low residence time or low shear stress with a high residence time, the rup-
turing of RBCs might take place. Which, in its turn, leads to the release of
hemoglobin, also known as hemolysis.
1.2 Kidney
e two kidneys are located in the posterior part of the abdomen, below the
peritoneum, on each side of the vertebral column. ey account for about
22%of the total bloodowand are therefore, under physiological conditions,
the organ with the highest blood supply [3]. Each adult kidney weighs about
150 g and has the size of a clenched st.
e primary function of a kidney is removing toxic by-products of the
metabolism and other molecules smaller than 69000Da1 by ltration.ey
also regulate body uid composition and volume, and control the electrolyte
balance (K, Cl and Na).e kidneys also have an endocrine function.ey
produce hormones including renin and erythropoietin (EPO) and are thus
contributing to the regulation of the blood pressure and the RBCproduction
[4].
1.3 Upper extremity
In the scope of this work on vascular accesses for hemodialysis, the vessels
in the upper limbs (shoulder to arm) are the most important. An overview
of the arterial and venous vessels involved in this research/clinical topic can
be found in Figure 1.4 and Figure 1.5, respectively. At the heart side, the
1One Dalton is dened as one twelh of the rest mass of an unbound neutral atom of
carbon-12 in its nuclear and electronic ground state (1.66 10−27 kg)
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blood to the arm is delivered from the aorta to the subclavian artery over
to the axillary artery. e arterial network in the arm can be simplied to
the brachial artery in the upper arm and the radial (thumb side) and ulnar
artery in the lower arm to the palmar arch in the hand. For the venous tract,
the main vessels are the cephalic vein in both lower and upper arm and the
median cubital, the basilic and axillary vein in the upper arm. e venous
tract can be completed towards the heart by the subclavian, external jugular
and internal jugular vein up to the superior vena cava.
It is estimated that under normal physiological conditions, around 2-3%
of the total blood supply is distributed towards one arm.is is similar to the
blood supply directly to the heart muscle, but is very low when comparing
it to values for other direct branches of the aorta such as the brain or the
kidneys with respectively around 14% and 22% of the blood supply [3].
6
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Figure 1.4: Arterial anatomy of the upper extremity [1].
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Figure 1.5: Venous anatomy of the upper extremity [1].
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From a failing kidney to the need
for a vascular access
2.1 Chronic Kidney Disease (CKD)
As stated by Levey et al., chronic kidney disease (CKD) is a world wide pub-
lic health problem, with adverse outcomes of kidney failure, cardiovascular
disease and premature death [5]. CKD can be classied into 5 stages from
patients with damaged, but still normally functioning kidneys (CKD1) up to
patients with total kidney failure in the urgent need of a renal replacement
therapy (CKD5).e latter group, representing approximately 2%of all CDK
patients [6], are oen called end-stage renal disease (ESRD) patients [5, 7].
Severe loss of kidney function is a threat to life and requires removal of
toxic waste products and restoration of both body uid volume and com-
position. ESRD results from progressive chronic renal impairment (CKD1-
4) or unrecovered acute renal failure. Without renal replacement therapy
(RRT), death from metabolic derangement follows rapidly.
e cost of ESRD patients for health care should not be underestimated.
Approximately 6% of Medicare’s (US) overall budget is required despite a
prevalence of just 0.17% (year 2009) [8]. e incidence of patients with
ESRD is expected to rise by 5-8% annually, with an average of 200 incidence
patients per million population in Flanders and 122 in the Netherlands (Jan-
uary 2009) [9–12]. is rise in ESRD worldwide most probably reects the
9
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global epidemic of type 2 diabetes and the aging of the population in devel-
oped countries, so a higher incidence in elderly people [6]. At the end of
2009, 7 110 ESRD-patients were in Flanders on RRT (prevalence) [12]. e
evolution of ESRD-patients on RRT in Flanders is visualized in Figure 2.1.
It can be estimated that nowadays over 2 million patients worldwide are de-
pending on RRT [10, 11].
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Figure 2.1: Prevalence of ESRD-patients in Flanders on a RRT (renal transplanta-
tion (Tx), peritoneal dialysis (PD) or hemodialysis (HD)), on the 31th of December.
Note: Patients below the age of 20 were not reported in the ERA-EDTA Registry.
(Data from ERA-EDTA annual reports 2004 to 2009, as referred in [12])
2.2 Renal Replacement Therapy (RRT)
ree commonly used techniques for renal replacement therapy are: renal
transplantation (Tx), peritoneal dialysis (PD) and hemodialysis (HD). Tx
can be seen as an acute RRT compared to the more chronic peritoneal dial-
ysis and hemodialysis therapies.
2.2.1 Renal Transplantation (Tx)
e most optimal therapy for ESRD patients is receiving a transplant kid-
ney from a deceased or living donor. Major complications are transplant re-
jection, infections and sepsis due to the immunosuppressant drugs that are
required to decrease the risk of rejection. Donors sharing as many Human
Leukocyte Antigens (HLA) as possible and, although non-ABO-compatible
donation is possible, having the same ABO blood group with their recipient
lead to an optimal transplant outcome. However, the biggest drawback for
10
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transplantation is the fact that the number of donors cannot keep up with
the number of transplant candidates.
e latest data (December 2010) of the Eurotransplant International
Foundation1 (EU) and of the National Institutes of Health (US) state, re-
spectively, that there is a kidney waiting list of 10 800 and 50 000 active2
patients [13, 14].e European and United States organizations report 5 000
and 17 000 transplants each year and that 2 years aer listing 53.4% and 51.3%
of the patients are still waiting for a transplant. e evolution of the Euro-
transplant activewaiting list and transplant numbers are shown in Figure 2.2.
In 2010, 3 705 patients received a kidney from a deceased donor and 1 262
received a kidney from a living donor (55% of them from a family related
donor); for Belgium, these numbers are 404 and 49, respectively.e most
recent numbers (2011) on kidney transplants from deceased donors show a
20% increase (up to 485) and a kidney waiting list of 837 patients for Bel-
gium3.
In Figure 2.2, you can see clearly that the number of needed kidneys (pa-
tients on active waiting list) cannot be covered by the number of transplants.
e graph shows that since 2000 the number waiting patients is decreasing
and the number of kidney transplants (living and deceased donors) steadily
1Including a selection of hospitals from Belgium, Germany,e Netherlands, Austria,
Luxembourg, Slovenia and Croatia.
2Inactive candidates are considered to be temporarily unsuitable by their transplant cen-
ter as transplant candidates (not transpantable).
3http://www.eurotransplant.org/
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Figure 2.2: Patients on a kidney transplant waiting list compared to the number of
kidney transplants from deceased and living donors as registered by Eurotransplant
International Foundation from 1980 to 2010 [13].
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increasing. us, the increase of the transplants is more than the increase
of registrations on the waiting list. Note that one has to take into account
that not all patients needing dialyzes are put on the waiting list and that this
might have an inuence on the decrease as well. e percentage of ESRD-
patients in the dierent Eurotransplant countries not suitable for Tx is not
known [personal communication].
ough transplantation is the best treatment, patients usually have to
start with dialysis, due to a shortage of organs. Next to these patients on the
waitinglist, a number of ESRD patients, not suitable for transplantation, are
treated chronically with dialysis.
2.2.2 Peritoneal Dialysis (PD)
In peritoneal dialysis, a catheter is placed in the patient’s abdomen through
the skin. A bag of water-based electrolyte solution (containing i.a. sodium
and glucose) is connected to the peritoneal catheter and drained into the
peritoneal cavity by gravity. e process uses the patient’s peritoneum in
the abdomen as a membrane to exchange uids and dissolved substances
(electrolytes, urea and other small molecules) with the blood. When the
dialysis is nished (4-6 hours), the uid is drained back into a bag, which
is then disconnected and discarded (Figure 2.3).is technique, which uses
only gravity, is called continuous ambulatory peritoneal dialysis (CAPD).
Around four uid exchanges are used every day. Another method is called
automatic PD (APD). Here, a machine refreshes uid from the peritoneal
cavity automatically for an 8-12 hours period. Patients use this system (APD)
every night to avoid changing bags during the day (CAPD). APD has been
considered to have several advantages over CAPD such as reduced incidence
of peritonitis and mechanical complications [15]. However, the solute re-
moval for CAPD seems larger than for APD [16].
Dialysis (fresh - waste) DrainingInfusion
Figure 2.3: Schematic representation of peritoneal dialysis treatment.
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In 2004, 11% of dialysis patients worldwide were receiving PD [10]. In
Europe, in 2009, 6% of RRT patients had PD.e number of PD patients on
APD was reported as 63% [12].
2.2.3 Hemodialysis (HD)
A third option as RRT is hemodialysis. In this chronic therapy, blood is
taken from the patient using a vascular access (VA) and is sent through an
extracorporeal circuit where waste products (e.g. urea) and water are re-
moved from the blood in a hemodialyzer (articial kidney). e puried
blood ows on towards the VA of the patient. More details can be found in
Figure 2.4.e hemodialyzer succeeds in purifying the blood and extracting
the excess water due to basic transport phenomena, such as diusion, ultra-
ltration, and osmosis. For that reason the hemodialyzer can substitutemost
of the (failed) kidneys’ function, but administering EPO to the patients on
dialysis is needed. A general hemodialysis treatment takes about 9-15 hours
a week, mostly spread over three (half day) sessions. An alternative is hav-
ing several night sessions (e.g. 3 times 8 hours) a week. It can take place in
a hospital, a low care unit or at home. Nowadays, thousands of people with
irreversible renal failure are being treated for 15 to 20 years by hemodialysis.
Despite the widespread use of peritoneal dialysis, hemodialysis remains
themain renal replacement therapy inmost countries [10]. Inwestern coun-
tries over 90% of all patients on a chronic RRT are depending onHD [12, 17].
At the end of 2009, 3 784 patients were receiving HD in Flanders (Figure 2.1)
[12]. In Europe, it is estimated that, nowadays, more than half-a-million pa-
tients with end-stage renal disease are treated with hemodialysis [9–12].
Since dialysis cannot completely maintain the normal body uid com-
position and cannot replace all the functions performed by the kidneys, the
health ofHDpatients usually remains signicantly impaired. Despite signif-
icant advances in the understanding of the biology of chronic kidney disease
and the risk factors for poor outcome on HD, and improved dialysis tech-
nology, the annual mortality in HD patients remains as high as 15% to 25%
worldwide [18].
2.3 Vascular Access (VA) for hemodialysis
If hemodialysis is the chosen RRT, the most essential ingredient for long-
term success is a reliable vascular access that can achieve a blood ow in
excess of 600ml/min [19]. Vascular access remains the lifeline for ESRD pa-
tients treated by chronic HD, and a major source of ESRD morbidity, mor-
tality and hospitalization, with annual costs in the United States in excess of
13
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Figure 2.4: Schematic overview of hemodialysis treatment.
1.5 billion US dollar in 2007 [20]. VA procedures and complications account
for over 20% of hospitalizations of dialysis patients [21].
e challenge to achieve successful vascular access grows as the dialysis
population has an increasing proportion of diabetic, elderly and hyperten-
sive patients, many with serious cardiovascular comorbidities. For example,
in 2009, 44.5% of the patients on HD in the US were diabetic, 44.6% were
older than 65 years and 28.8% were hypertensive [17].
According to the EBPG4 (European) [22] and NKF-K/DOQI5 (Amer-
ican) [19] guidelines for vascular access, an adequate pre-operative assess-
ment of the patient is essential, including patient history and physical exami-
nation, clinical evaluation bymeans of duplex ultrasonography of the upper-
extremity arteries and veins, and central vein evaluation. Next to the impor-
tance of surgical planning, the timing of the referral of potential chronic HD
patients to the nephrologist and/or surgeon is crucial. e optimal referral
4European Best Practice Guidelines
5National Kidney Foundation - Kidney Disease Outcomes Quality Initiative
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timing for preparing a vascular access is when patients reach stage 4 of their
CKD (CKD4) [19, 22].
As stated by Kjellstrand, as early as 1978, the vascular access remains the
‘Achilles’ heel’ of chronic hemodialysis therapy [23, 24].
e three main options in vascular access for HD are the arterio-venous
stula (AVF), the arterio-venous gra (AVG) and the central venous catheter
(CVC).
15

C
h
a
p
t
e
r
3
Arterio-Venous Fistula (AVF)
3.1 General
An Arterio-Venous Fistula (AVF) is an autologous direct connection, cre-
ated by a surgeon, between an artery and a vein.is anastomosis connects
the high pressure arterial circuit to the low pressure venous circuit.e nor-
mal high resistance pathway, the capillary bed, is bypassed. e increased
ow and pressure in the venous segment initiates the maturation process.
Both vessel remodeling (i.e. dilation) and ow increase are essential in order
to use the stula as vascular access.e dilation of the vein is needed to be
cannulated by large needles (eg. 15G. needles). e ow increase is needed
to perform an ecient hemodialysis treatment [19, 21, 25, 26]. Generally de-
ned, a stula is mature when it can be routinely cannulated by two needles
and can deliver a minimum blood ow (typically 350-450 ml/min) for the
total duration of dialysis, usually 3-5 h for high eciency hemodialysis [27].
e rst AVF reported in literature was one in 1966 created surgical side-
to-side radial artery to cephalic vein stula by surgeon Dr. Kenneth Appell
of the team of Dr. James E. Cimino and Dr. Michael Brescia [28, 29] (Fig-
ure 3.1).is stula is called the Cimino or Cimino-Brescia stula and is still
the basis of the currently created AVFs.
It should be possible to cannulate anAVF reproducibly.e access should
deliver a high enough access blood ow (≥ 600ml/min) to deliver an ade-
quate dialysis dose [30, 31]. A preoperative ultrasound screening to deter-
mine adequate arteries and veins to create an AVF and postoperative ow
17
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Figure 3.1: Cimino-Brescia shunt as described in the original paper (le: surgical
connection; right: double needle puncturing) [28].
measurements to monitor maturation are a standard procedure [32, 33] and
is advised by both the EBPG and NKF-K/DOQI guidelines [19, 22].
Most common locations to create an AVF are the lower and upper (non-
dominant) arm, with the preference of choosing the position as distal as
possible.is to preserve more proximal locations for future interventions.
Although there exists a large number of variations in AVFs in the arm, three
of the most common locations are shown in Figure 3.2.
AnAVF can be seen as a 7 segment circuit, as schematically illustrated in
Figure 3.3, consisting of the proximal artery (1), the distal artery (2), arterial
collaterals (3), the proximal vein (4), the distal vein (5) and venous collaterals
(6), added with the anastomosis itself (7).
3.2 Complications
emain complications leading toAVF failure are thrombosis (44%) and the
overall failure tomature (23-46%) [36, 37]. An overview of the complications
and their required treatment are listed below.
3.2.1 Infection
Wound complications, as infection, tend to occur early following the access
creation. When not treated properly and eectively, it can lead to VA failure
[38]. e infection of autologous stulas (AVFs) is rare compared to the
prosthetic gras (AVGs, Chapter 4) [39].
18
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Figure 3.2: ree dierent AVF congurations: Radio-cephalic; Brachio-cephalic
and Brachio-Basilic transposition [21].
3.2.2 Non-maturation
Aer the creation of an AVF, changes in hemodynamics and on anatomic,
molecular and functional level occur. e most important factor in stula
maturation is the response of the feeding artery and the draining vein to the
increase in shear stress (denition in Chapter 8) that occurs following the
AVF creation [40]. At a physiological level, this increase generally results
in a dilation of the vessel with a reduction of neo-intimal hyperplasia (ben-
ecial remodeling) [41]. is shear-stress-mediated dilation decreases the
level of peak shear stress back to the preoperative situation [42], while the
mean shear stress increases signicantly. Next to the shear stress, the vessel
wall responds to the increased transmural pressure by vessel wall thicken-
ing. So this medial hyperthrophy (growth of the media layer of the vessel) is
a necessary step in the maturation process in contrast with the neo-intimal
hyperplasia (growth of the intima layer of the vessel, stenosis formation) due
to shear stress unfavorable conditions which hamper the maturation. Non-
maturation can therefore occur due to dierent reasons:
1. An insucient increase in ow directly postoperative: It is shown
that AVFs with an initial, directly postoperative blood ow rate be-
low 400ml/min fail to mature in the majority of cases [26]. is in-
19
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Figure 3.3: Seven segment AVF circuit: Proximal artery (1); distal artery (2); ar-
terial collaterals (3); proximal vein (4); distal vein (5); venous collaterals (6) and
arterio-venous anastomosis (7) [34, 35].
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sucient increase in ow can be due to a blockage of the arterial in-
ow path or the venous outow path by a stenosis (see Section 3.2.4)
or might even be linked to the skills of the surgeon (vessel handling,
kinking, tortion, endothelial injuring) [41]. is can even lead to an
early thrombosis (total blockage of the ow path). e increase in
blood ow can also be hampered by an inadequate construction of
the anastomosis itself (e.g. a too small anastomosis opening). To
overcome these problems, percutaneous intervention is indicated for
any stenosis and surgical intervention can be performed if necessary
[22, 39].
2. A failure of arterial and venous dilation: e ‘quality’ of the vessels
can be dominant, where non-compliant arteries and veins (preop)will
probably lead to non-dilation aer AVF creation. Increasing age (cal-
cication of vessels), female gender, diabetics and presence of periph-
eral or coronary diseases are predictive to the non-maturation [41].
Also multiple venous puncturing before AVF creation can decrease
the chances for non-maturation.
As shown in Figure 3.4, the stulamaturation is themost dicult hurdle
to overcome when a stula, ready to cannulate, is required. Radiological or
surgical interventions to correct the underlying lesion, have been reported
to convert an immature stula to one that is usable for dialysis in 44 to 97%
of cases [30].
3.2.3 Ischemia or hypoperfusion syndrome
When constructing an AVF, a ‘preferential’ ow path of low resistance is
created. is can lead to a decrease in blood ow to the distal parts of the
arm (towards the hand), which is called steal syndrome. For the majority
of radio-cephalic stula (lower arm), there is a 40% decrease in blood pres-
sure in the thumb and in 70% of the cases the ow in the radial artery is
retrograde [38]. Although ‘steal’ appears in a large number of cases, it does
not always lead to complications as hypoperfusion or ischemia. Hypoper-
fusion is a general lack of oxygen supply, ischemia is the full obstruction of
oxygen, thus blood, supply and can even result in nger gangrene (necrosis
of the tissue). In Figure 3.5, you see an example of a hand suering from
ischemia (top-right), the same patient’s hand aer the ligation of the stula
(bottom-right) and a CT-reconstruction of the patient’s vessel bed (le).
Upper arm AVFs are more likely to develop critical ishemia symptoms
(10-25%) than lower armstulas (1-1.8%) [44]. Other risk factors are increas-
ing age and diabetes [45]. Causes of ‘steal’ and ishemia are oen a stenosis
in the distal artery (see section 3.2.4) or a too low pressure drop over the
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Figure 3.4: e ‘stula hurdle’. Several hurdles must be overcome successfully to
ensure that a patient initiates dialysis with a mature stula. ese include early
referral of patients with chronic kidney disease to a nephrologist, stula placement
well before reaching ESRD, adequate stulamaturation, and successful cannulation
of the stula by the dialysis sta [30] .
anastomosis, resulting in a huge stula ow. When a too large anastomosis
is created, to avoid non-maturation due to low ow for example, the ow in
an upper arm AVF can be up to 1 or 2 l/min.
ere are multiple options to decrease this high ow condition: Distal
Revascularization-Interval Ligation (DRIL) [46–48], Proximalization of the
Arterial Inow (PAI) [49], Revision Using Distal Inow (RUDI) [50] all to
create a longer ow pathway, narrowing of the initial draining vein at the
anastomosis side (banding) [51–53], and even creating an articial stenosis
in the draining vein [54].
All these solutions aim to increase the AVF ow resistance. is in-
crease reduces the access ow and/or increases the pressure in the distal
arteries. More care for the patients personal preoperative vasculature and
taking more care to the anastomosis size during VA creation would, in my
personal opinion, lead to fewer of these problems [34].
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Figure 3.5: Le: Computed Tomography (CT) angiogram 3-D reconstructions re-
vealing grossly dilated AVF, minimal arterial supply to the le hand, and venous
dilation along the le brachial plexus; Top-right: Le hand ischemia; Bottom-right:
Return of muscle mass, 3 months aer ligation of the high-ow stula [43].
3.2.4 Stenosis formation and thrombosis
Asmentioned in the section on non-maturation, neo-intimal hyperplasia or
growth of the intimal layer of the vessel is mostly due to a decrease in shear
stress. In addition to the absolute magnitude of the shear stress, the specic
pattern over time plays an important role as well. An oscillatory shear stress
oen results in a pro-inammatory state with an increase in cellular prolif-
eration [41, 55, 56]. Methods to quantify this will be discussed in Section
8.3.4.
e EBPG and NKF-K/DOQI guidelines dene a stenosis if the growth
of the vessel wall to the inside lumen is more than 50% of the vessel diam-
eter (75% of the vessel area) [19, 22]. Next to these hemodynamic factors,
surgical injury, the cannulation with dialysis needles, surgical stress and an-
gioplasty initiate neo-intimal hyperplasia formation, might result in stenosis
formation (Figure 3.6) [41].
e most common locations for stenosis formation in AVFs are shown
in Figure 3.7. Obstruction of the vessel by a stenosis can be treated by Percu-
taneous Transluminal Angioplasty (PTA, balloon dilation), stent placement
or by a surgical procedure.
23
3. Arterio-Venous Fistula (AVF)
Figure 3.6: Stenosis formation: from pathogenesis to pathology (adapted from
[41]).
Figure 3.7: Stenosis locations [57].
3.2.5 Venous hypertension
When the major pressure drop is not over the anastomosis but over a prox-
imal venous stenosis, venous hypertension may occur. e entire limb can
get swollen or a large aneurysm may develop.
3.2.6 Cardiac failure
Cardiac failure is a condition in the structure or function of the heart that
impairs its ability to supply sucient blood ow to meet the body’s needs.
Although not a short term complication, heart failure is the most common
cause of death in the dialysis population, being responsible for 45% of all
fatalities.
24
3.3. Devices
High-output cardiac failure is a rare complication, which occurs in pa-
tients with a high-ow stula. It has been estimated that cardiac failure oc-
curs when 20-50% of the cardiac output ows through the anastomosis [38].
Treatment usually involves sacricing the stula, although banding might
be an option [39].
3.3 Devices
In the eld of autologeous stula creation, new product design seems a ‘con-
tradictio in terminis’, however, one company found a device in the eld of
arterio-venous stulas. e Optiow was created by Bioconnect Systems,
inc. (Ambler, PA, USA) and is shown in Figure 3.8. e device replaces
the hand-sewn suturing for AVF creation. It is stated that the device intro-
duces a ‘laminar’ ow path to ‘optimize’ hemodynamics and provides a me-
chanical scaold to avoid peri-anastomotic stenoses. Aer pre-clinical test
on porcine AVFs, a preliminary clinical study on 54 patients in four coun-
tries was performed. e outcome of the study showed a 82% unassisted
primary patency1 aer 90 days, which is favorable when compared to pub-
lished unassisted primary patency rates of 70% [37, 58]. e device is still
under investigation and not yet for sale.
Figure 3.8: Optiow by Bioconnect Systems, inc. (Ambler, PA, USA)
1denition in Section 6.2
25

C
h
a
p
t
e
r
4
Arterio-Venous Grafts (AVG)
4.1 General
Oneof the rst vascular access creation techniqueswas the Scribner-Quinton
shunt in the 1960s [59]. is is a technique where one connected an artery
to a vein, in the lower arm, by means of an external Teon tube (Fig. 4.1).
is rst Arterio-Venous Gra (AVG) as vascular access opened the era of
chronic hemodialysis treatment. e most common problems associated
with this VA were clotting, systemic infections, necrosis at the Teon tubing
exit sites, dislodgement of the shunt resulting in severe blood loss and, last
but not least, severe patient anxiety [29].
In the 1970s, aer the introduction of the Cimino-Brescia AVF, the syn-
thetic gra of PTFE (polytetrauoroethylene) (Gore-Tex,W.L. Gore&Asso-
ciates, Elkton, MD, USA), became popular, especially in the US. Popularity
was growing fast because these AVGs were easier and faster to place and did
not suer from non-maturation complications as AVFs do.
Nowadays, an AVG is placed fully beneath the skin in loop congura-
tion (Figure 4.2) and consists mostly out of expanded PTFE (ePTFE).e
most common designs are the straight and the tapered version. However,
no clinical or computational results were found showing a dierence in per-
formance or patency of the tapered versus the straight version [60, 61].
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Figure 4.1: Scribner-Quinton (external) shunt [29].
Figure 4.2: Brachial artery to cephalic vein loop gra (adapted from [35]).
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4.2 Complications
AVGs suer more from stenosis formation, clotting and infections com-
pared to AVFs.
Although infections are more common in AVGs than in AVFs, it is the
appearance of a thrombosis that accounts for approximately 70-80% of gra
failures [30, 36].rombosed gras usually nd their origin in an underly-
ing stenosis, most oen at the venous anastomosis or in the draining vein
[30]. As for AVFs (Section 23), stenoses are most likely to occur on loca-
tions with low shear stress, or disturbed ow and shear patterns (oscillatory
shear for example). Stenoses at the arterial anastomosis or in the gra itself,
caused by chronic brin and cellular deposits, are more rare [62].
A lot of gra surveillance programs are ongoing in the dialysis centers,
ranging from stenosis detection by physical examination (palpation) to doc-
umentation of the (increasing) intra-access pressure or the (decreasing) ow
rate. Although the number of angioplasty interventions increased when in-
troducing a surveillance program, the overall thrombosis-free survival did
not dier [30]. One of the explanations might be that a stenosis aer angio-
plasty develops faster (re-stenosis) compared to a de novo access stenosis.
is is due to the vascular injury due to the angioplasty itself [63]. Even with
stents, it is needed to repeat the interventions to prevent the re-occlusion of
the access [64]. It seems that a pharmacological approach might prevent
neointimal hyperplasia more eectively [30].
4.3 Devices
In the eld of arterio-venous gra, in contrast to the autologous stula, a lot
more new technology is applied.e new devices on themarked can be split
in two groups: those related to the material of the gra and those related to
the geometry of the gra or the anastomoses.
4.3.1 New materials
Firstly, a large number of companies are producing new materials based on
PTFE, for example:
• Carbon-impregnated gras by C.R. Bard, Inc. (MurrayHill, NJ, USA)
for reduced platelet deposition and thrombosis formation.
• Centerex design by C.R. Bard, Inc. to reduce kinking.
• Gel-impregnated vascular gras by Atrium Europe B.V. (Manchester,
UK) to lower the porosity making it more blood tight.
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• Film lamination process by Atrium Europe B.V. to reduce kinking and
compression resistance for improved surgical handling and minimal
needle hole bleeding.
• No-prole radial support by Gore-Tex (W.L. Gore & Associates, Elk-
ton, MD, USA) to reduce kinking.
Secondly, more ‘exotic’ new material designs (compared to the historically
used silk, vinyon, Dacron, and later PTFE and expanded PTFE (ePTFE)) are
investigated and produced [8], for example:
• Treated xenogeneic or allogenic conduits (e.g. artery from a pig).
• Cell-seeded biodegradable scaolds [65].
• Tissue-based gras grown in vivo using the recipient’s body as an au-
tologous bioreactor (not (yet) in humans) [66].
• ‘Self-assembly approach’, where completely biological gras are grown
in vitrowithout the aid of any exogenous biomaterials or scaolds, for
example the LifeLine Vascular Gra (Cytogra Tissue Engineering,
inc, Novato, CA, USA).
4.3.2 New geometry concepts
e devices, working on the geometry of the gras or the anastomoses, all
aim to create more favorable hemodynamics and thus reducing the intimal
hyperplasia growth and inhibiting stenosis formation and thrombosis oc-
currence. Five designs are described hereaer in detail:
Hooded or cued gra
e Venao gra by C.R. Bard, Inc. (Figure 4.3) and the Flixene Trumpet
vascular gra byAtriumEurope B.V. (Figure 4.4) are based on the same prin-
ciple. e local hemodynamics at the venous anastomosis are changed to
avoid regions with unfavorable wall shear stress patterns. is is examined
earlier in a CFD study [67]. It is shown clinically that the patency rates in-
crease [68] and the stenosis formation (intimal hyperplasia) is reduced [69].
Helical design
e SwirlGra was created by VeryanMedical (Horsham,West Sussex, UK)
and is based on the so called SmallAmplitudeHelical Technology (SMAHT).
e gra was based on a ‘Helical gras’ patent by Caro et al. [70] and is
shown in Figure 4.5. It was expected that the helical design would lead to a
swirling ow and in-planemixing. As a result of this, a relative uniformwall
shear stress was expected with inhibition of ow stagnation, separation and
instabilities at the venous anastomosis to reduce stenosis formation.
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Figure 4.3: Venao gra by C.R. Bard, Inc. (Murray Hill, NJ, USA)
Figure 4.4: Flixene Trumpet Vascular Gra by Atrium Europe B.V. (Manchester,
UK)
e groups of Caro and Sherwin previously studied to a great extent
the inuence of ‘out-of-plane’ geometries on the ow eld [71, 72] and are
since 2011 working on a helical stent design (BioMimics 3D Stent by Veryan
Medical) [73].
e early idea on SMAHT was studied in a preliminary work introduc-
ing arterio-venous helical designed gras in loop conguration in pigs.ey
showed a reduction in intimal hyperplasia occurrence [74]. Despite the ad-
dition of a small CFD and ow visualization (ink) analysis, no analysis of
the ow in the anastomotic region was studied yet [75].
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Figure 4.5: SwirlGra by Veryan Medical (Horsham, West Sussex, UK)
Apreliminary clinical trial on 20 patients showed a comparable primary
patency1 with numbers from literature and an improved secondary patency
[76]. In some cases, the gra however was stretched under the skin and
the helical geometry was reduced.erefore these gras were working as a
conventional gra.
Finally, Glickman [77] reported in 2009 that a prospective randomized
study of 180 patients had been conducted in the US. At that point a mean
follow up of 6 months was conducted comparing the SwirlGra with a stan-
dard ePTFE gra. An improved primary and secondary patency was found
(Figure 4.6), but to this day, no full data report was published.
Figure 4.6: Primary (le) and secondary (right) patency of SwirlGra compared
to standard ePTFE gra aer 6 months follow up in 180 patients [77].
1denition in Section 6.2
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Spiral ow
Tayside FlowSpiral byTayside FlowTechnologies Ltd (Dundee, UK) is based
on the concept of Spiral Laminar Flow (SLF). In this design, the manufac-
turer claims that a ‘laminar’ ow is created at the venous anastomosis gra
section and that ‘turbulent’ ow patterns are inhibited.ey claim that these
ow patters trigger ow mediated signals that lead to vascular remodeling,
such as intimal hyperplasia formation. Although their denition of ‘lami-
nar’ and ‘turbulent’ is not in line with the general uid dynamics denition
(see Section 8.3.1), the concept of delivering an ‘undisturbed’ ow pattern to
the venous anastomosis can be understood from their claim. e Tayside
Flow Spiral wants to restore the ‘natural’ swirling ow (Figure 4.7) as rem-
edy to stenosis formation.e design is in a way similar to the helical gra
of Veryan Medical. To date, no clinical studies comparing the outcome of
the Tayside gra have been reported, nor any technical nor scientic papers
were published.
Figure 4.7: Tayside Flow Spiral by Tayside Flow Technologies Ltd (Dundee, UK):
(A) Natural blood ow within a healthy artery; (B) Turbulent blood ow from a
non SLF gra; (C) Blood ow from a SLF gra
Tapered arterial design
is is a gra design reported by Krueger et al [78].is idea was proposed
not to reduce the stenosis formation at the venous anastomosis, as in the
previous examples, but to reduce the stenosis formation at the arterial anas-
tomosis.e latter being comparable to the stenosis at the AV-stula anas-
tomosis, shown in Figure 3.7.e in vitro design is shown in Figure 4.8 and
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they found that when applying a narrowed section at the gra entrance, the
oscillating vortex at the arterial lumen wall disappeared, potentially reduc-
ing stenosis formation at the arterial anastomosis.
Figure 4.8: Flow visualization in a tapered gra inlet (le) versus a conventional
gra inlet [78].
Complete venous anastomosis design
Flixene IFG by Atrium Europe B.V. is a gra in which the venous anastomo-
sis and part of the proximal and distal vein are included.erefore, a PTFE
T-shape section, with stent support, is added at the venous end of the gra
(see Figure 4.9).is compression resistant nitinol reinforced distal outow
section provides a faster implantation technique and smooth ow transition
into the vein. No clinical or scientic study has (yet) been published on this
concept.
Figure 4.9: Flixene IFG by Atrium Europe B.V. (Manchester, UK)
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Central Venous Catheter (CVC)
5.1 General
A Central Venous Catheter (CVC) is a tube with one or two lumens, to be
inserted in a central vein leading directly to the right atrium.is VA option
should only be applied when a temporary vascular access is needed (‘acute’),
for example duringAVFmaturation, or if noAVF norAVG can be created in
the patient (‘chronic’). A short-term CVC is intended to be placed only for a
short period and are easy to place, sti and placed directly over a guidewire
into the central vein. A long-term or permanent CVC however is soer and
is placed by means of ‘tunneling’. is to provide an access with a lower
infection rate.
e rst catheter was used as acute vascular access and introduced by
Shaldon et al. in 1961 [79]. ey introduced two separate single lumen
catheters in the femoral artery and the femoral vein. Later, introducing a
CVC in the vena cava superior was referred to as the ‘Shaldon catheter’ and
is mostly used as short term solution [80, 81].e rst to introduce a CVC
in the subclavian artery were Erben et al. in 1969 [82]. However nowadays,
this method is more and more abandoned because the risk of occlusion of
the subclavian artery by a stenosis at the cannulation site is over 40% com-
pared to 10% in the internal jugular vein [83].e introduction of a catheter
in the internal jugular vein is however technically more dicult because the
anatomical landmarks are less prominent [84]. e right internal jugular
35
5. Central Venous Catheter (CVC)
vein is preferred because it is generally larger than the le side and a more
direct course to the vena cava superior. Develter et al. showed that single lu-
men catheters in the right internal jugular vein resulted in signicantly bet-
ter survival compared to other insertion sites [85]. For immobilized patients,
the femoral vein can be used as insertion location due to its easy puncture
and low risk of injuring vital organs.is option should however be avoided
due to infection risk [86]. At rst, only single lumen catheters were used,
but in the early 1980s, catheters with two lumens were introduced [84].e
suction lumen is called the ‘arterial’ lumen and the other one the ‘venous’
lumen.
Nowadays, as a long-term catheter, a tunneled central venous catheter in
the right jugular vein leading its tip in the vena cava superior or right atrium,
as shown in Figure 5.1, is the preferable option.
Figure 5.1: CVC in internal jugular vein leading to the right atrium over the vena
cava superior [87].
5.2 Complications
emost common type of failure is due to inadequate dialysis blood ow (up
to 51%) [36]. When catheter dysfunction occurs immediately aer insertion,
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the placement itself is more likely to be the problem. However, most patients
initiate dialysis with a well functioning CVC, but aer a while, the aspiration
of the ‘fresh’ blood becomesmore andmore dicult. Most centers intervene
if themaximal blood suction rate decreases below 200ml/min [88].e un-
derlying problemmight be an intraluminal or extraluminal thrombus (brin
sleeve or sheath formation) (Figure 5.2) and/or the suction of the arterial lu-
men to the wall.e reduction of the dialysis blood ow is a more common
problem with dual-lumen than with single lumen catheters [88], this might
be due to the sequential arterial (suction of blood to the articial kidney)
and venous phase (returning the blood to the patient) of the same lumen in
single lumen catheter dialysis.
Figure 5.2: (a) Clot seen at the catheter tip of the Maxid catheter (Mahurkar type).
e clot is anchored in the distal side holes and extends into the catheter. (b)e
clot aer extraction from the catheter. A cast of the side holes is seen on the distal
clot [89].
Low catheter blood ows may be corrected by forceful aspiration and
ushing with a small syringe, changing the patient’s position or switching
the arterial and venous lines [30].is last option increases the recirculation
of the catheter.
e standard procedure to reduce intraluminal clotting is injecting a
volume of anticoagulant into the catheter for locking. Heparin and Cit-
rate are commonly used anticoagulants: e.g. solutions of 5000 IU/mL to
2500 IU/ml heparin, 4% to 30% of citrate or even combinations as the Tau-
roLock Hep500 (Tauro-Implant GmbH,Winsen, Germany) (anti-microbial
Cyclo-Taurolidine, 4% citrate and for the Hep500 series added with
500 IU/mL heparine) are used. Locking solutions might leak into the pa-
tient’s body and therefore, the amount of injected locking solution (i.e. equal
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or larger than the catheter volume) as well as the speed of injection are still
a matter of debate [90–92].
When the ‘mechanical’ measures to overcome the low ow in a catheter
are unsuccessful, malfunctioning catheters can be treated acutely by use of
a thrombolytic agent, mostly in an empirical way. If catheter malfunction
persists despite repeated thrombolysis and the ow is insucient to provide
an adequate dialysis dose, then the catheter should be exchanged, preferably
over a guidewire [30].
Catheters are also prone to frequent infection [30]. Where the infection
rate per 1000 days is 0.2 for AVFs and 1 for AVGs, the infection rate increases
to 2.4 for tunneled and even 6.5 for non-tunneled CVCs [86, 93]. It was cal-
culated that a one episode catheter-related blood stream infection increases
hospital cost between 11 000 and 54 000 US dollars [86].
5.3 Devices
5.3.1 Material design
e requirements for catheters are obvious but to some extent contradictory.
e internal lumen should be as large as possible to reduce ow resistance
while the overall size should be small. Although a thinner wall might be
preferable, the catheter should be resistant to kinking, cracking or breaking.
e catheter should be rigid enough during placement to slide easily over
a guidewire, but be so and exible to be able to bend in the subcutaneous
tunnel and avoid the tip to damage the lumen of the vein. Some catheterma-
terials such as polyurethanes have thermoplastic qualities, so they are more
rigid during placement, but once they reach body temperature they become
soer.emost commonly usedmaterials tomanufacture permanentCVCs
are polyethylene, teon, silicone, polyurethane and carbothane [94].
5.3.2 Sha designs
Asingle lumen catheter can be designedwith orwithout sideholes. Sideholes
should give the advantage of providing enough blood ow rate in case the
catheter tip is blocked. However, more and more disadvantages are rising,
such as an increasing risk of clot formation at the sideholes (as in Figure 5.2)
upon the blocking the full lumen diameter [95].
Concerning dialysis over two lumens, the rst option is using two single
lumen catheters next to each other aswith theTesio (Medcomp,Harleysville,
HA, USA) [96] or the Canaud [97] catheter. For double lumen catheters,
three general sha designs are present: the double-D design; the oval-shape
design and the concentric design. Figure 5.3 shows an example of the three
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designs with the same cross-sectional area. e double-D and the concen-
tric design have a lower overall circumference compared to the oval-shape
design.e volume to contact surface area is low for the concentric design
compared to the other designs. is has a negative impact on the ‘shear
rate’ acting on the blood and can cause additional shear stresses, pressure
drop and blood damage. erefore, the concentric design is not a reason-
able option. is was also shown in a computational study by Mareels et
al. [98]. e volume to contact surface area for the oval-shaped catheter is
lower compared to the double-D design, but the larger outer perimeter is a
drawback for the oval-shape.
Figure 5.3:ree catheters (Double-D, Oval-shape and Concentric) with the same
lumen total cross-sectional area [94].
5.3.3 Tip designs
Considering the tip design, a straight cut (both lumens have the same length),
a shotgun (bayonet or step-tip design with the arterial lumen shorter than
the venous lumen), a split design (both lumen tips separated from each
other) or a variation are in use. Because the occurrence of ow recircula-
tion from the venous to the arterial lumen is higher with the straight cut tip,
the use of a more distal arterial (suction) lumen as in the shotgun design
seems more appropriate.
Examples of shotgun tip designs can be found in Figure 5.4, with, for the
double-D design, the Mahurkar catheter (le) and, for the oval design, the
Quinton catheter (middle) as commercial example (Covidien, Dublin, Ire-
land). On the right side of Figure 5.4, a catheter tip starting with a round ve-
nous lumen evolving to a double-D design at the arterial inlet, commercially
available as DuraFlow or DuraMax (AngioDynamics, Latham, NY, US), is
shown.
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Figure 5.4: Examples of shotgun tip designs: (A) double-D as inMahurkar catheter
(Covidien, Dublin, Ireland); (B) oval-shape as in Quinton catheter (Covidien,
Dublin, Ireland) and (C) round tip with double-D lumen as in the DuraFlow and
DuraMax catheter (AngioDynamics, Latham, NY, US).
e Tal-Palindrome catheter (Covidien, Dublin, Ireland), reported by
Tal in 2005 [99] and shown in Figure 5.5, is a design somewhere between
the straight cut and the shotgun. e double-D catheter has two symmet-
rical lumens of the same length but orientated in opposite direction. is
design has the advantages of the shotgun design added with the fact that,
with switching the catheter ports (e.g. when one of the lumens get partially
blocked), the recirculation does not increase. Tal showed that the overall
recirculation is also signicantly lower compared to other designs (even the
split tip), no clinical data have conrmed this yet [99].
e split tip design, as shown for some commercial examples in Fig-
ure 5.6, combines the advantage of the double-D sha, the simple placement
of a single-body catheter and the multiple sideholes (similar to the Tesio-
design) [94, 100]. Mareels et al. showed that a catheter with split tip (Ash
Figure 5.5: Drawing of the tip of the symmetric Palindrome catheter [99].
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Figure 5.6: Examples of split tip designs: e Ash Split Cath (A) and Split Cath
III (B) by Medical Components, Inc. (Medcomp, Harleysville, HA, USA) on the
le and the Pourchez RetrO catheter (C) and HemoSplit XK (D) by C.R. Bard, Inc.
(Murray Hill, NJ, USA) on the right.
split) had the lowest arterial tip volume with a shear stress above 10Pa, but
the blood residence time at this location was higher [98].e Ash Split Cath
(Medcomp,Harleysville, HA,USA), launched in 1997, became the ‘gold stan-
dard’ catheter for hemodialysis by securing nearly 60% of the U.S. market.
To nalize this overview, the latest variation on the split tip design, the
Centros (Ash Access Technology inc., Lafayette, IN, US) is shown in Fig-
ure 5.7.is self-centering catheter was designed to avoid complete sheath-
ing of the catheter and therefore holding a portion of the catheter in themid-
dle of the vena cava. e lumen tips bend inward from the contact points
at the lumen wall. Side holes are not present because the lumen tips should
not be in contact with the vena cava wall and should therefore not become
occluded. A seven week study on nine patients showed an increased average
ow for the Centros compared to standard catheters [101].
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5. Central Venous Catheter (CVC)
Figure 5.7: Centros catheter (Ash Access Technology inc., Lafayette, IN, US) [101].
5.3.4 Catheter-gra combination
ere is a combination of a catheter and gra on themarket under the name
HeRO (Hemodialysis Reliable Outow) (Hemosphere, Inc., Eden Prairie,
MN, US) as shown in Figure 5.8. e device has a traditional arterial gra
anastomosis and to avoid the venous anastomosis complications in AVGs
(stenosis and thrombosis), the 6mm ePTFE gra is connected to a 5mm
(16Fr.) silicone outow catheter. e venous outow component is placed
in the central venous vasculature with the distal tip in the right atrium. A
clinical study [102] showed that the infection rate per 1000 catheter days was
reduced to 0.7, i.e. between the values for AVF andAVG.e device had also
similar patency rates compared to AVGs.
Figure 5.8: HeRO gra-catheter by Hemosphere, inc. (Eden Prairie, MN, US).
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6
Comparison between vascular
access options
6.1 Occurrence
e Dialysis Outcomes and Practice Patterns Study (DOPPS) has shown
large international variations in vascular access practices.e patients sur-
veyed1 used an arterio-venous stula in 66% of the cases in Europe, as com-
pared to 15% in the United States. A central venous catheter was used in 31%
in Europe as compared to 60% in the US. Physicians used an arterio-venous
gra in 2% of the cases in Europe as opposed to 24% in the US [103]. As
mentioned before, elderly, diabetics and female patients tend to have lower
quality native vessels, and therefore a lower patency of AVFs. is can be
seen in the prevalence of AVFs created in the examples shown in Figure 6.1.
Allon et al. state, aer reviewing the literature, that among patients who
are referred for their initial vascular access surgery, placement of a forearm
stula is feasible in only 40 to 50%. However, placement of an upper arm
stula is possible in an additional 25 to 35% of patients. us, some type of
stula can be placed in at least 75% of patients, with the remainder requiring
the creation of a gra [30]. So the numbers of stulas created in Europe are
in line with these ndings, while the large number of AVGs created in theUS
should be decreased. Aer the results of the DOPPS study were published,
1New access types from 1996 until 2000
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Figure 6.1: Arterio-venous stula (AVF) use among patients in Europe (EUR) and
theUnited States (US) for three dierent patient groups (n refers to the total number
of patients in the particular subgroup) [103].
the Fistula First Breakthrough Initiative (FFBI) was started in July 2003. At
the start of the DOPPS study, the prevalence rate of AVFs in the US was 24%
(80% for Europe)[103] and is now increased to 59.5% (August 2011) [104].
However, in recent years, the chronic dialysis population has become
substantially older, more likely to be female and diabetic, and has higher co-
morbidity. Many of these patients appear to have vessels of low quality for
construction of native stulas. erefore, it is expected that in Europe the
percentage of AVGs created will increase [21].
6.2 Patency - Mortality
Primary patency is the interval from the time of access placement until the
rst intervention to maintain or re-establish patency or until access throm-
bosis. Assisted primary patency is the interval from the time of access place-
ment until access thrombosis, in this case including surgical or endovascu-
lar interventions to maintain the functionality of a patent access. Secondary
(cumulative) patency is the interval from the time of access placement until
access abandonment, including surgical or endovascular interventions and
even aer thrombosis. [105].is is visualized in Figure 6.2.
e one year primary patency rates for AVFs and AVGs are similar (43%
versus 41%), but when only the matured AVFs are taken into account, this
one year primary patency rate increases to 54% [36, 107].
For CVC, patency rates are not frequently described in literature, mainly
due to the short term ormedian-long term (6-9months) use of this vascular
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Figure 6.2: Visual explanation of patency rates. Primary patency is the
intervention-free access survival. Assisted primary patency is the thrombosis-free
access survival. Secondary patency ends when the access is abandoned.[106]
access option. Hodges et al. reported however a primary patency rate at one
year of 9% [36].
When analyzing the secondary patency rates in multiple large studies,
the ratio between one year secondary patency of gras versus stulas is uc-
tuating around 1, as shown in Figure 6.3.
Concluding from these secondary patency rates that AVGs are as good
working as AVFs is too easy. When analyzing the revision rate to keep the
access patent, the interventions required for AVGs is 3 to 4 times higher
compared to AVFs (See Figure 6.4). So the costs to keep an AVG from total
failure will be higher as well as the burden for the patients. For AVGs, it is
Figure 6.3: Secondary patency rate at 1 year for gra/stula. Note that the ra-
tio is approximately 1.0, indicating comparable secondary patency for gras and
stulas.[30]
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calculated that for every revision procedure performed, the ‘new’ primary
patency rate is reduced (23-16-17% for revision 1, 2 and 3).
For CVCs, when the probability of maintaining the patient on a CVC
(including use of new catheters) is included, the one-year survival is 81%
compared to the one-year survival of one single catheter of only 48.7% re-
ported byMcLaughlin et al. [108]. While also other values of the cumulative
one-year survival between 47% and 93% were reported in literature [88].
emortality is two- to three-fold higher in patients who initiate dialysis
with a catheter, as compared to those having a stula [109]. In numbers, the
mortality of 16.8% for patients with a non-tunneled CVC and 15.2% for those
with a tunneled CVC compared to 9.3% and 7.1% for those with an AVG
and AVF [110]. Moreover, mortality is reduced by approximately 50% in
patients who switch from a catheter to a permanent access (stula or gra),
as compared with those who remain catheter dependent [111]. DOPPS data
even showed that in incident hemodialysis patients, access failure for both
AVG and AVF is greater in patients with prior CVC, even a relative risk of
1.81 for AVF failure aer CVC use is reported [112, 113].
Figure 6.4: Revision rate per access-year for gras/stulas. Note that all of the
ratios are > 1, indicating a much higher revision rate in gras than in stulas.[30]
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Global approach (ARCH)
Despite themagnitude of the clinical problem related to AVF-creation, there
has been an absence of novel therapeutic interventions in this eld due to
complex mechanisms responsible for AVF complications. Most complica-
tions are closely related to both the sudden and sustained hemodynamic
changes involved in AVF creation.
With this knowledge, an international consortium submitted a project
to the European Commission (EC) for the FP7-ICT-2007-2 call that got
granted for 3.5 years starting June 2008 until November 2011.e project was
calledARCH(Patient-specic image-based computationalmodeling for im-
provement of short- and long-term outcome of vascular access in patients
on hemodialysis therapy 1) and had a working budget of around 3.76million
euro.e consortium consisted out of 8 main partners with another 3 ‘third
parties’ as shown in Table 7.1.
e ARCH project aimed at the development of a service infrastruc-
ture for patient-specic assessment, surgical planning and follow-up of the
vascular access (Figure 7.1). is infrastructure was based on a multi-scale
computational modeling framework, coupling 1D network models of the
systemic circulation to 3D computational uid dynamics (CFD) or Fluid
Structure Interaction (FSI) models of selected vascular tracts (stenosed ves-
sel segments, branching, anastomosis or venous valves).e input data was
1http://www.vph-noe.eu/vph-projects
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Name Country Role
Istituto di Ricerche Farmacologische ‘Mario Negri’ a Italy Engineering
Technische Universiteit Eindhoven b The Netherlands Engineering
Universiteit Gent Belgium Engineering
The University of Sheffield UK Engineering
Maastricht University Medical Center The Netherlands Clinical
Ghent University Hospital b Belgium Clinical
Ospedali Riuniti di Bergamo b Italy Clinical
University Medical Centre Ljubljana Slovenia Clinical
Philips Medical Systems Nederland b.v. The Netherlands Industry
Philips Electronics Nederland b.v. The Netherlands Industry
Esaote Europe b.v. The Netherlands Industry
a Coordinator
b Third party
Table 7.1: Members of the ARCH consortium.
drawn from medical imaging and functional evaluations through innova-
tive image analysis and signal processing techniques.e development and
the validation of the patient-specic image-based computational modeling
tools were a main feature in the projects outline.
e general goal was to improve treatment quality and to decrease the
costs ofVA creation andmanagement. A considerable part of the projectwas
therefore directly aimed at tackling fourmajor clinical issues in VAmanage-
ment: non-maturation, long-term patency, steal syndrome and heart failure.
Pilot observational studies were performed on volunteers and on hemodial-
ysis patients during model development for calibration and for verication
of theoretical predictions.e consortium published the clinical study pro-
tocol for the ARCH project in 2011 [114].
Figure 7.1: ARCH concept: Patient-specic modeling for AVF surgical planning
based on medical images [115].
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General fluid mechanics
8.1 Fluid characteristics
8.1.1 Density
e mass density or specic gravity, ρ, of a uid is the mass per unit volume
(kg/m3). ρ is a function of temperature and pressure. For example, pure
water will reach its maximal density at atmospheric pressure at a tempera-
ture of 4○C, namely 999.97 kg/m−3. At 37○C and at atmospheric pressure,
the density of blood is about 1 050 kg/m3.
8.1.2 Viscosity
Dynamic and kinematic viscosity
If a force acts on a uid, the uid will exert a certain resistance to ow (inter-
nal friction).e rate of resistance is uid specic and is called viscosity. For
example, syrupwill deform less easily thanwaterwhichmeans that syruphas
a higher viscosity than water. e dynamic viscosity, µ, sometimes simply
called viscosity, has the dimension of kg/m.s or Pa.s. An old dimension of
µ is poise which equals 0.1 Pa.s. When the dynamic viscosity is negligible
(µ ≈0) the uid is said to be ideal, which means that in this case no shear
stress will appear.
e dynamic viscosity is only slightly dependent on the pressure while
it is highly dependent on the temperature. For uids, the viscosity will de-
crease with increasing temperature as the cohesion and the intramolecular
forces will decrease.
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e viscosity of water, µwater , is 10−3 Pa.s at 20○C and the viscosity of
plasma is around 1.3 10−3 Pa.s at 37○C.e viscosity of blood is highly de-
pendent on the hematocrit level (concentration of RBCs in blood) and will
be discussed in the section on blood rheology (p.54).
Another viscosity parameter is the kinematic viscosity, ν. e relation-
ship between dynamic and kinematic viscosity is:
ν = µ
ρ
(8.1)
in [m2/s] = [kg/(m.s)] / [kg/m3].
Newtonian uid
Newtonian uids are characterized by a linear relationship between shear
stress, τ, and velocity gradient, du/dy, in the x-direction perpendicular to
the ow direction, also known as Newton’s Law of viscosity (Figure 8.1):
τ = µ du
dy
(8.2)
in [N/m2] = [N.s/m2].[1/s]
e velocity gradient, du/dy, is also oen called the shear rate.
y
u
x
0
y=0
du
dy(
(
Figure 8.1: Shear stress.
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Non-newtonian uid
A non-Newtonian uid can be characterized by a viscosity that varies with
motion.
Most non-Newtonian uids have a molecular chain structure. For some
of these uids, the molecules will tend to orient in planes of maximum ten-
sion resulting in a decreasing viscosity with increasing velocity gradient.
ese types of uid are called pseudo-plastics or ‘shear-thinning’ uids. On
increasing shear rate, the uid is ‘thinning’. For others, the viscosity will
increase with an increasing velocity gradient.e latter uids are called di-
latant or ‘shear-thickening’ uids. Blood and polymer-solutions are shear-
thinning, while suspensions (paints) are shear-thickening. For non-Newton-
ian uids, the viscosity varies with the shear rate (Figure 8.2).
For all the uids mentioned above, the shear stress will disappear at the
moment the shear rate approaches zero. Some other uids only will start to
deform at the moment the shear stress exceeds a certain critical level.ose
uids are called plastic uids (e.g. toothpaste). One needs to overcome a
given shear force before the uid ows.is critical value of the correspond-
ing shear stress is called the yield-stress, τ0.
τ
τ0
ca
ss
on
-fl
ui
d
pl
as
tic
d
ila
ta
n
t 
(s
h
e
a
r 
th
ic
ke
n
in
g
)
ne
w
to
ni
an
pse
udo
plas
tic (
she
ar th
inni
ng)
du
dy
Figure 8.2: Rheological behavior of dierent uids.
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Blood rheology
e study of the rheological behavior of a uid implies the hypothesis of a
continuummedium.erefore, one has to cautiously examine within which
limits the continuous model is still applicable. It is dicult to obtain rheo-
logical data which is directly related to the whole rheological properties of
blood.e blood is a complex living medium, which can be considered in a
rst approach as a concentrated dispersion of mainly red blood cells (RBC)
(erythrocytes) in blood plasma.
If for simplicity a Newtonian model of the blood is used, one should
take into account that the viscosity changes with hematocrit, H. In men the
average hematocrit is around 45%, in women around 43%, but this value can
vary enormously [116]. e Newtonian viscosity is oen calculated by the
equation derived by Mockros and Leonard for bovine blood[117]:
µ = µp e0.0235H (8.3)
with H the hematocrit (in %) and µp the plasma viscosity. 3.5mPa.s is com-
monly used as the Newtonian viscosity value for blood, corresponding to a
hematocrit of 42% and a plasma viscosity of 1.3 10−3mPa.s.
An example of a shear thinningmodel of blood viscosity is theQuemada
model, depending on the shear rate and hematocrit [118, 119].e dynamic
viscosity is dened as:
µ = µp(1 − 1/2 kH)2 (8.4)
with parameter k a function of the intrinsic viscosities.
k = k0 + k∞√γ/γc
1 +√γ/γc (8.5)
with ln k0 = 3.874 - 10.410 H + 13.800 H2 - 6.738 H3
ln k∞ = 1.3435 - 2.803 H + 2.711 H2 - 0.6479 H3
ln γc = -6.1508 + 27.923 H - 25.600 H2 - 3.697 H3
k0 characterizes the red blood cell aggregation at zero shear stress, k∞
describes the orientation and deformation of red blood cells at a shear rate
value far above the critical shear rate γc and γ characterizes the shear rate.
In Figure 8.3, the inuence of the hematocrit and the shear rate on the
viscosity can be noticed for an example with a plasma viscosity of 1.3mPa.s.
For the zones with low shear rate (e.g. bulk ow in the middle of an arterial
lumen), the dynamic viscosity is high (See Figure 8.3, top), while for the
zones at the wall (shear rate around 2000), the viscosity decreases to 3.2-
4mPa.s (Figure 8.3, bottom).
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Figure 8.3: Dynamic viscosity for two ranges of shear rate and three dierent values
of hematocrit calculated by the Quemada model.
8.2 Fluid dynamics
Generally, a uid ow is a rather complex three-dimensional, time-depend-
ent phenomenon. However, in many (biological) situations it is possible to
make simplied assumptions that allow a much easier understanding of the
problemwithout sacricingmuch needed accuracy. One of these simplica-
tions involves simplifying a real 3D-ow to a one- or two-dimensional ow.
In almost any ow situation, the velocity eld actually contains all three ve-
locity components (u, v, w) and each is a function of all three space coordi-
nates (x,y,z):
v = uex + vey +wez (8.6)
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In a lot of situations the three-dimensional ow characteristics are im-
portant in terms of the physical eects they produce. For these situations it
is necessary to analyze the ow in its complete three-dimensional character.
Neglecting one or two of the velocity components in these cases would lead
to considerable misrepresentation of the eects produced by the actual ow.
erefore, there are four unknowns, when considering an incompressible,
3-D, Newtonian uid; the three velocity components, u, v and w and the
pressure, p.erefore, there is a need of four independent equations to cal-
culate these parameters in every point of the ow eld.ese equations can
be found in the foundational axioms of uid dynamics also known as the
the conservation laws. ese conservation laws consist of the conservation
of mass, the conservation of momentum and the conservation of energy. If
only velocity and pressure are taken into account, the conservation of en-
ergy (or rst law of thermodynamics) can be neglected.erefore, only the
conservation of mass and momentum equations are derived and described
in the following sections.
8.2.1 Conservation of mass
If a dierential element as presented in Figure 8.4 is considered, the mass
ow in the x-direction is given by:
(ρu + δ(ρu)
δx
dx
2
) dy dz − (ρu − δ(ρu)
δx
dx
2
) dy dz (8.7)
Resulting in a net rate of mass outow equal to:
δ(ρu)
δx
dx dy dz (8.8)
An analysis similar to the one used for the ow in the x-direction gives the
overall net rate of mass in y-direction and in z-direction, so the net rate of
mass outow is given by:
(δ(ρu)
δx
+ δ(ρv)
δy
+ δ(ρw)
δz
) dx dy dz (8.9)
e rate of mass change in an interval dt is:
(ρ + δρ
δt
dt) dx dy dz
dt
− ρ dx dy dz
dt
⇒ δ
δt
(ρ dx dy dz) (8.10)
e dierential equation for conservation of mass is:
δρ
δt
+ δ(ρu)
δx
+ δ(ρv)
δy
+ δ(ρw)
δz
= 0 (8.11)
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Figure 8.4: Schematic representation of the velocity in a 3D-dierential element.
Equation 8.11 is also commonly referred to as the continuity equation. In
vector notation, the full conservation of mass equation becomes:
δρ
δt
+∇ ⋅ ρv = 0 (8.12)
For steady ow it reduces to:
∇ ⋅ ρv = 0 (8.13)
For incompressible uids, the uid density, ρ, is constant throughout the
ow eld and equation 8.13 becomes:
∇ ⋅ v = 0 (8.14)
or
δu
δx
+ δv
δy
+ δw
δz
= 0 (8.15)
In a control-volume approach, the equation is transferred to:
∬
c.s.
ρ(v .n)dA+ δ
δt∭
c.v .
ρdV = 0 (8.16)
With c.s. being the control surface of the control volume, c.v., and n the
normal on the surface.
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8.2.2 Conservation of momentum
Conservation of linear momentum is expressed by Newton’s second law ap-
plied to a mass m:
F = m a (8.17)
Where F is the resulting force acting on the mass, m, and a the correspond-
ing acceleration. In general, two types of forces need to be considered:
1. Surface forces, which act on the surface as a result of the interaction
with the surroundings of a uid element.ey consist of normal stress
due to pressure and shear stresses due to viscosity.
2. Body forces, which are distributed throughout the uid element.
In analogy with the method used to derive the conservation of mass equa-
tion, the resultant surface forces in the x-direction, for a dierential element,
can be seen as:
(δ(σxx)
δx
+ δ(τyx)
δy
+ δ(τzx)
δz
) dx dy dz (8.18)
Where σxx represents, as shown in Figure 8.5, the normal stress on a plane
perpendicular to the x-direction. τyx and τzx represent the shear stresses
in the x-direction on a plane perpendicular to, respectively, the y- and z-
direction of the dierential element.
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Figure 8.5: Schematic representation of surface forces in the x-direction in a 3D-
dierential element.
For most purposes, the only body force of interest is the weight of the
dierential element which can be expressed as:
Fx = ρ gx (8.19)
58
8.2. Fluid dynamics
Where gx is the component of the acceleration of gravity vector in the x
direction. Other possible body forces are coriolis force or forces due to cap-
illarity.
When the surface force of Equation 8.18 and the volume force of Equa-
tion 8.19 are inserted in the le hand side of Equation 8.17, one can derive
the general dierential equation of motion in uid in the x-direction:
ρgx + δ(σxx)δx + δ(τyx)δy + δ(τzx)δz = ρ (δuδt + u δuδx + v δuδy +w δuδz ) (8.20)
Hereby, the right hand side of Equation 8.17 is derived, similar to themethod
used in the section on conservation of momentum, by adding the net rate of
momentum outow with the time rate of change of momentum.e equa-
tion can then be simplied by the use of the substantial dierential DDt , to
ρgx + δ(σxx)δx + δ(τyx)δy + δ(τzx)δz = ρDuDt (8.21)
In contrast to the conservation of mass equation, the conservation of mo-
mentumequations should bewritten in all three dimensions, so three equa-
tions (x, y and z) make the complete set of equations to solve the conserva-
tion of momentum in a uid. In a control volume approach, these equations
become: ∑ F =∬
c.s.
ρv(v .n)dA+ δ
δt∭
c.v .
ρvdV (8.22)
e three conservation of momentum equations (in all three directions), in
combination with the conservation ofmass equation, form together the four
necessary, independent equations to calculate in each point of the ow eld
(for an incompressible, laminar ow, with constant viscosity) the unknowns
u, v, w and p.
8.2.3 Navier-Stokes equations
e Navier-Stokes equations are a specic representation of the conserva-
tion of momentum equations, with inclusion of body force, pressure force
and viscous force.
ρF −∇p + µ∇2v = ρDu
Dt
(8.23)
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8.2.4 Euler and Bernoulli equations
For the inviscid ow (ideal uid) in which all shearing stresses are zero, the
general equation of motion is reduced to (in vector notation):
ρg −∇p = ρDu
Dt
(8.24)
ese equations are commonly referred to as the Euler equations of mo-
tion. It can be seen as a simplied version of the Navier-Stokes equation
(with only the gravity taken as body force, F, and with no viscous force in-
cluded).
If the only external force is the gravity in the z-direction and the equation
is applied to a streamline (1D), the formula reduces to:
z + p
ρg
+ v2
2g
= constant (8.25)
is is the Bernoulli equation. Note that the equation can only be applied
along a streamline and that the ow is assumed to be steady and inviscid. If
one takes into account the (head) losses, hloss [m], in a ow from point 1 to
2, the Bernoulli equation becomes:
z1 + p1ρg + v212g = z2 + p2ρg + v222g + hloss (8.26)
An application of this is for instance the blood ow through a narrow-
ing in the coronary arteries (stenosis). When looking at the basic Bernoulli
equation (no head losses) for an ‘ideal’ uid, there will be no pressure gradi-
ent over the stenosis, only a transfer in energy (pressure energy pre-stenosis
to kinetic energy inside the stenosis and pressure energy recovery post-ste-
nosis). A viscous uid owing through a narrow stenosis however, intro-
duces a signicant energy loss. In the contraction segment, the head loss is
low when shiing the potential energy to kinetic energy. On the contrary, in
the expansion segment, amore ’energy expensive’ transfer is present. Energy
is lost by formation and maintenance of vortices (viscous drag) [120].
As experimentally shown by Berguer &Hwang (Figure 8.6), in the cases
of a small radius reduction (below 50%of diameter or 75%of area reduction),
the ow is not yet signicantly disturbed and the energy recovery, distal to
the narrowed section, is still high (no signicant head loss) [120]. When the
diameter reduction is above 50% (75% area reduction), the pressure drop has
a quadratic relation with the ow rate. Here the decrease in blood ow will
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become clinically relevant. If the patient suers from a low blood perfusion,
for example in his coronary artery due to a stenosis formation, the area re-
duction will already be around 75% of the lumen area so that an intervention
(e.g. balloon dilation or stenting) becomes necessary.
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Figure 8.6: Qualitative plot of ow rate and pressure drop over a stenosis based on
the work of Berguer & Hwang [120].
8.3 Characteristics of fluid motion
8.3.1 Laminar and turbulent ow
ere is a huge dierence when a ow is laminar or turbulent. In laminar
ow, uid particles move along xed streamlines with negligible particle
mixing across the streamlines. e ow is called laminar because it looks
like a series of thin sheets of uid (laminate) sliding over one another. A
turbulent ow is characterized by random uctuations in uid velocity and
by intense mixing of the uid on macroscopic level and large energy dissi-
pation on microscopic level.
e Reynolds number is used to decide whether the ow is laminar or
turbulent.e dimensionless Reynolds number is dened by :
Re = ρUL
µ
(8.27)
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where ρ is the uid density, U the average velocity, L a relevant character-
istic length of the studied problem (e.g. the diameter of a vessel) and µ the
dynamic viscosity of the uid.e Reynolds number is a dimensionless pa-
rameter that gives a measure for the ratio of inertial to viscous forces. As a
rule, one can use for sti tubes (with L the diameter of the tube):
○ Re < 2000 laminar ow○ 2000 < Re < 4000 transient ow○ Re > 4000 turbulent ow
It should be emphasized, however, that this classical distinction of types
of ow is only correctly dened for steady ow in rigid tubes. Further-
more, complex ow including the appearance of secondary vortices, does
not mean that the present ow eld is turbulent. By our ‘engineering’-def-
inition above, these ow disturbances might be present in a laminar ow
regime. It should be noted that in clinical environments, the term ‘turbulent
ow’ is oen used for ow regimes far below the turbulent threshold. Antiga
and Steinman stated in their work ‘Rethinking turbulence in blood’ that
blood ow is typically laminar; however, high frequency uctuations sug-
gesting turbulence have only been observed in vivo in the ascending aorta
and arterio-venous gras, and in ows past mechanical heart valves [121].
8.3.2 Poiseuille or plug ow
When starting from the equation of conservation of momentum, for a hori-
zontal tube (no gravity forces), with a stationary, laminar ow (no derivative
to time) and 1D ow (v and w are zero) with only a friction and a pressure
force, all applied to a small cylindrical control volume (radius r and length
L):
(p2 − p1) pir2 = µ δvδr 2pirL (8.28)
δv
δr
= − r
2µL
(p1 − p2) (8.29)
v = − r2
4µL
(p1 − p2) + constant (8.30)
For r = R and v = 0 (’no-slip’ at the wall)
v = (p1 − p2)
4µL
(R2 − r2) (8.31)
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For r = 0, v=vmax (in the center)
vmax = (p1 − p2)4µL R2 (8.32)
v(r) = vmax(1 − ( rR)2) (8.33)
Note that vavg = vmax/2 and that the velocity is in a quadratic relation to the
radius, this is called a parabolic velocity prole. An example of the prole
can be seen on the le panel of Figure 8.7 (Section 8.3.3). If we dene the
ow rate Q as ∫ R0 2pi v r dr, the expression above becomes:
∆p = 8µL
piR4
Q (8.34)
is is the Poiseuille or Hagen-Poiseuille equation. is equation states
that the pressure drop along the tube is directly proportional to the length
of the tube, the rate of ow and the viscosity of the uid, and inversely pro-
portional to the fourth power of the internal radius, R.
is equation is applicable to a steady and laminar ow in a long and
rigid cylindrical tube, with no slip at the wall and a homogeneous and New-
tonian uid.e term Poiseuille ow describes this parabolic ow prole.
If the ow prole is constant over the radius of the tube, v(r) = vavg =
vmax , it is called plug ow. When a Newtonian uid enters a rigid tube with
a plug ow prole, aer a certain length, due to the viscous force, the prole
will developed into a Poiseuille ow prole.
8.3.3 Oscillatory ow
To illustrate oscillatory ow, we start from the momentum and continuity
equations for a homogeneous, incompressible andNewtonian uid in a rigid
cylindrical, horizontal tube (radius R) and assume a periodic motion. e
velocity in the longitudinal direction (x) then becomes:
u = un(r) δpδx e iωt (8.35)
With (in radial direction)
un(r) = iρω
⎡⎢⎢⎢⎢⎣1 −
J0(α rR i3/2)
J0(αi3/2)
⎤⎥⎥⎥⎥⎦ (8.36)
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With J0 being a zero order Bessel function and α the Womersley number.
is dimensionless parameter is the square root of a representation of the
inertia force divided by the viscous force:
α = R√ω
ν
= R¿ÁÁÀρ.2pi f
µ
(8.37)
With ω the angular frequency [rad/s] of the oscillations with frequency f
[1/s], R the radius of the tube [m] as scale length and ν the kinematic viscos-
ity [m2/s].
An example of the (scaled) ow proles for dierent Womersley num-
bers can be found in Figure 8.7. If the Womersley number is small (α<1), a
quasi-static Poiseuille prole can be found which is in-phase with the pres-
sure gradient (as in the Poiseuille equation).e Womersley proles for in-
termediate Womersley numbers are characterized by a phase-shi between
the ow in the boundary layer (near the wall) and the ow in the central
core of the tube. If the number is large (α»1), a plug ow is found which is
90 degrees out of phase with the pressure gradient.
In a blood vessel network, the frequency, the viscosity and the density
can be assumed to be constant. erefore the Womersley number is larger
in larger vessels and small in smaller vessels. Typical values for a man are
around 22 in the aorta and 4 in the brachial artery.
8.3.4 Shear stress calculations
e relationship between shear stress,τ, and shear rate, du/dy, as shown in
Figure 8.1, is given by Equation 8.2 (Section 8.2). When applying this for-
mula in the proximity of the wall, taking the local viscosity and the velocity
gradient close to the wall, the Wall Shear Stress (WSS) can be calculated:
WSS = µ ∣δu
δy
∣
y=0 (8.38)
is 1D formulation can be transferred to a 3D formulation by taking the
derivative of the velocity to the normal, at the wall:
WSSx = µ ∣δuδn ∣wal l (8.39a)
WSSy = µ ∣ δvδn ∣wal l (8.39b)
WSSz = µ ∣δwδn ∣wal l (8.39c)
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Figure 8.7: Womersley proles for dierent Womersley parameters assuming a
constant (real) pressure drop over the tube length.e velocity prole is visualized
for dierent phase angles [2].
ese three equations form the wall shear stress vector:
WSS = [WSSx ,WSSy ,WSSz] (8.40)
Time-Averaged Wall Shear Stress (TAWSS)
For non-steady ow regimes, the WSS has a changing value in time. For
a periodic ow, the Time-Averaged Wall Shear Stress (TAWSS) [Pa] can be
calculated as the integral over time of the absolute value of the WSS-vector:
TAWSS = 1
T ∫ T0 ∣WSS∣dt (8.41)
Malek et al. [122] indicate that in a normal artery the TAWSS should be be-
tween 1 and 7 Pa, in a normal vein between 0.1 and 0.6 Pa.e authors state
that in arterial regionswithTAWSSbelow0.4 Pa, atherosclerosis (arterywall
thickening due to the accumulation of fatty substances) will appear, while re-
gions with a TAWSS above 7 Pa are only found in narrowed regions such as
stenoses or heart valves.
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Oscillatory Shear Index (OSI)
To investigate the oscillatory behavior of the WSS, the change in direction
of the ow and therefore the velocity gradient during a cardiac cycle, the
Oscillatory Shear Index (OSI) [-], originally introduced by Ku et al. [123],
can be calculated.
OSI = 1
2
⎛⎜⎜⎝1 −
∣ 1T ∫ T0 WSS dt∣
1
T ∫ T0 ∣WSS∣dt
⎞⎟⎟⎠ (8.42)
with
∣∫ T0 WSS dt∣ = √(∫ T0 WSSx dt)2 + (∫ T0 WSSy dt)2 + (∫ T0 WSSz dt)2 (8.43)
For a ow eld that highly oscillates, with the numerator (∣∫ T0 WSS dt∣)
equal to zero, the OSI will become 0.5, its maximal value. For a unidi-
rectional ow eld, over the entire period, the numerator (∣∫ T0 WSS dt∣)
is equal to the denominator (∫ T0 ∣WSS∣dt) and the OSI becomes zero, its
minimal value.
Regions in blood vessels with high OSI indicate a high oscillatory shear
stress on the endothelial cells at the inner wall of the arterial lumen.is pe-
riodic change in direction of the shear stress on the cells, can causes cellular
proliferation and intimal hyperplasia growth [41, 55].
Relative Residence Time (RRT)
A third wall shear stress parameter that is oen used, is the Relative Resi-
dence Time (RRT) [Pa−1], introduced by Himburg et al. [124] and dened
as:
RRT = T∣∫ T0 WSS dt∣ (8.44)
is parameter can also be seen as a weighted combination of TAWSS and
OSI:
RRT = 1(1 − 2.OSI).TAWSS (8.45)
e parameter is called ‘relative’ residence time, because all particles are
moving and have no absolute residence time on a single location.
More hemodynamic wall parameters and their relationship are listed in
the work of Lee et al. [125].
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8.3.5 Helicity
Next to parameters evaluating the ow eld at the wall, it is possible to char-
acterize the ow in the bulk as well. Belian et al. suggested the use of the
density of the kinetic helicity per volume unit, Hk .is parameter seems to
have a great inuence on the evolution and stability of both turbulent and
laminar ows [126]. Hk is dened as the scalar product of the velocity vector,
v and the vorticity vector, ω, of the ow eld:
Hk = v ⋅ ω = v ⋅ (∇× v) (8.46)
e vorticity is the ‘curl’ of the ow eld, around an axis (the direction of
the vorticity vector). For a given total kinetic energy, the kinetic helicity is
maximal when the velocity and the vorticity are in the same direction.e
helicity is zero, when the direction of the velocity vector and the direction
vorticity vector are perpendicular or, of course, when the vorticity or velocity
are zero. Grigioni et al. transformed this equation to a Local Normalized
Helicity (LNH) [127, 128]:
LNH = v ⋅ ω∣v∣ ∣ω∣ (8.47)
e LNH is a parameter between -1 and 1, depending on clockwise or counter-
clockwise rotations of the ow eld. Finally, the helicity, H, can be dened
as the volume integral of Hk :
H = 1
V ∭ HkdV = 1V ∭ v ⋅ (∇× v)dV (8.48)
or of the volume integral of the absolute value of Hk :
H = 1
V ∭ ∣v ⋅ (∇× v)∣ dV (8.49)
e latter formula is used to avoid that clockwise rotations in the volume can
be compensated by counter-clockwise rotation resulting in a zero volume-
averaged helicity. It should be noted that the helicity is function of time,
therefore, analysis of the oweld is oen concluded by calculating the time-
average over one cardiac cycle of the helicity.
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9.1 Experimental methods
9.1.1 Particle Image Velocimetry (PIV)
Particle Image Velocimetry (PIV) is a method to visualize the velocity dis-
tribution in uids. As shown in Figure 9.1, a visual clear uid ows through
a visual clear model, and is seeded with small tracing particle (e.g. 100 µm
silver polyamide particles). e density of the particles should match the
density of the used uid. e region of interest (ROI) is illuminated with a
laser sheet (2D) (e.g. Neodym-YAG (Nd:YAG) laser). A camera records the
particles owing through the illuminated region of interest (e.g. full frame
interline CCD camera).e location of the particle over consecutive images
are compared to achieve the ow velocity over a dened discrete timestep.
A 2D velocity eld can be acquired by use of only one camera to achieve
the velocity in two components (2D-2C standard PIV). If multiple laser
planes, positioned perfectly next to each other, are taken into account, it
is possible to calculate even the 3D-2C or even 3D-3C velocity. When stereo
PIV is applied, two cameras in an angle of 90 degrees of each other (45 de-
grees of the laser sheet) are positioned. Hereby 3 component vectors can be
calculated in the 2D plane (2D-3C).
Nowadays, the use of PIV for the validation of CFD computations is
a common procedure. In the eld of biomedical engineering and hemody-
namics, many cases have already been published. Next to themore idealized
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Figure 9.1: General PIV setup [129].
or generalized phantom models of for example an idealized arterial steno-
sis [130] or aneurysm [131], PIV validation is applied on a large scale in the
eld of medical devices as central venous catheters [98], blood pumps [132–
135], stents [136] or articial heart valves [137–139]. Even when shiing to
anatomical realistic models, like in studies focusing on the validation of pa-
tient specic aneurysms [140] or stenosis regions [141], a good agreement
between in vitromeasurements and computational results was found.
Two studieswere performed: (i) a largemulti-center study, inwhich they
compared dierent PIV algorithms on pre-dened models [142], and (ii) a
FDA’s ‘Critical Path’ Computational Fluid Dynamics (CFD) / Blood Dam-
age Project, in which the use of PIV analysis in the CFD validation process
is studied [143]. Both studies concluded that PIV is capable to measure ac-
curately the mean (time-averaged) velocities, if the uctuations in the ow
conditions and the uid properties are minimized.
9.1.2 Experimental assessments on silicon tube models
If a more general assessment of a hydraulic circuit is needed, a siliconmodel
can be constructed.e siliconmodel does not need to be transparent, as for
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PIV, because it will be used in a hydraulic bench test for pressure and ow
evaluations. Once the silicon model is constructed, it can be coupled to a
stationary or pulsatile pump, with or without adding some ow splits, wind-
kessels or resistances (clamps) before or aer the model ending. A setup is
mostly ended with an open outow or with constant height outow reser-
voirs (Figure 9.2).e windkessel, when proximal, can be used to adjust the
pulse pressure entering the model (damping) or when used distal from the
model to mimic the peripheral compliance.e height of the outow reser-
voirs can be set to achieve a constant pressure boundary condition. Outow
distribution can be changed by opening or closing the clamps.
Figure 9.2: Example of experimental setup consisting of a pump (not shown), a
windkessel, connecting tubes, the silicon model, clamps and outow reservoirs.
Pressure measured by a pressure transducer with pressure-lines and owmeasured
by a ow transducer.
To measure the pressure in a model, there are two options. Firstly,
needles can be placed in the model, perpendicular to the silicon tube wall.
Secondly, uid-lled epidural catheters (pressure-lines)(Portex EpiduralCa-
theter, Smiths Medical ASD inc., Keene, US) can be slid through the lumen
of the model. With the pressure-lines, it is possible to measure the pres-
sure on dierent locations without damaging the lumen. e needles or
pressure-lines are connected to a calibrated uid-lled pressure transducer
(e.g. P10EZ-1 or DT-X PLUS (Becton Dickinson, Franklin Lakes, NJ, US))
which on its turn is connected to a DAQ-unit to process the pressure data.
Flow rates can bemeasured by volumetric measurements (collecting the
uid outow for a period of time). Next to this very robust and reliable
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method, it can be necessary to monitor and analyze the instantaneous ow
rate over time.erefore a ow transducer (e.g. Transonic owmeter Team
21 Compatible (Transonic Systems Inc., Ithaca, NY, US)) is clamped onto the
circuit.
Next to the pressure and owmeasurements, collecting geometrical data
is important, especially when using the experiment to validate computa-
tional results. Most geometrical data can be collected with simple rulers.
When for example the diameter at working pressure or the diameter change
during a pressure change is needed, an ultrasound system (e.g. Picus ul-
trasound system, ESAOTE B.V.,e Netherlands) can be used with, if nec-
essary, some wall-tracking soware (e.g. ArtLab, ESAOTE B.V.). For ex-
act model reconstruction, high resolution X-ray Computed Tomography
(micro-CT) can be used with a voxel size down to 210 µm.
To have a full set of experimental data, one should determine the uid
characteristics. Viscosity can be measured with a capillary Ubbelohde vis-
cometer (Schott, Germany). Hereby, a U-shaped glass tube is lled with a
uid and placed in a reservoir with controlled temperature.e time needed
for the uid to ow (by gravity) between 2 predened markers on the cap-
illary is taken. is time can then simply be multiplied by the calibration
factor of the specic glass tube to obtain the kinematic viscosity. e den-
sity of the uid on the other hand can be measured by lling a constant vol-
ume ask and comparing its weight with the weight of the ask lled with
puried water.
Because uid characteristics might change with temperature (Section
8.1), it is important to monitor the uid working temperature during the
experiments. When for example a mixture of water-glycerin is used, the vis-
cosity can decrease from 8.1 mPa.s to 6.9 mPa.s if the temperature increases
slightly from 18 to 22 ○C (51% glycerin-water mixture).
9.2 Numerical methods
9.2.1 Computational Fluid Dynamics (CFD)
Computational Fluid Dynamics is a computational method to calculate all
uid dynamics (ow, pressure, heat,...) in a well dened domain, with well
dened boundary conditions. A owchart with the dierent steps in CFD
analysis is shown in Figure 9.3.
e model is, in the eld of biomedical engineering, mostly drawn in a
CAD program (e.g. SolidWorks (Dassault Systèmes SolidWorks Corpora-
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Model Construction
Meshing
Defining Boundary Conditions
Defining Material Properties
Defining Equations
CFD calculations
Post-processing
CAD:   Solidworks
Medical Images:  Mimics
                                 VMTK
Gambit
pyFormex
Fluent
Tecplot
ParaView
Matlab
Figure 9.3: Flowchart of Computational Fluid Dynamics analysis with examples of
the used programs in this work.
tion, Concord, MA, US)) or reconstructed frommedical images (CT-scans)
(e.g. Mimics (Materialise, Leuven, Belgium) or vmtk1).
Before CFD calculations can start, the uid domain is split into a dis-
crete number of cells (meshing).ese volume elements can be either large
(coarse mesh) or small (ne mesh) according to the uid domain.e cells
canhave dierent shapes as tetrahedrons, hexahedrons or prisms.emesh-
ing process can be done in either commercially available packages as Gambit
(Ansys Inc., Canonsburg, PA, US) or open-source programs as pyFormex2.
Once the domain is meshed, the boundary conditions and material
(uid) properties should be dened. At the wall of the domain (e.g. the ves-
sel wall), mostly, a no-slip condition is applied, assuming that the velocity
at the wall is zero. At the entrance of the model, a constant or non-constant
(e.g. periodic signal (heart rate) ow rate or velocity can be applied either
1http://www.vmtk.org
2http://pyFormex.org/
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as plug or Poiseuille prole (see Section 8.3.2). At the outow tracts of the
domain, a ow distribution can be applied or a pressure or velocity can be
imposed. For the used uid, viscosity and density should be dened.
Within all cells (nite volume method), the equations of conservation
of mass and momentum are calculated in relation to the neighboring cells;
most oen, the Navier-Stokes equations (sometimes added with the con-
servation of energy) are used (Eq.8.23). For the CFD calculations reported
in this work, the commercial program Fluent (Ansys Inc., Canonsburg, PA,
US) was used.
If the iterative computations of these equations converge, with low resid-
uals, the ow and pressure eld can be analyzed (example in Figure 9.4). In
this post-processing stage, derivatives of these results, e.g. wall shear stress
(See Section 8.3.4) can be calculated. Analysis can either be done directly in
Fluent, in the post-processing soware ParaView (http://www.paraview.org)
or Tecplot (Tecplot inc, Bellevue, WA, US) or even in general programs as
Matlab (e Mathworks, Natick, MA, US).
(a) Static pressure
(b) Velocity vectors
Figure 9.4: Arterial (top) and venous (bottom) anastomosis of an AVG congura-
tion.
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9.2.2 Kinetic modeling
In general, kinetic modeling describes the variation in time of a physical
entity (e.g. mass, energy) which is exchanged among dierent systems, or
between a system and the environment.is dynamic process is ruled by a
driving force.
e human body can be considered as a biological system, consisting of
dierent anatomical compartments, which are separated by semi-permeable
membranes. Approximately 58% of the human body consists of water, which
is divided over the extracellular (plasma water and interstitial water) and in-
tracellular compartments. Transport between the dierent compartments
can happen passively by free diusion of non-loaded particles (e.g. water,
oxygen, urea) or loaded particles (ions), and by forced diusion via carri-
ers or channels. Next to a passive, concentration driven process, transport
can also occur as an active process where the energy is supplied by the ATP
(Adenosine TriPhosphate), or as secondary active transport according to an
electrochemical gradient.
To describe physiological processes in the human body mathematically,
the body can be divided in dierent compartments which not necessarily
correspond to an anatomical reality and in which a physical entity is consid-
ered uniformly distributed over the compartmental volume.
Such a kinetic model might consist of a large number of arbitrarily small
compartmental entities, necessitating a statistical description.e resulting
formula is then not based on fundamental physical principles, but is derived
from (multiple) linear or non-linear regression analyses. However, an im-
portant limitation of these statistical models, is that predictions can only be
safely made for the parameters that are clinically measured. Instead, inmost
cases, a mechanistic model with a limited number of compartments might
be sucient to describe solute kinetic behavior.e advantage of mechanis-
tic models is that predictions beyond the scope of the examined parameters
are more robust as these models are based on fundamental physical princi-
ples such as the conservation of mass and the conservation of energy.
So a puremathematical non physiology-basedmodel following the clas-
sic pharmacokinetic approach can be used.is model may consist of one,
two or several compartments/pools (double pool example in Figure 9.5).
Each compartment is characterized by a homogenous internal solute con-
centration (C1, C2,...) and a distribution volume (V1, V2,...), all changing
in time caused by dierent transport processes: input (I) and output (O)
(i.e. dened as an interaction in between compartments and/or the envi-
ronment), and solute generation (G) and/or elimination (E) (i.e. dened as
taking place inside the compartment).e mass input and output might be
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Volume 1 Volume 2
E1 E2G1 G2
1 1
V   C
2 2
V   C
K12
I O
Figure 9.5: General representation of a double pool kinetic model. V: Volume; C:
Concentration; G: Generation; E: Elimination; I: Input; O: Output and K12: Inter-
compartmental clearance.
proportional to the concentration itself (clearanceK) or to the concentration
dierence (intercompartmental clearance K12).
Finally, for each compartment separately, themass balance is written as a
dierential equation. In case ofmore than one compartment, the dierential
equations should be solved simultaneously and treated as a coupled mathe-
matical problem. From the representation in Figure 9.5, the basic equations
can be dened as:
d(V1C1)
dt
= G1 − E1 + K12 ⋅ (C2 − C1) (9.1a)
d(V2C2)
dt
= G2 − E2 + I − O − K12 ⋅ (C2 − C1) (9.1b)
In the eld of hemodialysis treatment, kinetic modeling can be applied
in two dierent ways: identication of the unknown model parameters (i.e.
calibration of the kinetic model), or simulation of intra and/or interdialytic
parameters using an already calibrated kinetic model.
Identication is based on the determination of the unknown model pa-
rameters by tting the solution of the (coupled) mass balance equation(s)
to the clinically measured blood or plasma concentrations at dierent time
76
9.2. Numerical methods
points during dialysis. Problems with identication might arise when too
many parameters are unknown and the measured concentration data set
is too small to yield enough accurate information. Calibration has been
performed previously in the context of hemodialysis for β2-microglobulin
(β2M) by Stiller et al. [144], for phosphate by Spalding et al. [145] and for
urea and guanidino compounds by Eloot et al. [146].
Once a calibrated kineticmodel is available, simulations can be achieved,
predicting the time course of solute concentration for future time points.
Hence, simulations allow the comparison of solute removal and/or time-
averaged concentrations when applying dierent dialysis strategies.
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Computational study of flow in AVF
anastomoses
K. Van Canneyt, T. Pourchez, S. Eloot, C. Guillame, A. Bonnet, P. Segers
and P. Verdonck.
Hemodynamic impact of anastomosis size and angle in side-to-end
arteriovenous stulae: a computer analysis.
Journal of vascular access. vol.11. 2010:52-58.
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10. Computational study of flow in AVF anastomoses
10.1 Introduction
e eciency of hemodialysis treatment for end-stage renal disease patients
is to a great extent dependent on the quality of the vascular access. In gen-
eral, themost appropriate way of establishing a vascular access is by creating
an arterio-venous stula (AVF) as rst described by Brescia et al. in 1966
[28] or a modication to this approach. However, as the construction of this
autologous connection between the arterial and venous network is still the
underlying cause of many clinical complications, optimization of the vascu-
lar access is the subject of many ongoing and nished studies as described
by Cimino [29].
Nowadays, most clinicians start from the idea of an AVF as a 6 segment
circuit consisting of the proximal artery (1), the distal artery (2), arterial col-
laterals (3), the proximal vein (4), the distal vein (5) and venous collaterals
(6). However, to have a total hemodynamic description of the AVF, it is im-
portant to insert at least a seventh segment in the ow path, the anastomosis
itself.e 7 segment approach is schematically illustrated in Figure 10.1.
6
1
4
3
2
5
7
Figure 10.1: Seven segment AVF circuit: Proximal artery (1); distal artery (2); ar-
terial collaterals (3); proximal vein (4); distal vein (5); venous collaterals (6) and
arterio-venous anastomosis (7).
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Given the virtually total absence of studies addressing the geometry of
the anastomosis in the setting of an AVF, it can be stated that this is an as-
pect largely disregarded as a potentially determining factor of the access ow.
erefore, the present study was set up to study in detail the uncoupled ef-
fect of the anastomosis angle and anastomosis size in the setting of arterio-
venous stulas. With Computational Fluid Dynamics (CFD), the pressure
drop and ow distribution curves were calculated and stream line patterns
were studied [147, 148] in order to have an in depth insight in the access ow
and the ow eld at the anastomosis.
10.2 Material andMethods
A 3-D geometry of a matured side-artery-to-end-vein AVF was designed
consisting of an artery with a diameter of 4 mm connected to a vein with
a diameter of 6 mm (Figure 10.2). e connection was made by an anas-
tomosis with given angle (A) and cross-sectional area (CSA), assuming an
ellipsoidal cross-section with a given anastomosis length (L) and width (W).
Steady ow in the geometry was assumed, following Sivanesan et al. [149].
All AVF models were constructed on an in vivo scale in the CAD pack-
age SolidWorks 2005 (SolidWorks Corporation, Concord, MA, U.S.A.) and
exported into the grid generation soware Gambit 2.2 (Ansys Inc., Canons-
burg, PA,U.S.A.) via the IGES (Initial Graphics Exchange Specication) data
format. e mass and momentum conservation equations are discretized
and solved in the CFD package Fluent 6.3 (Ansys Inc., Canonsburg, PA,
U.S.A.) aer prescribing all boundary conditions. In the CFD-model, the
blood ow is treated as 3-D, non-pulsatile, laminar, Newtonian (dynamic
viscosity of 3.5 mPa.s representing a hematocrit around 40% [116]) and in-
compressible [150]. e post processing of the CFD results was executed
using Tecplot 360 (Tecplot inc., Bellevue, WA, U.S.A.). Regression analy-
sis, tting a quadratic relation to the data, was used to assess the pressure
drop results. Goodness of t was expressed by the R2 value. Analysis was
done using SigmaPlot 10.0 (Systat Soware Inc., San Jose, CA, U.S.A.). Our
study addressed two issues: the impact on hemodynamics of the size and
the impact on hemodynamics on the angle of the anastomosis.
10.2.1 Substudy 1: impact of anastomosis size on hemodynamics
e reference geometry for this rst substudy, serving as point of compari-
son for all results, was an anastomosis characterized by A = 30○, L = 6mm
and W = 4mm (CSA = 18.8mm2), with 900ml/min inow at the arterial
inlet (Qai) and with a ow distribution of 8% and 92% towards the arte-
rial outlet (Qao) and venous outlet (Qvo), respectively (see also Figure 2).
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Figure 10.2: Reference arterio-venous stula conguration.
e anastomosis size varied using geometries (LxW) of 8x2, 6x3, 8x3, 6x4
and 10x3 (L and W in mm), resulting in a cross-sectional area of 12.6mm2,
14.1mm2, 18.8mm2, 18.8mm2 and 23.6mm2, respectively.
We rst calculated the ow eld and pressure drop over the anastomo-
sis for 5 dierent anastomosis geometries, imposing ve dierent ow rates
(600, 750, 900, 1050 and 1200ml/min) but maintaining a xed ow distri-
bution of 8% arterial versus 92% venous outow.e pressure drop over the
anastomosis was calculated from the area-averaging static pressure at 25mm
from the anastomosis in the proximal artery and proximal vein.
Second, we ran an additional series of computer simulations to deter-
mine whether the anastomosis size also aects the ow distribution. To do
so, the inlet and outlet pressures of the artery (Pai , Pao) and outlet pressure of
the vein (Pvo) in the reference cases were considered as general conditions.
10.2.2 Substudy 2: impact of anastomosis angle on hemodynamics
Reference for this substudy is an anastomosis characterized by A = 53○, L =
6mm and W = 4mm (CSA = 18.8mm2), with 900ml/min inow at the ar-
terial inlet (Qai) and with a ow distribution of 8% and 92% towards the
arterial (Qao) and venous outlet (Qvo), respectively. e anastomosis angle
was varied over 27○, 34○, 45○, 53○, 63○, 76○and 90○, a clinically relevant range
[149].
Again, simulations were rst done imposing dierent ow rates (with a
constant ow distribution) while studying the pressure drop over the anas-
tomosis for the dierent angles, followed by simulations with xed pressure
boundary conditions and studying the eect of the angle on the ow distri-
bution towards arterial and venous outlet.
10.3 Results
10.3.1 Substudy 1: impact of anastomosis size
Figure 10.3a shows the pressure drop over the anastomosis for a stula ow
range of 600 to 1200ml/min for dierent anastomosis sizes, but xed anas-
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tomosis angle of 30○. As anticipated, the pressure drop decreases with in-
creasing anastomosis cross-sectional area. For the smallest anastomosis size
(L = 8mm, W = 2mm, CSA = 12.57mm2), the pressure drop varies from
8.1mmHg (Qai 600ml/min) to 30mmHg (Qai 1200ml/min), while for the
casewith the largest CSA, (L= 10mm,W=3mm,CSA=23.6mm2) the pres-
sured drop starts from 5mmHg (Qai 600ml/min) to rise up to 18.6mmHg
(Qai 1200ml/min).e case of L = 8mm andW= 3mm is almost similar to
the case of L = 6mm and W = 4mm.is is due to the fact that both cases
have the same cross-sectional area (CSA = 18.8mm2).
Figure 10.4a shows the eect of anastomosis size on the ow distribution
for xed pressure boundary conditions. For increasing anastomosis size, the
arterial inow increases to nally stabilize from a CSA of 20mm2 on. Fur-
thermore, it is also clear from gure 4a that ow distribution is shied to-
wards the venous outowwhen the anastomosis size increases. For a CSA of
12.6mm2, the ow distribution towards the arterial and venous outlet is 22%
and 78%, respectively, while these numbers shi to 5% and 95% for CSA =
23.6mm2.
10.3.2 Substudy 2: impact of anastomosis angle
Figure 10.3b shows the pressure drop for dierent anastomosis angles for a
xed anastomosis size of 6mmx4mm(CSA= 18.9mm2).e pressure drop
slightly increases for increasing anastomosis angle from 26○over 33○to stabi-
lize at 45○. For anastomosis angle from 45○up to 90○, the pressure drop de-
creases signicantly.e maximal dierence in pressure drop among cases
of dierent anastomosis angle at 1200ml/min is 12.8mmHg, which is in the
same range as in the parameter study for the anastomosis size of Figure 10.3a
(11.4mmHg). Among the studied geometries, the maximal pressure drop is
obtained for the 45○anastomosis (24.1mmHg).
It can be seen in Figure 10.4b that venous outow reaches a minimum
around 43○anastomosis angle, while it is continually increasing for larger
angles. Even for an anastomosis angle of 58○, the venous outow exceeds
the proximal arterial inow, and with it, the ow in the distal artery changes
direction.
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Figure 10.3: (a) Pressure drop over anastomosis versus blood ow rate for dierent
anastomosis sizes (Length x Width, both in mm), anastomosis angle xed at 30○.
(b) Pressure drop over anastomosis versus blood ow rate for dierent anastomosis
angles, anastomosis size xed at 6x4 (CSA = 18.8mm2).
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Figure 10.4: (a) Flow rate at arterial inlet, outlet and venous outlet for dierent
anastomosis sizes, starting from reference case L = 6mm; W = 4mm and A = 30○.
(b) Flow rate at arterial inlet, outlet and venous outlet for dierent anastomosis
angles, starting from reference case L = 6mm; W = 4mm and A = 53○.
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10.4 Discussion
Although several in vitro and computational studies [147, 148] already in-
vestigated the ow in AV-stulas, none of them focused, according to our
knowledge, on the hemodynamic impact of the geometry of the anastomo-
sis. erefore, the present study was set up to assess the importance of the
AVF-anastomosis geometry by calculations of owdistribution andpressure
drop at the anastomosis site.
e 6 segment approach (not taking into account the anastomosis) is re-
ported in detail in literature overviews, describing AVF-complications and
solutions [151, 152]. When, for example, an ischemic case is presented (where
blood ow towards the hand is too low because of a too high AVF ow),
suggested solutions are DRIL (distal revascularisation-interval ligation) [47,
48], PAI (proximalisation of the arterial inow) [49] or RUDI (revision us-
ing distal inow) [50] to create a longer ow pathway, besides banding (the
narrowing of the initial draining vein) [51–53] and even creating an articial
stenosis in the draining vein [54]. ose are dierent solutions, aiming to
increase the AVF ow resistance, and with it, to decrease access ow and/or
increase pressure in the distal artery.
In this study, we focused on the 7th segment, the anastomosis itself, as
a very important factor in the AVF hemodynamics. In this approach, there
is a clear distinction between the pre- (6 element) and the postoperative (7
element) system. Before AVF creation, the main pressure drop between the
high proximal artery pressure and the low proximal vein pressure is situated
in the distal microcirculation and capillary bed. Aer creation of an AVF as
vascular access, the high pressure in the proximal artery ismaintained by the
sympathic reex which increases the cardiac output and the enlargement of
the feeding vessels. On the other hand, the low pressure in the proximal vein
is maintained by the enlargement of the draining veins. However, the main
pressure drop is now, in the ideal case, situated over the anastomosis. In this
case, a high arterial pressure and a low venous pressure are maintained.
A chronically large anastomosis size causes a small anastomosis resis-
tance.is small resistance will probably result in a high ow in the vascu-
lar access and the ’main’ pressure drop will now be divided over the anas-
tomosis and a narrowing of the vascular system.is high ow can trigger
ischemia. e model of Barnes et al. enlightened that ischemia is avoided
when the ratio of the resistances of the anastomosis versus proximal artery
is smaller than the ratio of the resistances of the distal bed versus the arte-
rial collaterals [153]. In the opposite situation, the possibility of ow reversal
and ischemia is signicant. Some authors suggest, as ideal solution for these
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high ow cases, the closure of the large anastomosis and the creation of an
anastomosis with a more appropriate size [153, 154]. But, on the contrary, in
in vivo studies where analogous boundary conditions are meant to be cre-
ated, anastomosis length (length of surgical incision) variations of 25% are
permitted [155] and the hemodynamic impact of the anastomosis size seems
neglected.is study shows that this change in anastomosis size has a large
and underestimated impact on blood ow and local pressures.
Beside the size of the anastomosis, a secondparameter determining anas-
tomosis resistance is the angle of the anastomosis, as it will highly determine
the local velocity eld and hemodynamics, and hence the energy dissipation
(pressure drop) over the anastomosis. In literature, the impact of the angle
of an anastomosis has been studied in numerical, in vitro and in vivo stud-
ies in the domain of distal leg artery bypasses [156], human aorta bypasses
[157] and pig aorta bypasses [158], but not in the context of AVF. Although
the study of Chua et al. is using the conguration similar to the side-to-end
AVF, the applied geometry has a very small gra-to-artery diameter ratio of
0.3 [157].
Because of the lack of studies dealing with the anastomosis resistance,
the present study focused on the anastomosis size and anastomosis angle. It
can be observed from our results that the pressure drop rises quadratically
with increasing ow rate (all curves with R2-values above 0.99) and that,
as expected, the pressure drop decreases with increasing anastomosis size.
e quadratic term superimposed on the linear term (as observed inHagen-
Poiseuille ow) in the pressure drop curves is due to the secondary ow at
the anastomosis site.is secondary ow can be seen in Figure 10.5(a-c). In
the case of 90○, it is clear from Figure 10.5c that at the inner wall, a low ow
zone appears.is can also be seen as a low wall shear stress (WSS) zone in
Figure 10.5f, which may lead to a region with increasing intimal hyperplasia
and stenosis formation. Figure 10.5c and 10.5d show aWSS distribution with
higher peak values and less signicant low value zone.
In the cases exceeding 58○of anastomosis angle, reverse ow in the distal
artery is present. It should be noted that this ‘steal’, can lead to the distal
hypoperfusion syndrome [159, 160] and results in ischemia [44, 161].
As limitation of the present study, it can be brought up that the used
geometries and boundary conditions are a simplication of the complex
cardio-vascular human anatomy and physiology. For example, the study of
the cardiac adaptation (with the heart as the eight component of the circuit)
was neglected.e model represents an ideal anastomosis without taking in
consideration parameters as athero- and arterio-sclerosis and intimal hyper-
plasia formation, loss of wall distensibility, elasticity of the venous wall, en-
dothelial dysfunction, AVF maturation and repeated cannulation,. . .But on
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Figure 10.5: Le: Velocity magnitude [m/s] and in-plane streamlines (sagittal
plane); Right: Wall shear stress [Pa] on the wall surface at the anastomosis side.
All gures for inow rate of 1200ml/min: (a, d) 27○anastomosis angle; (b, e)
45○anastomosis angle and (c, f) 90○anastomosis angle.
the other hand, the idealized model allowed us to study the separated local
hemodynamic impact of the anastomosis angle and size, hereby uncoupling
anastomosis size and angle from each other and from other anatomic and
physiologic factors. is is, obviously, dierent from clinical reality where
the anastomosis angle and size are not totally independent, but a compro-
mise of what is achievable in a given patient with a given arterial and venous
territory.
e used non-parametric models and relative basic CFD calculations
can be seen as a limitation, but do however not change the overall message
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and conclusion of this study. Numerical values shown in Figures 10.3 and
10.3 cannot be seen as absolute values but more as indicative values to show
the global trend of pressure drop and ow distribution variation in changing
anastomosis dimensions. CFD is a well-established technique and it can be
noted that the in vitro validation of CFDmodeling has already been done in
many other cases, among others in the eld of vascular accesses (as in Sec-
tion 11.2). Furthermore, it can be remarked that the anastomoses were oval
shaped, due to minimize computational geometric and calculation errors.
e side-artery-to-end-vein conguration was chosen in this study in favor
of the side-to-side alternative, because the choice of anastomosis size and
angle is more pertinent in the creation of this AVF [162].
Finding an optimal anastomotic length for a stula, usable for all pa-
tients, is unrealistic due to the varying, patient-specic anatomic and phys-
iologic conditions. As general idea should it always be kept in mind that the
main pressure drop in the arterio-venous circuit should be over the anasto-
mosis to avoid high pressure in the venous system and distal ischemia prob-
lems. A too small anastomosis on the other hand will have a tendency to
non-maturation or poor ow during dialysis session.
From our clinical practice, the best anastomosis length at the wrist or
forearm is probably 7mm for small vessels. Evolving towards an elliptic
shape aer maturation and therefore taking 3 to 4mm of width, an anas-
tomosis size of 16.5 to 22mm2 can be found. ese sizes are comparable
with the results of lower pressure drop and higher venous outow as seen
in Figure 3a and 4a. e angle is, in most cases, easy to make with 30 to
45○, depending on the anatomy.e aim of making an angle of about 135○is
demandingmore vein length andwas therefore also taken out of the compu-
tational study. For vessels already dilated, and especially for arteries, with a
diameter more than 5mm, the length is best about 5 to 6mm.ese lengths
give an anastomosis size between 11.8 to 18.5mm2 (for 3 or 4mm of width),
resulting in the higher pressure drop values in Figure 3a. A longer anasto-
mosis will cause too much ow in these cases, from our clinical experience.
At the elbow, the reasoningmentioned for dilated, large, arteries can be used.
So anastomosis lengths from 5 or 6mmare themost appropriate choice.e
angle to choose is depending on the anatomy, and should vary from 25 to
90○. For very big vessels at the elbow, the length ought to be 4mm to avoid
distal ischemia and the evolution toward a very high owstula. Finally, one
should keep in mind that the initial size of the anastomosis and the vessels
might change during maturation.
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10.5 Conclusion
While the hemodynamic impact of the anastomosis size and angle of anAVF
is in many studies and daily practice largely underestimated, we have shown
in this computer analysis that the owdistribution and pressure drop change
signicantly with anastomosis size and angle.e results prove that the AV-
anastomosis should be considered as an important and full component of
the total AVF ow circuit. In particular, it is shown e.g. that a change of
2mm in anastomosis length can increase the pressure drop by more than
30%. erefore, in the surgical creation of an AVF as vascular access, the
anastomosis geometry should be chosen with care while keeping in mind
the impact of the geometry on pressure drop and ow distribution, both
during creation of a stula as during complication solving interventions.
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11.1 Experimental validation of pulse wave propagation model
11.1.1 Introduction
Hemodialysis is a common treatment for end-stage renal disease (ESRD) pa-
tients [9, 10]. To facilitate hemodialysis, a well-functioning vascular access
is needed. e vascular access should be able to provide a high blood ow
and should be easily accessible for repeated cannulation over time [21, 25].
e preferred vascular access is an arterio-venous stula (AVF) in the arm,
which is a surgically created connection between artery and vein (anasto-
mosis), resulting in a signicant ow increase (up to thirtyfold) and vessel
remodeling [19, 21, 25, 26].
e AVF is usually created three months prior to initiation of hemodial-
ysis either at wrist level (lower arm AVF) or at elbow level (upper arm AVF)
[44, 163–165]. In current clinical practice, the selection is based on the pa-
tient’s medical history and the caliber of the involved vessels, i.e. when the
caliber of the radial artery and the distal cephalic vein assessed by duplex ul-
trasound exceed 2 mm a lower arm AVF is created, otherwise an upper arm
AVF. Despite the preoperative diagnostics, complications aer AVF creation
occur frequently. Lower arm AVFs are hampered by non-maturation in up
to 50% of all cases which implies that six weeks aer surgery, either the AVF
is not dilated suciently, the blood ow is too low, and/or the AVF is lo-
cated too deep [19, 21, 25, 26, 44, 166]. Upper arm AVFs are hampered by
long-term complications like distal ischemia and/or cardiac failure in 20%
of all cases [21, 25, 44, 166].
To reduce the number of complications, tools to optimize the location
for an individual patient are therefore of interest. Since a too low brachial
ow directly aer surgery is associated with non-maturation [26, 167] and
since an immediate postoperative ow larger than 30% of the cardiac output
is associated with distal ischemia and cardiac failure [44, 163–165], it might
be benecial for surgical decision-making to have a tool that is able to pro-
vide, preoperatively, a quantitative patient-specic estimate for the immedi-
ate postoperative ow.
Previously, a (distributed lumped parameter) pulse wave propagation
modelwas developed that is able to simulate pressure andowwaveforms af-
ter both upper and lower armAVF surgery [168].is computationalmodel,
that is fed by patient-specic data was used to predict immediate postoper-
ative mean ows in ten ESRD patients. It was shown that the model selected
the sameAVF location as an experienced surgeon in nine out of ten patients.
However, the postoperative ow measured by Doppler ultrasound was only
adequately predicted in six out of ten patients. Dierences between model
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predictions and measurements might have several reasons. First, the accu-
racy of the measured ows, input data and boundary conditions might limit
the correspondence between the simulated and measured ows. Second,
the model neglects vascular adaptation and autoregulation of the periph-
eral bed which might result in dierences between measured and predicted
ows. Another reason might be that the physical description of the pulse
wave propagation of the pressures and ows is incomplete.
e only way to determine if the physical description is complete, is by
validating the pulse wave propagation model with an experimental setup
which mimics the surgical AVF procedure and gives the possibility to de-
termine a larger number and more accurate mechanical, geometrical and
hemodynamic (pressure and ow waveforms) data than would be possible
in an in vivo situation [169, 170]. In addition, vascular adaptation and regu-
lation of the peripheral beds are excluded and do not inuence the compar-
ison of experimental and simulation results. Furthermore, the experimental
setup can be used to validate the simulated pressure and ow waveforms
which are needed when adaptation laws will be included in future work.
For arteries, in vivo and experimental validation studies for pulse wave
propagation models [169–173] have been performed. However, these study
mainly focused on the systemic arterial tree with arterial owsmuch smaller
than the ow aer AVF creation. No validation study is reported that vali-
dates a pulse wave propagation model simulating the extreme ow increase
aer AVF surgery. Moreover, the propagation of measurement uncertainty
in the model input to uncertainty in the model output (i.e. precision) was
not analyzed previously. However, a quantitative estimate of the precision is
required for a proper comparison as well as when inferences based onmodel
predictions will be made.e output uncertainty can be assessed by using a
method based on generalized chaos expansion [174] or by means of Monte
Carlo simulations [175]. e advantage of the method of Xiu et al. is that
less model runs are needed than for Monte Carlo simulations. However, the
implementation is less straightforward since the model equations are made
stochastic and the most suitable polynomials for expansion of the stochastic
function need to be selected.
e aim of this study is to validate the previously developed distributed
lumped parameter pulse wave propagationmodel for the prediction of pres-
sure and ow before and aer AVF creation. In this way it is determined if
the physical description of the pulse wave propagation is correctly captured
by the model. e uncertainty in pressure and ow waveforms, resulting
from uncertainties in the model input parameters, is accounted for by using
Monte Carlo simulations.
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e manuscript is outlined as follows. First, the experimental setup is
described and how mechanical, geometrical and hemodynamic properties
are determined. is is followed by a brief description of the distributed
lumped parameter pulse wave propagation model. Next, it is discussed how
the model was adapted to the experimental conditions and how the model
was validated with the experimental setup. In this context, the uncertainty
analysis is described in detail.
11.1.2 Material and methods
In vitro experimental setup
Previous studies that used an experimental setup consisting of silicone tubes
to validate a pulse wave propagation model mainly focused on the systemic
arterial tree [170, 173] or single arterial tubes [172]. In addition, the simu-
lated arterial ows were much smaller than the ows in the arm aer AVF
creation. In this study, a pulse wave propagationmodel is validated that sim-
ulates the ow increase aer AVF surgery. Furthermore, the hemodynami-
cal complex anastomosis is incorporated in this experimental study, whereas
this was not addressed earlier in a silicone tube network.
e experimental silicone tubemodel,mimicking the anatomy andphys-
iology of the human vasculature in the arm, was built based on patient-
specic data obtained in a previous study [168]. e arterial geometrical
data, obtained from magnetic resonance (MR) and ultrasound (US) exami-
nations, were used to generate a three-dimensional (3D) CAD-model which
was used as benchmark for manufacturing the 3D silicone tube model. For
the construction of the silicone arterial model, Rapid Prototype models and
dip-coating techniqueswere used (in-house techniques and knowledge).e
venous silicone model, representing the venous outow tract, was based on
geometrical data obtained from US measurements of an ESRD patient and
was constructed by painting silicone, layer by layer, on a steel rod [176].is
technique was chosen over dip-coating techniques as it was expected to re-
sult in lower wall thicknesses and thus lower stiness. To mimic the AVF,
the arterial and venous silicone models were connected by an anastomosis
with an aperture of approximately 15mm2 and an in-plane angle of 30○ [34].
e resulting silicone network model consisted of the brachial, radial, ulnar
and interosseus artery (arterial tract) and of the cephalic, basilic, axillary
and subclavian vein (venous tract).
is network model was built in a mock loop [177, 178] including a sili-
cone aorta and subclavian artery constructed by Hemolab B.V. (Eindhoven,
e Netherlands)(Figure 11.1, top). e arterial and venous silicone net-
work was placed in a water tank to allow for ultrasound measurements.
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Figure 11.1: Network model mock loop scheme (top) and computational domain
(bottom).e numbers refer to the edges given in Table 11.2. Pressure (x) and ow
(0) waveform acquisition locations are shown.
e complete circulation circuit was lled with water and the water was
pumped through the mock loop by a step pump (Parker Hannin GmbH,
Oenburg, Germany) that was regulated by a normalized modied sinus-
squared ISO5840 function (Figure 11.2) in LabView (National Instruments
Inc., Austin, Texas, USA).is resulted in a pump ow rate of approximately
5 l/min which is comparable to a physiological cardiac output [179]. e
uid entered the proximal aorta via a exible valve (Hemolab B.V) and could
thereaer ow in two directions: to the distal aorta which was closed by a
windkessel, and to the subclavian artery which was the inow artery of the
97
11. Experimental validation
0 1
0
1
Time [s]
No
rm
ali
ze
d 
am
pl
itu
de
 [−
]
Figure 11.2: Pump input step function (modied sinus-squared ISO5840).
silicone network model.is silicone network model had three outows in
the arterial part (at radial, ulnar and interosseus artery) and one in the ve-
nous part (at the subclavian vein). Formimicking the preoperative situation,
the venous outow was closed with a clamp, whereas for the postoperative
situation the clamp was released to mimic the presence of a lower arm AVF.
e lower arm AVF was chosen because it involves the largest arterial and
venous network and thus the most complex topology was studied.
Experimental measurement techniques
Geometrical measurements. e lengths of all arteries, connecting tubes
and veins weremeasured using a ruler. In addition, the ruler was used to de-
termine the location of the anastomosis with respect to the brachial bifurca-
tion.e proximal and distal arterial and venous diameters were measured
at working pressure with ultrasound (Picus ultrasound system, ESAOTE
B.V.,e Netherlands).e diameters of connecting tubes were determined
with a micrometer.
Flowmeasurements. Flowwaveformsweremeasured, at the proximal aorta
and the proximal subclavian artery (Figure 11.1) with a Transonic ow me-
ter acquisition system (Team 21 Compatible, Transonic Systems Inc., Ithaca,
NY,USA).e signal was sampled at 500Hz using a data-acquisition (DAQ)
unit (BMC-2090, National Instruments Inc.).e acquisition soware was
programmed in LabView (National Instruments Inc., version 7.1, Austin,
Texas, USA). For all outow tracts, the time-averaged outows were mea-
sured volumetrically.
98
11.1. Experimental validation of pulse wave propagation model
Pressure measurements. Pressure waveforms were measured, using pres-
sure transducers (P10EZ-1, Becton Dickinson Critical Care Systems, Sin-
gapore) connected to a multi channel compact amplier system (PICAS,
Peekel Instruments, Rotterdam,e Netherlands).e measurements were
performed at predened locations along the experimentalmodel (Figure 11.1)
by sliding a uid-lled epidural catheter (Portex Epidural Catheter, Smiths
Medical ASD inc., Keene, USA) through the experimental model.e pres-
sure transducers were also connected to the DAQ-unit.
Mechanical properties of the silicone vessels. e diameter change (dis-
tension) of the arteries and veins was measured by using wall-tracking so-
ware (Artlab) that is incorporated in the Picus ultrasound system (ESAOTE
B.V.,e Netherlands). Since pressures were measured simultaneously, the
distension, ∆d, and the pulse pressure, ∆p, were used to determine the local
distensibility, D:
D = 1
A0
∂A
∂p
≈ 1
A0
∆A
∆p
= 2ddia∆d + (∆d)2
d02∆p
(11.1)
in which A0 and d0 are the cross-sectional area and the diameter at mean
pressure, and ddia the diastolic diameter.e distensibility of the subclavian
artery was estimated by using its wall-thickness-to-radius ratio of 0.1 and by
assuming the Young’s modulus equal to the one of the experimental aorta,
as the subclavian artery was made from the same material.e distensibili-
ties of the connecting tubes were assessed from static volumetric compliance
measurements or set to 10−7 Pa−1 otherwise.
Pressure dropover the anastomosis.e extra pressure drop over the anas-
tomosis was captured via a minor loss coecient, dened as Kloss = ∆p1
2 ρv
2 ,
in which ∆p is the pressure drop from the inow artery to the outow vein,
ρ is the density, and v is the mean blood velocity in the inow artery. Kloss
was determined bymeasuring the pressure drop as function of the Reynolds
numbers from Re=200 to 3500 (Figure 11.3A).
Mathematical model
e pulse wave propagation model used here was previously developed by
Huberts et al. [168], and will only be described in short.e computational
domain for the simulations consisted of a truncated part of the aorta, the
subclavian, brachial, radial, ulnar and interosseus arteries, the anastomosis,
the cephalic, median cubital, basilic, axillary and subclavian veins, and, in
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Figure 11.3: e experimentally derived minor loss coecient as function of the
Reynolds number (A) and the reducedminor loss equation (Equation (11.4)) imple-
mented in thewave propagationmodel developed byHuberts et al. [168] as function
of anastomosis angle (B). In panel C, the comparison between the experimentally
derived loss coecient (Reynolds number) and the loss coecient implemented in
the wave propagation model (anastomosis angle) is shown.
addition, all connecting tubes (Figure 11.1, bottom).e vessels were divided
in segments with a maximum length of 5 cm. In each segment the local rela-
tion between pressure and ow is described. For the scope of modeling the
eect of vascular access creation on blood pressure and ow distribution,
segments are needed that represent arteries, veins and the anastomosis. All
arterial and venous segments weremodeledwith a lumped parametermodel
derived from local mass and momentum equations. e anastomosis seg-
ment was modeled with a nonlinear resistance based on two semi-empirical
loss coecients, Kv and Kd , that describe the loss from the proximal artery
to, respectively, the proximal vein and the distal artery and have been de-
ned by Gardel [180, 181]:
Kv = k1(1 − q∗)2 + q∗2[k2cot θ2 − k3 + k4−k5A∗A∗2 ] + k6q∗(1 − q∗)(1 + 1A∗ )cot θ2 (11.2)
Kd = k7(1 − q∗)2 + k8q∗2 − k9q∗(1 − q∗) (11.3)
in which q∗ is the ratio between ow through the vein and ow through
the proximal artery, A∗ is the ratio between cross-sectional area of the vein
and cross-sectional area of the proximal artery and θ is the angle between
proximal artery and proximal vein. Empirically determined values for the
constants k1 to k9 are given in Table 11.1.
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k1 k2 k3 k4 k5 k6 k7 k8 k9
0.95 1.3 0.3 0.4 0.1 0.4 0.03 0.35 0.2
Table 11.1: Semi-empirical determined dimensionless constants k1 to k9 for equa-
tion (11.2) and (11.3).
Parts of the cardiovascular system, for which no detailed information on
pressure and ow was required, were truncated and terminated with three-
element windkessel models. Assembling all lumped segments resulted in a
system of dierential equations that describes the pulse wave propagation
of the pressure and ow waveforms. is system was solved by numerical
integration applying the trapezium rule for implicit time integration. On
the rst node, a measured (aortic) ow was prescribed, whereas the venous
outow was closed with a xed intravenous pressure.
In this study, pressure and ow waveforms of the pulse wave propaga-
tion model were validated with experimentally derived pressure and ow
waveforms.e input parameters of the pulse wave propagationmodel were
adapted to the experimental setup. For this, geometrical (vessel length, ves-
sel diameters) and mechanical characteristics of the vessels (vascular com-
pliance) were mandatory. Furthermore, information on anastomosis con-
guration (location, angle), windkessel parameters, uid properties (den-
sity and dynamic viscosity), intravenous pressure and an input (aortic) ow
waveformwere required. How these input parameters were obtained will be
discussed in the next section.
Experimental validation: Model parameters for the pulse wave propagation
model
e input parameters for the pulse wave propagation model were derived
from the measurements and are given in Table 11.2. In addition, uncertainty
domains of these input parameters were estimated as they are input for the
uncertainty analysis.
Geometrical parameters. e measured lengths were directly used in the
pulse wave propagation model and the uncertainty domain was set to ± 5%,
which equals to ameasurement error of 1 mm in the shortest vessel. Also the
position of the anastomosis was variedwithin± 5%.e uncertainty domain
for the diameters was set to ± 10%. For the arterial and venous diameters,
linear tapering within a vessel was assumed. e inuence of tapering was
investigated by changing the smallest diameter of a vessel while changing
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the largest diameter in the opposite direction. e uncertainty domain for
these changes were based on 10% of the smallest diameter.
Mechanical parameters. For the pulse wave propagation model, the local
vessel wall compliance per segment length was needed.is was derived by
multiplying the distensibility in Table 11.2 by the local cross-sectional area,
thus assuming a constant distensibility within each vessel. For the distensi-
bilities obtained with ultrasound, themeasurement uncertainty domain was± 15%, whereas for the distensibilities derived by volume compliance mea-
surements, the measurement uncertainty domain was ± 20%.
Pressure drop over the anastomosis. To match the minor loss coecients
in the pulse wave propagation model with the measured loss coecient, we
assumed that the majority of the proximal artery ow ows through the
proximal vein (q∗ ≈ 1) and that the arterial and venous cross-sectional areas
were almost similar (A∗ ≈ 1). Equation 11.2 and Equation 11.3 then reduce to
Kv = k2cot θ2 − k3 + k4 − k5 = 1.3cot θ2 and Kd = 0.35 (11.4)
is relationship for Kv is shown in Figure 11.3B. For an anastomosis angle,
θ, between 3 and 12 degrees, the loss coecient, Kv , matches the experi-
mentally determined loss coecient, Kloss, in the range of Reynolds num-
bers 250-4000 (Figure 11.3C). Finally, the loss coecient, Kv , was modeled
by the original Equation 11.2, while the anastomosis angle was varied be-
tween 3 and 12 degrees. Because the ow through the distal artery was small
compared to the ow through the proximal vein, loss coecient, Kd , was
neglected.
Constants. e uid used in the experiment was water which has, at room
temperature (20○C), a density of 103 kg/m3 and a dynamic viscosity of 10−3
Pa.s.ese model parameters would hardly vary during the experiment and
therefore the uncertainty domains were set to ± 1% and ± 5%, respectively.
Boundary conditions. e peripheral resistance, Rp, of each windkessel
was determined as the ratio of local mean pressure and local mean ow.e
local mean ow was assessed by the volumetric measurements, while the
mean pressure was assessed by time-averaging the measured local pressure
waveforms.e characteristic impedance, Z0, was assessed by using
√
ρ
DA02
in which ρ is the blood density, D the local distensibility and A0 the cross-
sectional area [182].
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Finally, the compliance, C, for each windkessel was determined by di-
viding the time constant, by the dierence between the peripheral resistance
and the characteristic impedance (Rp−Z0). For the aorta, the time constant
was assessed from the local pressure waveform via the ‘area method’ [183].
e time constant in the radial artery was assessed frommultiplying the lo-
cal peripheral resistance with the compliance of the outow tube. For the
ulnar and interosseus arteries, the radial artery time constant was assumed.
As a result, the time constant was 5.4 s in the aorta and 0.4 s in the other
outow arteries. In the uncertainty analysis, the time constants were varied
by ± 20%.
For the inow boundary at the aorta (i.e. the ascending aorta ow),
we used the pre- and postoperative aortic ow measurements, with an esti-
mated uncertainty domain of ± 5%. As outow condition at the subclavian
vein, we used the measured mean pressure with an uncertainty domain of± 10%.
Uncertainty analysis
Simulations with the pulse wave propagation model were performed for
both the pre- and postoperative conguration. To examine the propaga-
tion of input uncertainty to the output, Monte Carlo simulations were per-
formed. Varying all input parameters independently within their uncer-
tainty domain might result in non-physiological combinations of input pa-
rameters and thus non-physiological output (e.g. a small artery continuing
in a larger artery).erefore, the input parameters of adjacent vessels were
changed simultaneously (Table 11.2). is resulted in 44 independent in-
put parameters for the preoperative conguration and 58 parameters for the
postoperative conguration. Input samples were generated by Latin Hyper-
cube sampling, i.e.: For each input variable, its previously dened uncer-
tainty domain is divided into equiprobable intervals and within each inter-
val a value is randomly selected. Consequently, an input value is used only
once for each interval and a full coverage of the parameter input space is ob-
tained [184]. One sample is thus a point in the input parameter space. e
total number of samples generated was 5000 times the total number of input
parameters in analogy with previous studies of Huberts et al. [185].
For the preoperative conguration, the simulated pressure waveforms
in the aorta, the proximal and distal brachial artery, the proximal and distal
radial artery and the proximal ulnar artery were compared to the measured
pressure waveforms (Figure 11.1, bottom). is was extended by the distal
and proximal cephalic vein, and the basilic vein for the postoperative con-
guration. e ow waveforms were compared at proximal aorta and sub-
clavian artery. For the comparisons, the median of the simulated pressure
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Edge name Edgenumber Length [mm] Diameter [mm] Distensibility [Pa
−1] Mean flow [ml/min] Mean pressure [mmHg] Time con-stant [s]
begin end pre post pre post
rigid connecting element 1 50 (5%) 28.9 (10%) 28.9 (10%) 10−7 a(-)
proximal aorta 2 150 (5%) 28.9 (10%) 28.9 (10%) 2.1 ⋅10−5 (15%)
distal aorta 3 310 (5%) 28.9 (10%) 28.9 (10%) 2.1 ⋅10−5 (15%) 4650 (10%) 4375 (10%) 98 (10%) 90 (10%) 5.4 (20%)
subclavian artery 4 100 (5%) 8.0 (10%) 8.0 (10%) 7.7 ⋅10−6 b(20%)
rigid (tapered) connecting
tube 5 60 (5%) 8.0 (10%) 10 (10%) 10
−7 a(-)
compliant connecting
tube 6 130 (5%) 10 (10%) 10 (10%) 1.1 ⋅10−6 b(20%)
rigid connecting tube 7 80 (5%) 10 (10%) 10 (10%) 10−7 a(-)
compliant (tapered) con-
necting tube 8 20 (5%) 10 (10%) 6.0 (10%) 1.1 ⋅10−6 b(20%)
rigid connecting tube 9 55 (5%) 6.0 (10%) 6.0 (10%) 10−7 a(-)
brachial artery 10 215 (5%) 6.0 (10%) 4.5 (10%) 1.7 ⋅10−5 (15%)
proximal ulnar artery 11 67 (5%) 3.6 (10%) 3.6 (10%) 1.1 ⋅10−5 (15%)
distal ulnar artery 12 173 (5%) 2.7 (10%) 1.9 (10%) 1.7 ⋅10−5 (15%) 46 (10%) 42 (10%) 96 (10%) 88 (10%) 0.4 (20%)
interosseus artery 13 110 (5%) 1.3 (10%) 1.3 (10%) 1.1 ⋅10−5 (15%) 5 (10%) 5 (10%) 98 (10%) 88 (10%) 0.4 (20%)
radial artery 14 240 (5%) 3.4 (10%) 3.2 (10%) 1.5 ⋅10−5 (15%) 50 (10%) 46 (10%) 96 (10%) 84 (10%) 0.4 (20%)
cephalic vein lower arm 15 210 (5%) 2.9 (10%) 3.0 (10%) 1.4 ⋅10−5 (15%)
cephalic vein upper arm 16 180 (5%) 4.3 (10%) 4.3 (10%) 2.4 ⋅10−5 (15%)
subclavian vein 17 32 (5%) 5.6 (10%) 5.6 (10%) 8.4 ⋅ 10−6 (15%) 5.7 (10%) 5.7 (10%)
median cubital vein 18 30 (5%) 4.5 (10%) 4.5 (10%) 8.4 ⋅10−6 (15%)
basilic vein 19 180 (5%) 4.5 (10%) 4.6 (10%) 8.4 ⋅10−6 (15%)
a Assumed value for the rigid tubes.
b Estimated from static volume compliance measurements.
Table 11.2: All input data for the wave propagation model that are derived from measurements on the experimental setup. e mean
pressure, mean ow and time constant are only given for the edges that are closed by a windkessel segment. In brackets the estimated
measurement uncertainty is given in percentages.e vessels that are changed simultaneously during the uncertainty analysis are grouped
in one cell.
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and ow waveforms of all Monte Carlo simulations was used as well as a
condence interval, formed by the 25th and 75th percentile interval.
11.1.3 Results
Preoperative results
Table 11.3 shows that the simulated mean ows correspond to the measured
mean ows in the aorta, subclavian artery, the radial artery and the ulnar
artery. e shapes of the simulated aorta and subclavian artery ow wave-
forms correspond to the measured ow waveforms, though the simulated
subclavian artery ow appears less attenuated (Figure 11.4).
For all arteries, simulated andmeasuredmean pressures are similar (Ta-
ble 11.3).e shapes of the simulated pressure waveforms (Figure 11.4) cor-
respond to the measured pressure waveforms, although the simulated pres-
sures are less attenuated resulting in amore pronounced second peak, which
is clearer in distal pressure waveforms. For the aortic pressure waveform, a
phase dierence of approximately 50ms is observed. Presumably, the tim-
ing of the measured aortic pressure waveform is inaccurate as the systolic
pressure peak arrives before the ow peak.
Mean pressure [mmHg] Mean flow [ml/min]
measureda simulatedb measureda simulatedb
proximal aorta 95 93 (88,99) 4750 4747 (4682,4813)
subclavian artery 101 98 (36,161)
proximal brachial artery 98 93 (88,99)
distal brachial artery 98 93 (87,99)
proximal ulnar artery 98 93 (87,99) 46 44 (35,53)
proximal radial artery 98 93 (87,99) 50 48 (34,63)
distal radial artery 98 92 (86,99)
aMeasured value without uncertainty interval.
bMedian value with 25th and 75th percentiles.
Table 11.3: Measured preoperative mean pressures and ows and their simulated
values.
Postoperative results
During the analysis of the postoperative results it was observed that, in rst
instance, the resistance in the distal cephalic vein was not properly deter-
mined. Aer excising the distal cephalic vein from the setup, a non-smooth
vessel lumen that was twisted over the full length was found resulting in a
large pressure drop of 24mmHg from the distal cephalic vein to the proximal
cephalic vein (Table 11.4). is pressure drop was approximately ten times
larger than the expected pressure drop as calculated from Poiseuille’s law.
As this additional pressure drop was not captured by the model, all Monte
105
11. Experimental validation
Median of simulation results
25th-75th percentile of 
simulation results
Experimental result
60
80
100
120
140
160
0 1Time [s]
Pr
es
su
re
 [m
m
Hg
]
0 1Time [s]
Pr
es
su
re
 [m
m
Hg
]
70
90
110
130
150
40
60
80
100
120
140
160
0 1Time [s]
Pr
es
su
re
 [m
m
Hg
]
60
80
100
120
140
160
0 1Time [s]
Pr
es
su
re
 [m
m
Hg
]
0 1
−1
0
1
2
3
4 x 10
4
Time [s]
Fl
ow
 
[m
l/m
in]
Proximal aorta
70
80
90
100
110
120
130
140
0 1Time [s]
Pr
es
su
re
 [m
m
Hg
] Proximal aorta
0 1
−500
0
500
1000
1500
Time [s]
Fl
ow
 
[m
l/m
in]
Subclavain artery
40
60
80
100
120
140
160
180
0 1Time [s]
Pr
es
su
re
 [m
m
Hg
] Distal radial artery
Proximal brachial artery
Distal brachial artery
Proximal ulnar artery
Proximal radial artery
-1000
Preoperative
Arteries
Figure 11.4: e preoperative pressure and ow waveforms on several arterial lo-
cations.
Carlo simulations were performed oncemore with a tenfold increased resis-
tance in the distal cephalic vein with an uncertainty of ± 10%. Since vessel
abnormalities could also be present in human vasculature and the resulting
additional pressure drop has signicant eect, the results of both analyses,
with and without the extra resistance, are presented in Table 11.4.
When considering the additional resistance of the distal cephalic vein,
the simulatedmean ow of the subclavian artery and the distal cephalic vein
in Table 11.4 now correspond to the measured mean ow. Beside a better
agreement between measured and simulated ows, this is also the case for
the pressures. In Table 11.4, it can be observed that the previous observed
underestimation of the measured mean arterial ows and pressures are re-
duced, while measurements and simulations now coincide. is especially
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holds for the distal cephalic vein pressure. As in the preoperative simula-
tions, the simulated arterial pressure waveforms (Figure 11.5) are less atten-
uated than the experimentally measured ones. In addition, a similar phase
dierence in the aorta is observed.e shape of themeasured and simulated
venous pressurewaveforms (Figure 11.6) are similar, although the dierences
are larger than for the arterial site, i.e. a phase dierence of approximately
50ms in the proximal cephalic and basilic vein.
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Figure 11.5:e postoperative pressure and ow waveforms on several arterial lo-
cations for simulations with additional resistance.
11.1.4 Discussion
In this study, we aimed to experimentally validate a previously developed
pulse wave propagation model for the prediction of pressure and ow be-
fore and aer AVF creation. In this way, it was determined if the physical
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cations for simulations with additional resistance.
description of the pulse wave propagation in both cases was captured cor-
rectly by themodel. It was found that the pulse wave propagationmodel was
able to accurately simulate the pre- and postoperative mean pressures and
ows in the experimental setup but that the simulated pressure and ow
waveforms were less attenuated than the measured waveforms. is most
likely results from viscoelastic behavior of the experimental tubes [172, 186].
Experimental setups have previously been used to validate pulse wave
propagation models, but not in the situation aer AVF surgery when ows
are signicantly increased compared to normal and the anastomosis is in-
cluded. Bessems et al. [172] have validated their pulse wave propagation
model with both a straight and tapered viscoelastic silicone tube. Swillens et
al. [173] used a silicone setup to validate their pulse wave propagationmodel
in an aneurysm case study. An experimental setup that included a more de-
tailed representation of the arterial tree and thus also physiological wave re-
ections resulting from bifurcations, was used by Matthys et al. [170]. Next
to these experimental validations, Reymond et al. performed, recently, an in
vivo validation of a patient-specic pulse wave propagationmodel of the sys-
temic arterial tree [169, 171]. However, although geometry, ow and pressure
measurements were all performed on one individual patient, it was impossi-
ble to measure all input parameters patient-specically (e.g. local vessel dis-
tensibility and peripheral resistance and compliance).ereby, pressure and
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ow measurements are only possible on a limited number of positions over
the systemic tree [169–171]. In addition, clinical measurements are usually
hampered by large measurement uncertainties, which were not considered
in any of the studies.
In this work, in contrast to these studies, the uncertainty of the model
input was taken into account, yielding an estimation of the precision on the
pressure and ow waveforms. e 25th-to-75th percentile interval captured
a decrease or increase ranging, dependent on location, from 2 to 14% of the
median value for the mean pressures, while for the mean ows larger uncer-
taintieswere observed. Preoperatively, the uncertainties of themean ows in
the subclavian artery, the radial artery and the ulnar artery were respectively
60%, 20% and 30%, while postoperatively the uncertainties of these vessels
were about 17%, 20% and 25%. e uncertainty in mean ow in the distal
cephalic vein was approximately 13%.e large uncertainties in mean ows
can be explained by the fact that the ow waveform oscillates around zero
which means that a small deviation in the waveform will result in a signi-
cant change in mean ow. Clinically, an uncertainty of approximately 20%
in the mean ow in the subclavian/brachial artery is acceptable because the
surgeon aims at an inow of 400-500 ml/min while 300 ml/min is sucient
for proper hemodialysis treatment. When considering specic time points,
the width of the 25th-to-75th percentile interval for the ows is maximum
300 ml/min and for the pressure maximum 20 mmHg. us, considering
the precision is advised for validation studies.
When simulating the postoperative situation, at rst instance, it was ob-
served that the subclavian artery owwaveforms had similar shapes but that
the mean ow signicantly diered between measurement and simulation.
Furthermore, the simulated mean pressure in the distal cephalic vein was
signicantly smaller than the measured mean pressure. Upon closer exam-
ination, a large pressure drop from the distal cephalic vein to the proximal
cephalic vein was found in the experimental setup and all simulations were
repeated with a larger resistance over the distal cephalic vein. As a result, the
correspondence between simulated and measured pressure and ow wave-
forms signicantly improved.us, when incorporating the additional pres-
sure drops resulting from structures such as twisting or kinking in the com-
putational model, the model is able to simulate the postoperative situation
more adequately. For this, a clear picture of the vascular topology is required.
Clinically, this can be obtained by using MR or ultrasound.
e experimental setup constructed for this study allowed for model
validation, since we were able to mimic ow enhancement aer AVF cre-
ation and since all measured pressure and ow waveforms were comparable
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to physiological ones [187, 188]. e mean pressures and ows, both arte-
rial and venous, simulated by the pulse wave propagation model, were ade-
quately predicted and the overall shape of the pressure and ow waveforms
were similar.
However, the simulated waveforms were less attenuated than the mea-
sured ones, indicating that introduction of viscoelasticitymight improve the
computational model’s capability to describe the physical phenomena. Pre-
vious studies [170, 171, 173] already showed that a pulse wave propagation
model is able to simulate pressure and owwaveforms in elastic arteries and
that the introduction of viscoelasticity improves the simulations [169, 172,
189, 190]. Since viscoelasticity is observed in human arteries [191, 192], in-
cluding viscoelasticity in themodel for patient-specicmodeling is required
when the waveforms are of interest.
But, even aer incorporating viscoelasticity into the pulse wave prop-
agation model, which should result in a better description of the physical
phenomena, clinical implementation might still be challenging. e rea-
son for this is that the model needs to be adapted to patient-specic con-
ditions which requires patient-specic model input parameters. Clinically,
it is dicult to determine these parameters accurately due to limitations in
measurement modalities or because the burden on the patient should be
minimized. Fortunately, a sensitivity analysis can be applied to the model to
determine which model input parameters are most important to assessed.
Consequently, the number of required patient-specic measurements can
signicantly be reduced [185]. Another challenge is including vascular adap-
tation (e.g. ow-mediated dilatation, maturation) and regulation (e.g. au-
toregulation of the peripheral bed) in the model. is physiological mech-
anisms should be introduced, especially, when the (long-term) adaptation
of a vascular access is of interest. e current model is only able to predict
mean ows directly aer surgery.
11.1.5 Conclusion
e pulse wave propagation model was successfully validated with an ex-
perimental setup, mimicking pressure and ow changes following an AVF
creation. Mean pressures and ows were adequately predicted and the over-
all shape of the pressure and ow waveforms were similar for the experi-
ment and measurement. However, the experimental waveforms were more
attenuatedmost likely resulting fromneglecting viscoelasticity in themodel.
Furthermore, it was found that the uncertainties in model input parameters
signicantly inuence the output and should thus be taken into considera-
tion in the analysis.
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Mean pressure [mmHg] Mean ow [ml/min]
measureda simulatedb simulated measureda simulatedb simulated
with extra Rb with extra Rb
proximal aorta 90 83 (79,88) 86 (81,91) 4750 4748 (4676,4821) 4740 (4667,4812)
subclavian artery 378 508 (422,594) 362 (302,424)
proximal brachial artery 90 83 (78,87) 85 (80,91)
distal brachial artery 90 81 (76,87) 85 (79,90)
proximal ulnar artery 88 81 (76,87) 84 (79,90) 42 38 (31,46) 40 (32,47)
proximal radial artery 86 80 (75,86) 84 (78,89) - - -
distal radial artery 84 76 (71,82) 81 (76,86) 46 42 (30,53) 44 (34,55)
distal cephalic vein 31 8.3 (7.5,9.2) 28 (25,32) 285c 420 (352,490) 270 (239,305)
proximal cephalic vein 7.0 6.0 (5.8,6.2) 5.9 (5.8,6.0)
basilic vein 6.0 6.0 (5.8,6.2) 5.9 (5.8,6.0)
subclavian vein 5.7d 5.7d 5.7d
aMeasured value without uncertainty interval.
bMedian value with 25th and 75th percentiles.
c Flow split percentages through proximal cephalic and basilic vein unknown.
d Prescribed intravenous pressure.
Table 11.4: Measured postoperative mean pressures and ows and their simulated values.
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11.2 Experimental validation of high-flow CFD solver
11.2.1 Introduction
Patient-specic computational hemodynamics have proven to be a reliable
tool for estimating ow, pressure elds and wall shear stress distributions in
vivo. Here we consider the possibility to numerically simulate the blood
ow behavior in the specic case of arterio-venous stula (AVF) for pa-
tients on hemodialysis therapy. In this context, the prediction of vascular
access short-term (maturation) and long-term (patency) functionality is of
primary importance to improve the outcome of stula creation and avoid
surgical revisions, as currently investigated by computational tools for AVF
surgery planning [115]. However, the non-physiological conditions occur-
ring aer anastomosis creation, such as high blood ow rates and ow in-
stabilities, pose a potential challenge to numerical solution strategies.
Recently, Botti and Di Pietro [193] proposed an INS-solver2 implemen-
tation aimed at simulating high-Reynolds number ows and tested it against
published benchmarks to demonstrate optimal convergence rates in both
space and time.eir strategy oers a very favorable trade-o between com-
putational cost and robustness with respect to convection-dominated ows
in complex 3D geometries, making the approach particularly suitable for
hemodynamic applications in the context of patient-specic simulation in
population studies.
e aim of the present study was the experimental validation of the
solver on a patient-specic case of vascular access for hemodialysis. On the
basis of a geometry reconstructed from medical images we consider a wide
range of ow rates, up to the range of those required to perform hemodial-
ysis treatment. To compare against experiments, we focus on the ow pat-
terns within the anastomosis experimentally acquired by means of Particle
Image Velocimetry (PIV) and the pressure drop across the anastomosis for
varying ow rates. In particular, this latter aspect is signicant to develop
reliable computational tools for vascular network modeling [115].
e use of PIV for the validation of Computational Fluid Dynamics
(CFD) solvers in the eld of biomedical engineering and hemodynamics has
been reported in literature for dierent cases but mainly under physiologi-
cal, low ormoderate ow, conditions. Next to themore idealized or general-
ized phantom models of, for example, an idealized arterial stenoses [130] or
aneurysm [131], PIV validation is applied in a larger scale in the eld ofmed-
ical devices as central venous catheters [98], blood pumps [132–135], stents
2Solver based on the incompressible Navier-Stokes equations
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[136] or articial heart valves [137–139]. Even when shiing to anatomical
realistic models, like in studies focusing on the validation of patient specic
aneurysms [140], stenoses [141] or AVFs [194], a good agreement between
in vitromeasurements and computational results is found. In the context of
unstable or turbulent ows both the results of the PIV-challenge [142] and
the FDA’s ’Critical Path’ Computational Fluid Dynamics / Blood Damage
Project study on the validation of a benchmark nozzle model [143] agreed
that PIV is capable to satisfactorily measure the mean (time-averaged) ve-
locities. However, in order to increase the accuracy and reproducibility the
uctuations in the ow conditions and in the uid properties need to be
taken under control [143]. Apart from PIV studies, in the context of transi-
tional ow conditions, the work by Loth et al. satisfactorily compared nu-
merical simulations and experimental velocity solutions acquired by means
of laser Doppler anemometry in a porcine arterio-venous gra [195].
e numerical solutions were computed considering accurate time inte-
gration and, due to the unstable nature of the ow, the solutions were aver-
aged to obtain the physical quantities of interest.e averaged velocity and
pressure solution were compared with the experimental data.
11.2.2 Material and methods
3D computational and experimental model generation
For the experimental evaluation, a numerical model of a patient-specic
anastomosis was reconstructed from high-resolution MR angiography im-
ages, acquired on a patient with a working AVF.e anastomosis geometry
was segmented fromMR images using the open-source soware vmtk3.e
threemain vessels, proximal and distal artery and proximal vein, composing
the end-to-side anastomosis, were segmented. Cylindrical ow extensions
were added to all inow and outow sections of the computational domain,
in order to impose fully developed steady-state Dirichlet boundary condi-
tion by means of a Poiseuille velocity prole.
e experimental anastomosis model was built at Vascular AccessMod-
els (Seaside, CA, USA) using a silicon block of 270x70x35mmwith a refrac-
tive index of 1.406 (Figure 11.7).e model was scaled by a factor 4:1 in or-
der to simplify the production process and ensure a low surface roughness.
Once the in vitro model was obtained, an additional high-resolution X-ray
Computed Tomography (voxel size 210 µm) was performed and the images
segmented and adopted as the nal computational domain. is workow
ensures a perfect match between the in vitro and the computational model
geometry.
3http://www.vmtk.org
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Figure 11.7: In vitro anastomosis model: PIV regions of interest (ROI) (red); Pres-
sure measurement points (green); Flow directions are indicated in blue.
e discretized computational mesh was obtained following the proce-
dure described in Antiga et al. [196]. Mesh size was specied on the basis
of local vessel size, so that the number of elements at the cross section is
kept constant irrespective of the local diameter of vessels.e hybrid mesh
consisted of 975,710 tetrahedral and 104,168 prismatic cells.
Assumptions on ow conditions
In order to simplify the experimental setup, validationwas performed under
steady inow conditions. is assumption is not in contrast with physio-
logic ow conditions since, due to small venous resistance and the high ow
rates involved, the role of pulsatility is limited and the arterio-venous stula
is dominated by ow instabilities associated to the convection-dominated
nature of the ow.
Furthermore, distal artery outow was occluded. All the ow enter-
ing from the proximal artery inow was forced through the venous outow.
Since the peripheral resistance of the distal artery is much higher than the
venous resistance, the ow is largely directed to the venous outow under in
vivo conditions, to the point that reverse distal artery ow (steal syndrome)
is commonly observed in clinical practice [197, 198]. Since we were inter-
ested in validating the CFD methodology in a wide range of ow regimes,
the imposition of a prescribed ow split would have required to clip the out-
ow section with a trial-and-error approach in order to match the ow dis-
tribution at each ow rate here considered. Due to the instabilities arising at
the highest ow rates, such a procedure would have been cumbersome and
would have potentially increased measurements errors.
Since the imposition of a sealed distal artery and steady inow boundary
conditions does not introduce any fundamental simplication in the numer-
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ical simulation task, we concluded that the described setup would not aect
the signicance of the validation process.
CFD computations
In the numericalmodel, a fully developedDirichlet boundary conditionwas
imposed at the inow of the proximal artery section, while a homogeneous
Dirichlet boundary condition was imposed at outow of the distal artery in
order to guarantee that thewhole ow actually goes through the anastomosis
toe towards the vein outow.e structure was considered as rigid and the
uid was modeled as Newtonian and homogeneous. We considered a wide
range of Reynolds numbers, namely Re equal to 100, 200, 550, 1000, 1500
and 2000, the latter being equivalent to a blood ow rate of 800 ml/min.
e dimensionless Reynolds number was calculated based on the average
velocity at the proximal artery (V), the proximal artery diameter (D) and the
the kinematic viscosity (ν) with Re = V ⋅Dν . Starting from a homogeneous
velocity-pressure eld, simulations were advanced with a xed time step,
determined according to the Reynolds number. For Re equal to 100 and
200, a steady state solution was reached using a pseudo-time integration
with time step equal to 0.01 s. For Re equal to 550 and 1000, with a time step
equal to 0.001 s and for Re equal to 1500 and 2000, with a time step equal to
0.0005 s, a steady state solution could not be reached, and the simulations
were halted aer a total integration time of 2 s.
At the highest Reynolds numbers, the solution was highly unsteady with
a steady inow, due to the combination of high Reynolds numbers and a
complex 3D geometry. In order to compare with experimental data, veloc-
ity and pressure elds were averaged taking into account all the time steps
during the last second of integration time. e rst second was ignored to
minimize the eect of transients from the resting state to fully developed
ow.
Particle image velocimetry
e velocity eld was acquired over a 2D-plane located at the anastomosis
by means of Particle Image Velocimetry (PIV) measurements. e mock
loop for the PIV measurements was constituted by a reservoir, a stationary
pump, a one meter long sti inow tube, the model and two outow path-
ways.e PIV equipment consisted of a CCDcamerawithmaximum spatial
resolution of 1376x1040 pixels (PCO, Kelheim, Germany), a double cavity
Nd:YAG laser, a synchronizer and acquisition and postprocessing soware
applications (ILA GmbH, Juelich, Germany).
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e water-glycerinmixture, with the same refractive index as the silicon
model, was seeded with 100 µm silver coated polyamid particles. e mix-
ture had a density of 1122 kg/m3 and a dynamic viscosity of 4.57mPa ⋅ s at
30○C.e ow rate was measured volumetrically before and aer each PIV
acquisition and a set of PIV results was used for the validation process only
when pre and post ow rates were within 2%.
e 32x32mm Region Of Interest (ROI) (Figure 11.7) was deliberately
positioned where the ow is expected to be more complex in order to chal-
lenge the numerical strategy. Based on this ROI location, the ow conditions
were assessed at Reynolds 550 and Reynolds 1000, representing 220 and 400
ml/min blood ow in the 1:1 patient-specic case. A second ROIwas dened
at the inlet (Figure 11.7) of the model to assess the ow pattern entering the
model. e acquired velocity, at a Reynolds number of 565, has been used
to conrm the assumption of parabolic inlet ow.
Pressure drop measurements
Since one of the main candidate contributors to the overall resistance of an
AVF is the concentrated resistance at the anastomosis, one of the most im-
portant points to be tackled by the validation process is the ability of the
INS-solver to accurately reproduce the pressure drops across the anastomo-
sis. At the highest ow regimes, in fact, the overall pressure drop is tightly
linked to the non-linear losses induced by instabilities at the anastomosis
and can be considered as surrogate global indicator of the capabilities of the
solver of capturing the overall ow dynamics.
For the pressure drop measurement experimental setup, the model was
built in the samemock loop as for the PIVmeasurements.e pressure drop
was measured at the upper wall (positive Z-axis), at 108mm from the prox-
imal side of the anastomosis (Figure 11.7), using two dierent 4 Fr. needles
connected to a single disposable pressure transducer (DT-X Plus; Becton
Dickinson, USA).
To minimize the uncertainties on the experimental results, more than
200 measurements of ow rate versus pressure drops were acquired. In or-
der to cover the full range of ow conditions with the same experimental
setup, dierent water-glycerin mixtures were used, from the highest viscos-
ity uid (17.5 mPa⋅s) required to achieve a measurable pressure drop (150
Pa for Re=50), up to the lowest viscosity mixture (4.2 mPa⋅s) allowing the
stationary pump to achieve the ow rate required for the highest Reynolds
number (4600 ml/min for Re=2200).
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11.2.3 Results
Overview of CFD results
e CFD velocity solutions at the anastomosis toe for Re equal to 100, 200,
1000 and 2000 are shown in Figure 11.8. For the case of Re 100, the region
of high velocity magnitude lls the proximal artery, while this region shis
more and more to the outer wall when increasing the inow rate. Next it
is clear that the complexity of the present ow eld at the anastomosis re-
gion and in the distal artery increases signicantly comparing the Re 100
and Re 200 with the Re 1000 and Re 2000 case.
e increase in ow complexity at the highest Reynolds numbers can be
appreciated in Figure 11.9 where the velocity magnitude contours are repre-
sented. Right aer the rst change in direction at the anastomosis, the bulk
Re = 100 Re = 200
Re = 1000 Re = 2000
Figure 11.8: Contours of velocity magnitude (mm/s) for Reynolds numbers 100,
200, 1000 and 2000.
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ow becomes more and more adherent to the outer wall of the vein as iner-
tial forces start to dominate over viscous forces. e intensity of the recir-
culating vortex at the anastomosis toe increases and the iso-surface widens,
reecting a strong mixing near the vein centerline.
Experimental versus computed velocity eld
e PIV and CFD velocity contours over the two-dimensional region of in-
terest at the anastomosis (Figure 11.7) are compared considering two values
of the Reynolds number, Re=550 and Re=1000, as shown in Figure 11.10.
Since we deal with unstable ows, we compare time-averaged CFD solu-
tions against PIV data, which is inherently time-averaged (4 Hz acquisition
for 100 seconds) in our setup. Overall, a good agreement is observed be-
tween in vitro PIV data and CFD results. Relevant ow features, such as the
high-velocity jet at the upper wall and the wake zone at the distal (closed)
artery, can be observed in both sets of data. Of note, the location of the re-
circulating vortex close to the proximal part of the anastomosis is accurately
captured at both ow regimes here considered.
In general, PIV data appear more diusive than CFD results.is is not
surprising given the fact that in unstable ows at high-Reynolds numbers,
the spatial and temporal resolution required to track swirling particles and
sharp jets is considerably high, and the eect of averaging unstable ows
(a) Re = 100 (20mm/s) (b) Re = 200 (50mm/s)
(c) Re = 1000 (345mm/s) (d) Re = 2000 (740mm/s)
Figure 11.9: Iso-surfaces of the velocity magnitude.
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(a) Re = 550
(b) Re = 1000
Figure 11.10: CFD (le) versus PIV (right) results for low speed (Re 550) (top) and
high speed (Re 1000)(bottom) ow regimes at the arterio-venous anastomosis. Im-
ages are color-coded by means of planar velocity magnitude (mm/s), arrows show
planar velocity vectors.
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over long acquisition times results in a low-pass ltering eect. A lack of
PIV data is observed at the bottom of the proximal vein.is was due to an
insucient penetration of the laser light sheet in the model up to this region
(laser light from right to le in Figure 11.10), probably due to a complex in-
terplay between the geometry of the model and the optical properties of the
liquid and the model.
Experimental versus computed pressure drops
Charts representing Euler number (∆p/ρv2) versus Reynolds number and
pressure drop (∆p) versus ow rate are presented in Figure 11.11. e pres-
sure drop versus ow results were calculated from the Eu versus Re solutions
taking the original 1:1 scaled geometry and assuming a blood viscosity and
density of 3.5 mPa s and 1050 kg/m3.
e agreement between the experimental and numerical pressure drops
across the anastomosis is remarkable. We found that all the experimental
values were within the standard deviation range of the numerical pressure
drops, meaning that all the experimental values would have potentially been
observed in the numerical simulation.
As visual in Figure 11.11 (bottom), the averaged numerical values allow
to conclude that the anastomosis exhibits a quadratic relation between pres-
sure drop and ow rate. e quadratic relation was also observed in the
(qualitative) computational results in Chapter 10. is conrms the need
to model the anastomosis in patient-specic studies geometrically accurate
in order to capture the eects of the instabilities and properly estimate the
non-linear pressure drops involved when adopting modeling approaches to
clinical predictions.
11.2.4 Discussion and conclusion
In this work, the solution strategy for incompressible Navier-Stokes equa-
tions proposed by Botti and Di Pietro [193] and previously tested against an-
alytical solutions of model problems has been validated in a patient-specic
case of an arterio-venous stula for hemodialysis at high ow rate regimes.
Although the in vivo conguration was simplied by sealing the distal artery
and adopting steady inlet ow conditions, all the challenges involved in the
simulation of convection-dominated ows in complex 3D geometries were
retained. As a result, both numerical pressure drops and velocity solutions
at the anastomosis were in excellent agreement with the experimental data.
It is worth to point out that these results have been obtained without the
adoption of the model or solver for turbulence or transition to turbulence.
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Aer successful validation of the proposed solution strategy for simu-
lations in realistic geometries at high ow regimes, the solver can now be
employed to reliably predict ow patterns and pressure drops in patient-
specic models of vascular access in patients on hemodialysis. More in gen-
eral, the solver, here validated, may be useful for the numerical analysis of
other vascular beds that are characterized by high-ow and blood veloci-
ties associated with alteration of vascular geometry such as atherosclerotic
plaques, bifurcations and branching as well.
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12.1 Pulse pressure analysis for stenosis detection
12.1.1 Introduction
Complications of the vascular access (VA) for hemodialysis are amajor cause
of morbidity and mortality in end-stage renal disease (ESRD) patients [19,
199], with thrombosis due to ow limiting stenosis being the main origin of
VA-failure [31, 200, 201]. e Kidney Disease Outcomes Quality Initiative
(K/DOQI) clinical practice guidelines dene a stenosis as relevant when it
shows at least a 50%diameter reduction, accompanied by a hemodynamic or
clinical abnormality [19, 199]. However, signicant owdecline and increase
in pressure drop appear only when the diameter is reduced to above 70%,
and these criteria are therefore a late sign of stenosis development (Exam-
ple in Figure 8.6 (p.61)).e current vascular access surveillance techniques
(ow measurements and static-access pressure measurement) are thus un-
able to detect relevant stenoses (<50% diameter reduction) in an early stage,
and these methods cannot further reduce the incidence of vascular access
failure due to thrombosis [120, 202–206].
Up to date, monthly measurement of access ow is considered the best
available surveillance tool for identication of patients at risk of access throm-
bosis [19, 199]. However, access ow shows variation between and within
hemodialysis sessions [207]. Measurement of mean intra-access pressures
is more straightforward and can be performed using pressure transducers
within the dialysis machine [202, 208]. Intra-access pressures reect ves-
sel resistance and can be measured at the site of cannulation in the arterial
and venous needle. However, current pressure measurements techniques
and protocols are tedious, time consuming, and not ‘user friendly’. Sta fre-
quently bypasses crucial steps (calibration, appropriate ushing, etc.), lead-
ing to poor quality data being collected and recorded [19, 199]. erefore,
monitoring techniques should be cheap, accurate, precise and easy to per-
form.e high thrombosis rates of arterio-venous stulas and gras in par-
ticular, require a sensitive and specic test that can unequivocally predict
the likelihood of thrombosis over a specic time. A combination of mean
intra-access pressure and ow measurements results in better prediction of
access thrombosis. However, the sensitivity of a combined surveillance pro-
tocol for prediction of access thrombosis is only 73.3% and 68.8% in AVF
and AVG, respectively [204].
To overcome the inability to predict early stage stenoses (<50 diameter
reduction) and the low sensitivity of currently used tests, a non-invasive and
inexpensive method based on the analysis of the pressure waveform prole
and amplitude (PPA; pulse pressure analysis) is here extensively tested.e
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method was assessed using a dedicated in vitro model of a radio-cephalic
arterio-venous stula (AVF).
12.1.2 Material and Methods
e vascular access model was integrated in a closed circuit (Figure 12.1). A
blood mimicking uid is pumped from a reservoir into a windkessel by a
pulsatile pump (Harvard Apparatus, Bloodpump 4021, Model 55-3339, Hol-
liston, USA).is creates a system where the pump represents the le ven-
tricle and the windkessel the large central systemic arteries. From the wind-
kessel, the uid is distributed over themodel and over a draining tube with a
resistance representing the blood ow towards the body (except to the arm).
A water-glycerin mixture at 25○C was used to mimic blood, with a kine-
matic viscosity of 3.2 10−6m2/s as measured with a capillary Ubbelohde vis-
cometer (Schott, Germany) and a density of 1090 kg/m3. is resulted in a
uid with a dynamic viscosity of 3.49mPa.s, corresponding to blood with a
hematocrit of 42% [117].
In the vascular access model, the artery was connected to the draining
vein (angle 60○). e internal diameters of the artery and vein were 4mm
and 7mm, respectively.e arterial compliance was 8.2 10−7ml/Pa/cm [209,
210], while the venous compliance was 46.0 10−7ml/Pa/cm (Unpublished
data).ese dierent compliance values were achieved by constructing the
dierent vessels with an appropriate number of silicon layers to obtain com-
pliances in the physiological range.
Tomimic the hemodialysis setting, two 15Gauge needles (BionicMediz-
intechnikGmbH, Frankfurt, Germany)were introduced.e arterial needle
was inserted against the direction of ow 5 cm downstream the anastomo-
sis and the venous needle was inserted along the ow and 5 cm more distal
(Figure 12.1). Both needles were punctured and entered the siliconmodel for
1 cm by an angle of approximately 30 degrees.e introduced stenoses were
made of rigid tubes with a length of 1 cm. Stenosis of 25% and 50% diameter
reduction were placed on three dierent locations: (I) 10 cm proximal to the
anastomosis (’proximal artery (PA) stenosis’); (II) in between the two nee-
dles (’distal vein (DV) stenosis’); (III) 3 cm distal to the needles (’proximal
vein (PV) stenosis’). So the DV-stenosis was located 3.5 cm downstream the
arterial needle tipwhereas the PV-stenosis was located 9 cmdownstream the
needle tip. See also Figure 12.1, which indicates the position of the stenoses.
For each case, the initial boundary conditions were set before introduc-
ing any stenosis in the following manner.e ow towards the vascular ac-
cess model was established using both the adjustable resistance towards the
arm and the rest of the body (Figure 12.1).e ow in the artery was divided
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Figure 12.1: Vascular access model integrated in mock loop (⋆ : stenosis locations)
into 90% towards the vein and 10% towards the distal artery, adjusting the
outlet resistance of the vascular access model.e inlet pressure prole was
measured in the proximal part of the artery and the air level in the wind-
kessel was regulated such as to establish a prole with a pulse pressure (PP;
systolic minus diastolic pressure) of about 40mmHg.
Starting from the reference situation described above (no stenoses, 90%
venous ow and 10% distal artery ow), the two dierent stenoses were suc-
cessively introduced at the three positions, and for each case arterial blood
ow (500-1300ml/min) and heart rate (60; 75 and 90 beats/min) were var-
ied.
e pulse pressure at the proximal part of the artery (PPPA) and at the
arterial needle (PPAN ) was measured using uid lled pressure transducers
(type DT-X PLUS, Becton Dickinson, New Jersey, USA).e signal was ac-
quired at a sampling rate of 200Hz and displayed on screen using dedicated
data acquisition hard- and soware (National Instruments, Austin, USA).
e values of PP used for analysis were the average of at least 6 cycles. A
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dimensionless factor, ’%-Pulse Pressure’ (%PP), was dened as:
%PP = 100 ⋅ PPAN
PPPA
(12.1)
e pulse pressure analysis, PPA, consists of a comparison of the %PP mea-
sured in the dierent cases.
Statistical analysis
Data are generally given as mean± standard deviation, with data averaged
per case (a given stenosis percentage at one given location) over the mea-
sured range of heart rate and blood ow. Analysis of variance (ANOVA)
was performed to obtain a statistical ground to evaluate the PPA-method on
detecting the presence of a stenosis, and discriminating between the loca-
tions of the stenosis. Post-hoc (Bonferroni) tests were used to assess details
on which cases are dierent from each other in terms of %PP. Linear regres-
sion analysis was used to assess the relation between%PP and hemodynamic
variables.
12.1.3 Results
Arterial blood ow rate versus %PP for the 50% stenosis is shown in Fig-
ure 12.2a.e %PP decreases with increasing blood ow and increases with
increasing heart rate. In the control model (no stenosis), %PP was 20.26± 4.55. A stenosis in the proximal artery signicantly decreased %PP to 7.69± 2.08 (P < 0.0001), while presence of a stenosis in the venous part of the
model increased %PP, with values of 36.20 ± 2.12 for the DV-stenosis and
32.38 ± 2.17 for the PV-stenosis (all P < 0.0001 compared to control). When
applying the analytical formulation of the regression curves for an arterial
blood owof 800ml/min (themean value of blood ow in the experiments),
the control case gives a %PP of 22.11. When we compare this to the PA-case,
this value decreases to 6.80. For the stenoses distal to the needle, the%PP in-
creases to 33.51 for the PV-stenosis and 36.92 for the DV-stenosis.e post-
hoc analysis shows that the %PP is signicantly dierent for the 50% stenosis
upstream versus downstream of the needle (P < 0.0001). It is even possible
to distinguish between the distal and the proximal vein stenosis (P < 0.0001).
Figure 12.2b shows the results for the 25% stenosis case, where %PP de-
creases from 20.26 ± 4.55 (control) to 15.45 ± 2.13 (p = 0.0022) for the PA-
stenosis, while it increases aer introduction of the DV-stenosis to 26.71± 3.01 (p = 0.0003) and to 26.53 ± 2.67 for the PV-stenosis (p = 0.0004).e
post-hoc analysis shows that%PP for the 25% stenosis discriminates between
the upstream and downstream location (P < 0.0001), but it is not possible to
distinguish the distal from the proximal vein 25% stenosis.
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Figure 12.2: %-PP for varying arterial blood ow rates: (a) 50% stenosis cases for
dierent heart rates versus the no-stenosis case; (b) 25% stenosis cases (-⋅- proximal
artery, – proximal vein and ⋅ ⋅ ⋅ distal vein stenosis) with heart rate of 60 bpm versus
the no-stenosis case.
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12.1.4 Discussion
ere is an urgent need for a method that detects stenoses in early-stage in
hemodialysis patients to prevent stenosis-related vascular access complica-
tions. In this work, we have presented a method, based on analyzing the
PP at the hemodialysis line, and tested the method in an experimental hy-
draulic bench model setting. Hans-Dietrich Polaschegg stated in his patent
[211, 212] that pulse pressure might be a method to detect stenosis, however
no investigations or in-depth analysis on the method was performed. Al-
though the basic principle of using pulse pressure is the same, the studied
method in this work is unique.
Our experimental results for a 25% and 50% stenosis conrm what has
earlier been described by Stergiopulos et al. using a computer model of the
arterial tree to study the eect of arterial stenoses [209]. When the PP is
measured proximal to the stenosis and compared with the PP in the case
without stenosis, it increases, while the PP decreases when it is measured
distal from the stenosis.is trend is conrmed for all positions of the steno-
sis.
For the reference and 50% stenosis case, a clear eect of the heart rate
and the arterial blood ow rate can be observed on the values of %PP (see
Figure 12.2, panels a and b). We have tested the method over an anticipated
range of heart rates and blood ow, and treated the measured data as inde-
pendent samples, without accounting for the covariance eect of ow and
heart rate. As such, the statistical test we applied is more conservative than
an analysis of covariance, which would also account for the relationship be-
tween%PP and heart rate and blood ow. We feel that this approach is closer
to the clinical reality, where at least the ow level is not known either. De-
spite this conservative approach, %PP was found to discriminate between
the three locations for the 50% stenosis, and between upstream and down-
stream stenosis of the PA needle for the 25% stenosis. As such, we feel that
the fact that heart rate and arterial blood ow rate may vary in a clinical set-
ting, this does not jeopardize the power of the PPA for detection of stenoses
in the dierent stenosis cases.
In experimental modeling, it is necessary to establish a ‘reference’ situa-
tion and report ‘normalized’ results, with changes from this reference posi-
tion. From a clinical point of view, the in vitro nature of the study is themain
limitation.e value of the proposedmethod of PPAwill increase if it can be
clinically proven that only the measurement of the PP at the needle (PPAN )
makes the stenosis detection method accurate and sensitive. e arterial
pulse pressure could, for instance, be obtained from the brachial sphygmo-
manometer cu or using techniques of applanation tonometry. Anyhow, an
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inexpensive and ‘user friendly’ surveillance technique will only be obtained
if the PP at the needle can be calculated directly within the dialysis machine,
as for intra-access static pressure measurements. Beside these remarks, an-
other limitation of the experimental model is the fact that it is a simpli-
cation of the human vascular system. Human vessels react on blood ow
and pressure changes by vasodilation or vasoconstriction in an acute setting
and structural remodeling in the longer term. When the method is used in
daily clinical practice, these changes in the cardio-vascular system may in-
terfere with the pressure prole analysis.erefore a clinical trial should be
performed to validate this detection method.
12.1.5 Conclusion
We have extensively in vitro tested a method, based on analysis of the pulse
pressure, enabling detection of the presence and location of a 50% stenosis
independent of heart rate and arterial blood ow rate. Nevertheless, a clin-
ical study will have to conrm these experimental results and the potential
of this low-cost method.
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12.2 The accuracy of ultrasound volume flow measurements
12.2.1 Introduction
In Europe, more than half-a-million patients with end-stage renal disease
(ESRD) are treated with hemodialysis and this population still increases an-
nually by approximately 5-8% [9–12]. Tomake hemodialysis possible, a well-
functioning vascular access is needed to facilitate high blood ow and to al-
low repeated cannulation over time [21, 25].e preferred vascular access is
created by surgically connecting an artery and a vein in the arm (an arterio-
venous stula; AVF). Ideally, the AVFmatures, resulting in the required ow
increase and vascular remodeling to allow for dialysis [21, 25, 26]. Despite the
extensive preoperative examinations, non-maturation occurs in 23 to 46% of
the cases [36, 37].
Direct postoperative owmeasurements can be linked, in an early-stage,
with the non-maturation in case of a too low stula ow and with distal is-
chemia and cardiac failure in case of a too high stula ow [26, 32, 44, 164,
167]. e ideal method to measure the ow rates should be non-invasive,
workable in daily clinical practice and reproducible. Nowadays, one of the
most widely available methods is based on pulsed wave Doppler (PWD) ul-
trasound (US), where PWD provides velocity information that is multiplied
with an estimate of the cross-sectional area of the vessel to obtain volumetric
ow.
Although PWD is a well-established method to measure ow velocities,
it has some intrinsic limitations.emost important one is the 1D-nature of
the measurement, since PWD only captures the velocity component in the
direction of the US-beam.e translation of this 1D velocity measurement
to the full cross-sectional velocity prole, in order to estimate the ow rate,
requires a great number of assumptions.ese uncertainties involved in the
ow rate calculation are expected to increase signicantly when a disturbed
and complex ow eld is introduced, as one may expect post AVF-creation.
So, despite the fact that the PWD ow estimation is non-invasive and used
on large scale in daily routine, the reproducibility, intra- and inter-observer
variability, and the accuracy remain unclear [213–217].
In this study, we want to assess the accuracy of the ow rate as mea-
sured by US compared to the actual ow rate present in the setting of AVF.
To ensure that we have gold standard information on the true velocity eld
measured by pulsedwaveDoppler, wewill follow an approach based onmul-
tiphysics simulations, integrating computational uid dynamics with an ul-
trasound simulator. Aswe demonstrated before, thismodeling technique al-
lows to simulate synthetic but realistic ultrasound images, based on a known
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but complex 3D-ow situation [218, 219]. As such, we will produce synthetic
PWDspectra to derive ow rates, which can then be compared to the ground
truth values known fromCFD. For this analysis, two patient-specic geome-
tries of one AVF patient, based on pre- and postoperative MR-images of the
arm vasculature, will be used.
12.2.2 Material and methods
Multiphysics simulations to generate synthetic pulsed wave Doppler data
(a) Flow simulations in a patient-specific model of AVF using
computational fluid dynamics (CFD)
Two sets of high-resolutionMR angiography images were acquired from the
same patient (51 year old, male, BMI 20.5), one set preoperatively and one
15 weeks aer AVF creation. From these MR data sets, both a preoperative
and a postoperative 3D-model were reconstructed.e preoperative model
consists of the brachial artery, which bifurcates into the ulnar and the radial
artery (Figure 12.3, top).e postoperative model additionally includes the
arterio-venous anastomosis and the distal cephalic vein (Figure 12.3, bot-
tom).e inow segment was articially prolonged for both pre- and post-
operative models to ensure fully developed ow conditions (independent of
the boundary conditions) at sites of ow investigation. To avoid disturbance
of the distal high ow vortices in the postoperative model, straight outow
segments were added as well.
e two geometries were segmented from the MR images, using the
open-source soware vmtk2.e model was meshed using pyFormex3, ac-
cording to themethods described by De Santis et al. [220, 221]. A conformal
and structured hexahedral mesh was applied on the models, resulting in 1.4
million cells for the preoperative case and 2.2 million cells for the postoper-
ative case. Amesh-sensitivity analysis was performed to ensure that velocity
elds were obtained independent of the mesh density.
A parabolic velocity prole was implemented as inlet boundary condi-
tion at the proximal brachial artery. e prole was determined based on
the pre- and postoperative MRI Q-ow acquisition from the selected pa-
tient, but was rescaled such that a mean ow rate of 100ml/min preoper-
ative and 1000ml/min postoperative were obtained. e ulnar artery re-
ceived 40ml/min in both the pre- and postoperative case, and the distal ra-
dial artery 60ml/min. For the postoperative case, this results in a ow of
2http://www.vmtk.org
3http://pyformex.org
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Figure 12.3: Pre- and postoperativemodel with indication of the assessed locations,
boundary conditions and uid properties.
900ml/min going through the vascular access, which is in range with clin-
ical practice and the European and American guidelines for vascular access
[19, 22].
Blood was modelled as an incompressible Newtonian uid with a den-
sity of 1050 kg/m3 and a viscosity of 3.5mPa.s. Rigid walls and no-slip con-
ditions were set. Womersley numbers, α, dened as:
α = R√2pi f ρ/µ (12.2)
(with R the radius of the vessel, ρ the density of blood, µ the viscosity of
blood and f the cardiac frequency), ranged from 1.8 to 3.3. For both geome-
tries, two cardiac cycles were calculated to avoid transient eects, with a 5ms
time step. Ansys Fluent 12 (ANSYS inc., Canonsburg, PA, USA) was used
to solve the Navier-Stokes equations with a nite volume method. Standard
pressure discretization and second-order upwindmomentum discretization
schemes were applied.
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(b) Ultrasound simulations
We used the Field II soware [222, 223] to simulate the radiofrequent (RF)
signals originating from the AVF blood ow elds. is simulator is based
on the spatial impulse response estimation approach as proposed by Tupho-
lme [224] and Stepanishen [225], and allows to model arbitrary transducers
and scanning sequences with great exibility. Field II represents blood as an
ensemble of random point scatterers on which the ultrasound waves reect.
As such, realistic Doppler spectra were obtained by moving the point scat-
terers during the simulated scanning procedure according to the AVF ow
elds obtained from CFD. We implemented a realistic linear array trans-
ducer for peripheral vascular applications, and RF-signals were obtained
by ring 8000 and 22000 sinusoidal pressure pulses during the cardiac cy-
cle, for the preoperative and postoperative case, respectively (pulse repeti-
tion frequency (PRF) = 8/22 kHz, f0 = 5MHz, pulse length = 2.5 pulse peri-
ods). is higher pulse repetition frequency postoperatively was necessary
to avoid aliasing for the higher ow velocities present in this setup. RF-data
were simulated at 2 locations (cfr. o in Figure 12.3): (i) the brachial artery,
5 cm proximal to the radial-ulnar bifurcation (proximal location), and (ii)
the radial artery, 5 cm proximal to the (location of the) anastomosis (dis-
tal location). Finally, the Doppler sonograms were produced by choosing
an appropriate depth and size of the sample volume, and applying Fourier-
analysis to the simulated RF-signals. For more background on the ultra-
sound simulator and the appliedmultiphysics simulation approach, we refer
to Swillens et al. [218, 219].
Volume ow calculation based on pulsed wave Doppler spectra
e instantaneous volume ow, Q(t), through a well-dened cross-section,
A, can be calculated as the integration of the spatial velocity prole over the
area:
Q(t) =∬ (v(t) ⋅ n)dA =∬ vn(t)dA (12.3)
with v(t), the 3D-velocity vector in a certain point of the cross-section and
n the direction of the normal of the cross-section A.e projection of the
velocity vector v(t) on the normal n is denoted as vn(t). However, evalua-
tion of this surface integral is highly cumbersome using conventional PWD,
since it typically entails a range of assumptions, which are potentially erro-
neous for complex ow conditions.e dierent steps and according chal-
lenges in correctly assessing Equation 12.3 are described below.
(a) Integrating over the cross-sectional area A
Equation 12.3 shows that a correct measurement of the ow, Q, requires
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knowledge of the spatial velocity distribution in the considered cross-section.
As such, the most straightforward ow assessment requires a direct mea-
surement of this spatial velocity prole. However, conventional PWD sys-
tems do not allow to simultaneously scan and process dierent sampling
locations. Hence, directly assessing the spatial velocity prole is typically
circumvented, and we investigated two commonly applied strategies in this
matter:
(i) Equation 1 is simplied to:
Q(t) = vn,mean(t) ⋅ A (12.4)
with vn,mean(t) the mean velocity in the considered cross-section, obtained
by stretching the Doppler sample volume (SV) over the complete cross-
section [226]. is method is further denoted as the large sample volume
acquisition.
(ii)e velocity is measured at a specic location of the cross-section
(typically the center point), and is further used to derive the spatial velocity
prole by assuming the actual ow conditions.e ow Q is then obtained
as:
Q(t) = β ⋅ vn,max(t) ⋅ A (12.5)
with β a correction factor that accounts for the shape of the velocity prole;
vn,max(t) the velocity in the center of the vessel cross-section and assumed
to be the maximal velocity (as is the case for fully symmetrical ow). A at
(β=1) or parabolic (β=0.5) prole are oen assumed, but more complex ow
proles can be derived using Womersley theory. e β-factor for Womer-
sley theory will be further indicated as βα . is method was simulated by
positioning a small sample volume (SV= 0.39mm) in the center of the cross-
sectional area.is approach is further denoted as the small sample volume
acquisition.
Another potential errorwhen estimatingQ is the assessment of the cross-
sectional area A, which is typically obtained from a simple measurement of
the diastolic diameter (piD2/4), hence assuming a circular shape of the cross-
section. As such, we also assessed the diameter at the assessed locations, but
directly from the 3D reconstructed vascular geometry, since rigid walls were
assumed in the CFD-simulations.
(b) Assessment of vn(t): angle correction
Using a mean frequency estimator, the velocity in the US-beam direction,
vPWD, was derived from the Doppler spectra [226]. To reduce the variance
of the spectrum estimates, the nal velocity curve was obtained by averag-
ing power spectra from several individual range samples within the sample
volume.
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Although this mean frequency estimator theoretically results in unbi-
ased velocity estimates vPWD [226], we also derived vPWD by tracking the
outer contour (envelope) of the spectrum based on image intensity (cfr. Fig-
ure 12.4). is is a common approach in clinical practice because it is less
sensitive to shis inmeasurement location compared to themean frequency
estimation [168, 227]. In the remainder of this paper, wewill refer to vPWD(t)
as obtained from respectivelymean-tracking ormax-tracking to indicate the
dierence.
Finally, the Doppler velocity vPWD was converted to the angle-corrected
velocity vn(t) as:
vn(t) = vPWD(t)cos(θ) (12.6)
With θ the angle between the ultrasound beam and the assumed ow direc-
tion. In this study, θ was set to 70○.
12.2.3 Results
Simulated Doppler spectra
Figure 12.4 shows the PWD-spectra when the small sample volume is po-
sitioned in the center of the cross-section (top-middle) and when a large
sample volume covering the full cross-section was chosen, with both mean-
tracking (solid white line) and max-tracking (dashed white line) visualized.
For the postoperative case, the complex ow conditions with high velocity
magnitudes result in increased spectral broadening and less smooth veloc-
ity curves, with a larger dierence between mean- and max-tracking curves
than for the preoperative case. For the large sample volume, the lower ve-
locities near the vessel wall are also picked up, as can be observed for the
spectra in the lower panels of Figure 12.4.
Velocity from PWD versus CFD
We focus on two cases when comparing the results from the synthetic PWD
spectra to the true ow velocities (CFD):
1. preoperative proximal (brachial artery in preoperative conditions), be-
cause the oweld in this region seems the least disturbed as it is close
to the straight inow section and demonstrates low ow.
2. postoperative distal (radial artery in postoperative conditions) since
the most complex ow eld was expected for this case
Figure 12.5 (top) compares the velocity as picked up by pulsed waveDoppler,
vPWD, (in the direction of the ultrasonic beam), with the projection of the
CFD velocity vector on this beam, vn. Results are demonstrated for a small
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Figure 12.4: PWD-spectra as obtained from the small sample volume acquisition
(top-middle) for all four case and PWD-spectra obtained for large sample volume
acquisition (bottom) for the two preoperative cases. Mean-tracking (solid white
line) and max-tracking (dashed white line) are indicated.
sample volume in the center of the cross-section. Comparison with the
ground truth shows that max-tracking of the Doppler spectrum results in
an overestimation of the velocity (mean bias of +65.5% for the preoperative
and +46.4% for the postoperative case). e mean-tracking, on the other
hand, shows a good agreement with the reference value obtained fromCFD,
with a slight underestimation of PWD (mean bias of -3.3% preoperative and
-8.1% postoperative).
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Figure 12.5: e upper panels show the velocity as picked up by PWD (in the
US beam direction), with the mean-tracking in solid gray and the max-tracking
in dashed gray.e CFD ground truth is displayed in solid black.e lower panels
show the velocity aer angle correction, with the same color coding as the upper
panels.is comparison is illustrated for a small sample volume acquisition, in the
preoperative proximal (le) and the postoperative distal region (right).
Figure 12.5 (bottom) compares the corresponding angle-corrected ve-
locity vn, with the projection of the CFD velocity vector on the normal of
the cross-section. e angle correction further enforces the overestima-
tion by the max-tracking (mean bias of +65.6% for vPWD and +99.1% for
vn in the preoperative case). Angle correcting the mean tracking results
in an overestimation preoperatively (bias=+16.3%) and an underestimation
(bias=-14.2%) postoperatively.
Flow from PWD versus CFD
Figure 12.6 shows the volume ows obtained from the PWD spectra, for a
small sample volume acquisition (solid gray for mean-tracking, dotted gray
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for max-tracking), assuming a Womersley ow prole.e applied correc-
tion factors βα , according to Equation 12.5, where 0.658, 0.626, 0.658 and
0.627 for preoperative proximal, preoperative distal, postoperative proximal
and postoperative distal, respectively. While the proximalmeasurements (in
the brachial artery) show a clear overestimation by ultrasound, both for the
mean- and max-tracking, results are less univocal for the distal site (radial
artery).
e deviation between the simulated volume ow measurements and
the ground truth is further quantied in Table 12.1, providing an overview
of the bias on the ultrasound data for the small sample volume acquisition.
Both mean- and max-tracking of the Doppler spectra are reported, as well
as dierent assumptions on the velocity prole (parabolic ow, Womersley
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tracking), for a small sample volume (SV) acquisition, calculated with the β-value
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ow, plug ow). Tracking the outer contour of the spectrum dramatically
overestimates volume ow, except for the postoperative distal case (radial
artery), where assuming a parabolic prole leads to an underestimation of
-14.8%. Volume ow obtained from mean tracking is also systematically
overestimated when assuming a plug ow prole or a Womersley prole
(except the postoperative distal case), but is underestimated when assum-
ing parabolic ow.
Small sample volume Mean PWD-tracking Max PWD-tracking
% bias Parabolic Womersley Plug Parabolic Womersley Plug
preoperative Proximal -1.2 +30.1 +97.7 +69.2 +122.7 +238.4Distal -10.8 +11.7 +78.5 +40.8 +76.3 +181.6
postoperative Proximal -1.4 +29.8 +97.3 +59.2 +109.5 +218.3Distal -46.5 -33.0 +6.9 -14.8 +6.8 +70.4
Table 12.1: e bias for the time-averaged ow rate, in case of the small sample
volume acquisition. Flows were calculated based onmean- andmax-tracking of the
Doppler spectrum, and dierent assumptions on the spatial velocity prole were
investigated. β-values for a fully parabolic (β = 0.5), Womersley and plug (β = 1)
ow were applied.
Large sample volume
To complete the analysis, the volumeows for a large sample volume (dashed
gray) with mean-tracking, calculated according to Equation 12.4 are shown
in Figure 12.6.esewere based onPWD-spectra as shown in the lower pan-
els of Figure 12.4.e bias of the simulated ultrasound data compared to the
CFD values (comparing time-averaged ows), is listed in Table 12.2. From
Figure 12.6 and Table 12.2, it is clear that the ow rates are overestimated by
the US-algorithms, again, except for the postoperative distal case.
Large sample volume % bias
preoperative Proximal +67.6Distal +46.6
postoperative Proximal +14.2Distal -6.3
Table 12.2: e bias for time-average ow rate, in case of large sample volume ac-
quisition.
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12.2.4 Discussion
In this paper, we studied PWD-based owmeasurements in the brachial and
radial artery in patients with an arterio-venous stula, both in the pre- and
postoperative case. We demonstrated that these PWD-based ow estimates
are subject to a high degree of inaccuracy. is inaccuracy is not directly
related to the inability of PWD to accurately capture the velocity component
in the direction of the ultrasound beam, but is induced via two factors:
1. the angle-correction, which does not correctly estimate the velocity
component along the assumed ow direction
2. the lack of knowledge on the ow prole
e inaccuracy induced by angle correction in volume ow estimation is
demonstrated in Figure 12.7. It illustrates the process of angle-correcting
the PWD velocity, both for the case of uni-directional laminar ow (= ve-
locity vectors aligned with the axis of the vessel) and complex ow (= ve-
locity vectors no longer aligned with the axis of the vessel). In both cases,
the velocity measured by PWD, vPWD (green), is the projection of the true
3D-velocity vector v (black), on the direction of the ultrasound beam (eus).
For uni-directional ow (Figure 12.7, top), vPWD is the projection of the lon-
gitudinal velocity, vx (blue), which in this case equals the velocity vector v.
However, when a complex ow eld is present, vPWD not only consists of
a contribution from the longitudinal component vx (blue), but also from
the radial vy component (red). As such, the angle-corrected Doppler ve-
locity vn does not only reect the longitudinal velocity component vx but
also the radial velocity component vy. erefore, depending on the ow
eld and the orientation of the velocity vectors, angle-correction of vPWD
can either over- (Figure 12.5 (le), preoperative, proximal) or underestimate
(Figure 12.5 (right), postoperative, distal) the velocity in the assumed ow
direction (vn(t)).
To illustrate that the orientation of the ow vectors indeed plays a role
in the cases considered here, we display the ow elds and the in-plane ve-
locity vectors for the four studied cases in detail in Figure 12.8. It is clear
that in all cases the in-plane velocity vectors have a non-zero component in
the radial y-direction, which is also picked up by the Doppler measurement
as shown in Figure 12.7. For the preoperative proximal case, the velocity
vectors point upwards, resulting in a positive velocity vy, while for the post-
operative distal case, the velocity vectors in the sample volume (indicated in
white) point downwards, resulting in a negative velocity vy. Note also the
highly asymmetric, skewed nature of the ow proles in the postoperative
case.
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Figure 12.7: Illustration on why angle correction of the Doppler velocity works for
unidirectional ow (upper case 1) but fails for complex ow (lower case 2).
Beside the angle-correction itself, the method applied to derive the ve-
locity curve from the Doppler spectrum can introduce considerable errors
in the ow estimation.emaximum frequency detector is seriously biased,
as noticeable in Figure 12.4, since the maximum frequency cannot be uni-
vocally determined because of intrinsic spectral broadening processes [226].
erefore, although it is a common approach in clinical practice [168, 227],
due to the lower sensitivity to shis in measurement location, the max-
tracking leads to signicant overestimation of the actual ow velocities and
ows. Further, it should be noted that while max-tracking is usually per-
formed by analyzing pixel intensity, mean-tracking requires direct access to
the spectral estimates and thus registration of the RF-data during the mea-
surement.
Further, the lack of knowledge on the spatial velocity prole contributes
to the inaccuracy of the ow estimation. When assessing the velocity in a
sample volumepositioned in the center of the cross-section, a correction fac-
tor β needs to be assumed, which relates to the shape of the velocity prole.
Our data seem to indicate that, for the investigated cases, there is no single
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Figure 12.8: Velocity magnitude [m/s] in the four selected region of interest with
the in-plane velocity vectors at the time point of peak velocity. e small sample
volume (0.39mm) is shown in white.
optimal choice for β.e β-values that one should use to match the PWD-
derived velocity data, analyzed by mean-tracking, to the true mean velocity
known from CFD are 0.506, 0.560, 0.507 and 0.935 for preoperative prox-
imal, preoperative distal, postoperative proximal and postoperative distal,
respectively. In the proximal locations, the assumption of a parabolic ow
prole for a small centered sample volume (β = 0.5) seems reasonable. For
the distal location in the small sample volume acquisition, the theoretical
value ranges from0.560 to 0.935 when changing from the pre- to the postop-
erative model. It is clear that the increase in overall ow rate induces a more
complex ow pattern, see Figure 12.8, with a β value closer to the solution
for plug ow. As stated before, the max-tracking signicantly overestimates
the ows. is results in ideal β-values of about 0.6 for the postoperative
distal case and about 0.33 (1/3th) for the other three cases.
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In the assumption of fully symmetrical ow proles, one expects that
the use of the larger sample volume, using mean-tracking (Equation 12.4),
should provide the most accurate estimate of the volume ow. Interestingly,
our data indicate that this was not systematically the case. First of all, this
method is challenged since the velocities in the vessel wall region are dicult
to measure, even in straight vessel segments [228–232]. Furthermore, this
method only assesses the mean velocity of the 1D velocity prole, instead of
assessing the mean velocity for the complete 2D cross-section.
e cross-sectional area used for the PWD ow estimate was calculated
based on the diameter measured perpendicular to the vessel assuming a cir-
cular cross-section.ese estimated areas only diered 2.2%, 2.0%, 6.0% and
2.4%, for preoperative proximal, preoperative distal, postoperative proximal
and postoperative distal respectively, with the 2D-cross-sectional areas cal-
culated from the CFD solution.erefore, the cross-sectional area calcula-
tion is, when comparing to the overall ow estimation bias in Table 12.1-12.2,
no major source of error in our evaluation.
As described by Swillens et al., the use of multiphysics ultrasound sim-
ulations bears some inherent limitations, the most important being the as-
sumption of linear ultrasound wave propagation, the use of rigid walls and
the absence of surrounding tissue, the latter typically aecting the accuracy
of blood velocity estimation [219].e result of a velocitymeasurement with
ultrasound is also dependent on the probe settings. e simulations were
performed for a typical linear array probe used for vascular examinations,
with PRF-settings that were tuned to allow capturing the maximum veloci-
ties as one would do in clinical practice. We believe that our specic choice
has only a minor inuence on the overall message and conclusion of this
study. However, an in-depth analysis of probe settings and imaging param-
eters, coupled with dierent ow regimes, could provide more inside in the
complex nature of PWD acquisitions. is could be included in a future
large parameter study.
It is clear that, based on our study, it is dicult to provide strict guide-
lines to estimate blood ow rate by PWD-acquisition. Overall, for the inves-
tigated cases, measurements based on the small sample volume positioned
in the center of the vessel, analysis based on mean-tracking and with the as-
sumption of a parabolic ow prole showed greatest accuracy, except for the
distal measurement in the postoperative case where the method underesti-
mates ow by about 50%.
From a clinical perspective, it might be safer to apply a method which
leads tomore conservative (underestimated) values of ow rather thanmeth-
ods leading to overestimation, although the better method performs well
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under all circumstances. More robust techniques are available when record-
ing owduring hemodialysis therapy, based on connecting the patient to the
extra-corporal circuit (e.g. ultrasound ow dilution (Transonic)). When as-
sessing preoperative or direct postoperative ow, replacing PWD derived
ow measurements can be more cumbersome. However, it should be noted
that more advanced ultrasonic ow estimators are being developed, but are
still in a preclinical phase. A potential solution for the demonstrated lim-
itations regarding PWD volume ow measurements, is the use of 2D ow
estimators (e.g. speckle tracking, vector Doppler) [233–243], avoiding the
need to angle correct a 1D velocity, but their clinical applicability is to be
demonstrated. In parallel, researchers have focused on the development of
multi-gate Doppler acquisitions, allowing to directly assess the velocity pro-
le, through simultaneous processing of several sample volumes along the
US beam [244].
12.2.5 Conclusion
We conclude that, in the setting of a forearm vascular access, ow estimates
based on pulsed wave Doppler are hampered by the complex ow patterns,
especially in the postoperative setting. Flow estimation based on centerline
measurement, analysed by mean-tracking of the spectral estimates and un-
der the assumption of a parabolic ow prole seem to provide reasonable
values for most cases.
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13. Computational study of flow in helical AVGs
13.1 Introduction
Nowadays, over 20 million patients worldwide are in need of renal replace-
ment therapy [10, 11]. In western countries, over 90% of the patients waiting
for a kidney transplant depend on hemodialysis [12, 17], and need a long-
term vascular access. Although an arterio-venous stula (AVF) is the rst
choice in most patients, in specic cases (e.g. low quality vessels in elderly
or diabetics) an arterio-venous gra (AVG) is the second best option [245].
Hereby an artery and a vein, mostly in the (lower) arm are connected by a
synthetic gra.
AVGs, however, deal with complications such as thrombosis and steno-
sis formation. As clinically observed, the stenosis formation with AVGs is
mainly located at the venous anastomosis or in the draining vein [30, 75,
246]. ese adverse events, due to maladapted intimal hyperplasia (IH)
[30, 36], are driven by abnormal hemodynamics. It is known from literature
that, aer vascular access creation, the ow eldmay play amodulating role,
with IH mainly located in regions of low wall shear stress, high oscillatory
shear stress and high residence time [75, 124, 125, 246–250]. Furthermore,
certain ow patterns in the bulk, induced by out-of-plane geometries, can
be linked to disturbed shear distributions at the luminal surface [71–73, 251].
More specically, helical ow tends to reduce these unfavorable hemody-
namic conditions [128, 252–255].
With this in mind, a helical shape was introduced in AVG designs by
Caro et al. [70, 74]. Up to now, the research on helical AVGs as vascular
access consists of an animal model study [74], a preliminary clinical study
on 20 patients [76], and a clinical trial on 180 patients, as suggested in the
work by Glickman et al. [77]. In other studies, computational uid dynam-
ics (CFD) was applied to analyze the hemodynamic performances of helical
gras in a stand-alone [256, 257] and in a bypass conguration [258], not
only to minimize disturbed shear but also to improve near wall and cen-
tral ow mixing. Sun et al. compared the helical gra design from Caro et
al. [74] with a new helical design, using steady-state ow conditions [256].
Cookson et al. investigated the in-plane ow structures and central ow
mixing in helical conduits in steady-state ow conditions [259]. Coppola
and Caro investigated the impact of arterial three-dimensionality on both
wall shear stress and oxygen transport/transfer [73]. Zheng et al. simulated
steady ows in helical gras and carried out a parametric analysis with re-
spect to the Dean Number and helical pipe geometric features, i.e., helical
pitch and amplitude [257]. Recently, Zheng et al. simulated the physiological
pulsatile ow in helical gras and observed that helical geometry creates am-
plied WSS magnitudes near the wall, that oscillatory shear never exceeds
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non-physiologically signicant values, and that the strong secondary ows
improve ow mixing between low-momentum uid near the surface and
high-momentum uid near the central ow [260]. Only Wen et al. studied
the gra in a coronary bypass setup (low ow, small diameter, no loop) and
one helical design was compared to the straight conventional design [258].
So, while dierent computational studies have been performed in low ow
(coronary) bypass congurations or in stand-alone congurations without
(arterial or venous) anastomosis, up till now, the clinically relevant, high
ow, helically-designed loop AVG conguration has not been studied in de-
tail [75].
erefore, the aimof this studywas to investigate, usingCFD, the impact
of the introduction of helical design in an AVG loop as a vascular access for
hemodialysis on the occurrence of (un)favorable hemodynamic conditions
at the venous anastomosis [30, 75, 246].
13.2 Material and methods
Six dierent parametric models of a gra connecting an artery and a vein
were created in pyFormex1. All models consist of a 4mm (diameter) artery,
a 6mm gra section and a 6mm vein, as shown in Figure 13.1. e gra
section has a length of 300mm in a loop conguration with both anasto-
mosis angles set at 45 degrees. As a reference model, a straight conventional
gra (SCG) was constructed. As shown in Figure 13.2, ve helical design
gras (HDG-1 to HDG-5) were created to analyze the inuence of a helical
design on hemodynamics.e amplitude of the helix of the gra was 3mm
(half the gra’s diameter) and one helix turn (pitch) was 105mm; 87.5mm;
70mm; 52.5mm or 35mm long, respectively. HDG-3 is based on the design
of the SwirlGra (Veryan Medical Limited, UK).
emodels were discretisedwith a fully conformal and structured hexa-
hedral mesh [220, 221, 261]. Because of the high ow rates and the expected
transitional ow patterns [262], an extensive mesh density and time step
analysis was performed. 200Hz sampling and consecutive mesh renement
up to 4.3million cells (4.5million nodes) resulted in WSS values at the ve-
nous anastomosis regionwithin 2% of the results obtainedwith a 6.4million
cell model. With the used hexahedral meshed meshes, about 140 hours, on
24 nodes of an in-house cluster, were required to calculate two consecutive
cardiac cycles, for one model.
1http://pyformex.org
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Figure 13.1: Summary of model, mesh, material properties and boundary condi-
tions (example of HDG-3). Region of interest at venous anastomosis site (ROI-1)
and region of interest in gra section (ROI-2) are highlighted.
e nite volume method was applied to solve the laminar governing
equations of the uidmotion, by use of the general purpose CFD codeAnsys
Fluent 12 (ANSYS inc., Canonsburg, PA, USA).
A post-operative ow waveform from a vascular access patient was ac-
quired by use of magnetic resonance imaging as described by Huberts et al.
[168]. A patient-specic ow waveform was set, in terms of parabolic veloc-
ity prole, as inlet boundary condition at the proximal artery (Figure 13.1).
e prole was scaled to achieve a time-averaged ow rate of 600ml/min,
which is in line with the European and American guidelines on vascular ac-
cess [19, 22].e inowwas redistributed such that 95% was sent to the gra
(with a further downstream division of 90% of to the proximal vein and 5%
to the distal vein), and 5% to the distal artery.
To mimic blood, a shear thinning uid, dened by the Quemada vis-
cosity model [118] (1.3mPa.s plasma viscosity and 40% hematocrit) with a
density of 1050 kg/m3, was implemented, as suggested Loth et al. [75].
As for the computational setting, standard pressure discretisation and
second-order upwind momentum discretisation schemes were applied. Af-
ter a time step sensitivity analysis, a 5ms time step was chosen and two car-
diac cycles were calculated. In all cases, the analysis and post-processingwas
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Straight Convenonal Gra (SCG) Helical Designed Gra (HDG-1) HDG-2
HDG-5HDG-4HDG-3
Figure 13.2: Overview of the studied designs.
performed on the second time step using Matlab (e Mathworks, Natick,
MA, US) and Tecplot (Tecplot inc, Bellevue, WA, US) .
reewall shear stress-based descriptors of the oweldwere calculated
in the region of interest (ROI) at the venous anastomosis (ROI-1, Figure 13.1).
e time-averaged wall shear stress (TAWSS) was calculated as the integral
over time of the absolute value of the WSS-vector, with T representing one
cardiac cycle:
TAWSS = 1
T ∫ T0 ∣WSS∣dt (13.1)
To assess the change in direction of the ow and, with it, the velocity gra-
dient during a cardiac cycle, the oscillatory shear index (OSI), originally in-
troduced by Ku et al. [123], was calculated:
OSI = 1
2
⎛⎜⎜⎝1 −
∣ 1T ∫ T0 WSS dt∣
1
T ∫ T0 ∣WSS∣dt
⎞⎟⎟⎠ (13.2)
e relative residence time (RRT), introduced by Himburg et al. [124] was
qualied as:
RRT = T∣∫ T0 WSS dt∣ (13.3)
To compare all six cases, two dierent methods were used. First, the
luminal surface area in ROI-1 subjected to low TAWSS and high OSI and
RRT values was quantied. Second, a patching-method, based on areas of
low TAWSS and high OSI or RRT, was explored. For the three parame-
ters, the geometrical distributed areas of all six cases were unied to achieve
one global patch per single parameter, as in Morbiducci et al. [263]. With
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this method, three non-operator dependent or non-biased ROIs were de-
termined (TAWSS-patch, OSI-patch and RRT-patch) and used to compute
the average TAWSS, OSI and RRT. In both the area- and the patch-method,
cut-o values of 1Pa for TAWSS, 0.1 for OSI and 1Pa-1 for RRT were used.
Next to these wall shear parameters, bulk ow features were assessed by
using a helicity-based descriptor. In the gra section (ROI-2; Figure 13.1),
bulk ow features were characterised using the helicity-based descriptor H,
expressed as the volume-average of the absolute kinetic helicity:
H = 1
V ∭ ∣Hk ∣ dV = 1V ∭ ∣v ⋅ (∇× v)∣ dV (13.4)
Note that the kinetic helicity intensity, Hk , is a measure of the alignment
of the velocity vector ,v , and the vorticity vector, curl v. Both instanta-
neous and time-averaged H were calculated over the gra section (ROI-
2; Figure 13.1). To achieve a more global quantity, the kinetic helicity in-
tensity, Hk , can be normalized with the velocity and vorticity magnitude
resulting in a Local Normalized Helicity (LNH) between -1 (counterclock-
wise helix when looking along with the ow direction) and 1 (clockwise)
[264]. Descriptor LNH is a non-dimensional quantity and a measure of the
alignment/misalignment of the local velocity and vorticity vectors and its
sign is a useful indicator of the direction of rotation of helical structures
[253, 255, 263].
Finally, the instantaneous and time-averaged static pressure drop were
calculated over the gra section. All results were compared with the refer-
ence case, i.e. the straight conventional gra (SCG).
13.3 Results
Figure 13.3 summarizes our ndings with regards to the area in ROI-1 ex-
posed to TAWSS below 1 Pa, OSI above 0.1 or RRT below 1 Pa−1. It is clear
that the results are not trivial to interpret, and the impact of the helical de-
sign is dierent for each investigated parameter. e area exposed to low
TAWSS is only lower for designs HDG-4 and HDG-5, while the area ex-
posed to high OSI values is reduced for designs HDG-3 and HDG-5. e
only parameter that shows a more or less consistent relation with increasing
helical pitch is the area exposed to high values of RRT, which rst slightly
increases but decreases for designs HDG-3 to HDG-5.
e parameter specic patches as well as the results for the average val-
ues in these patches are shown in Figure 13.4. Because for TAWSS a patchwas
created unifying the six zones (one for each case) with values below 1 Pa, the
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to the results from the area-method.e same overall reduction as for OSI
can be found when analyzing the RRT results.
When calculating the area with TAWSS below 0.4 Pa, a well-accepted
threshold for unfavorable WSS conditions [122], we nd an area of 0.11 cm2
for the SCG. is area increases by 20.7%, 29.1 %, 41.5 % and 5.4% when
analyzing design HDG-1 to HDG-4. For the HDG-5 model, a 100% low-
TAWSS area reduction is found. e minimum value of TAWSS in ROI-1
for the HDG-5 low pitch design is 0.57 Pa.
Interestingly, the absolute kinetic helicity values averaged over the vol-
ume of ROI-2 (Figure 13.5; top) clearly indicate that the helicity in the bulk
ow of the gra increases with the number of helix turns. In particular, a
2.6-fold increase in the time-averaged H is obtained in HDG-5, when com-
pared to the reference case.
e pressure drop over the gra section (ROI-2) is shown in Figure 13.5
(bottom). An increasing number of helix turns in the gra design leads to
a moderate increase in the pressure drop, which is most pronounced for
HDG-5 (5.8mmHg), compared to the 3.6mmHg in the SCG.
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Figure 13.5: Volume-average of absolute kinetic helicity in the gra section (top)
and pressure drop over the gra section (bottom) for the six parametric models:
Time-averaged (le); One cardiac cycle (right).
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e impact of the closed-loop AVG design on the bulk ow in the gra,
is visualized in Figure 13.6 by the use of LNH iso-surfaces. When adopt-
ing high threshold values of LNH (±0.7) for the visualization of markedly
aligned/opposed velocity and vorticity vector elds, dierent topological
features can be observed, depending on gra geometry. More in detail,
Figure 13.6 highlights that, at peak systole, counter-rotating uid structures
(positive and negative LNH values indicate counter-rotating helical struc-
tures) characterize the ow into the gras in such a way that is markedly
dependent on the number of pitches of the helical conduits. In particular, fo-
cusing the attention on the outow tract of the gra (i.e. the region of the ve-
nous anastomosis), it can be noticed fromFigure 13.6 that: (1) no intertwined
uid structures with marked LNH magnitude appear in the distal part of
SCG model; (2) the presence of high magnitude, counter-rotating (red and
blue LNH iso-surfaces), intertwined uid structures is a common feature of
the bulk ow in helical gras, independent of the number of pitches; and
(3) the higher the number of pitches in the gra, the more counter-rotating
uid structures are intertwined.
In Figures 13.7 to 13.9, the velocity magnitude and in-plane streamlines
are displayed at three dierent time points along the cardiac cycle. Two dif-
ferent venous cross-sections are considered for observation: (1) at the venous
anastomosis, where the ow starts to bend from the gra section towards the
horizontal vein (section A); and (2) at a venous cross-section located 10mm
(about 1.7 vein diameters, section B) downstream the venous anastomosis.
It can be observed from Figures 13.7 to 13.9 how the helical gra geometry
plays a primary role in the primary and secondary velocity patterns at the
venous anastomosis region.
At early systole, Figure 13.7 shows that all AVG designs show a ow eld
that is characterized by two counter-rotating vortices. As the number of
helix turns in the gra increases, the high axial velocity region shis in a
clock-wise direction. Moving from section A to section B, the high axial
velocity is shied to the opposite side with respect to the vein region and an
action of axial ow stretching is exerted in section A. At this point, the AVG
design seems to have a mild impact on the uid patterns establishing into
the region of the venous segment (i.e., ROI-1, Figure 13.1): Figure 13.7 clearly
shows that no marked dierences in terms of low velocity or recirculating
ow patterns are present very close to the ROI-1 of all the AVG models.
At peak inlet ow rate, Figure 13.8 shows marked dierences among the
dierent AVG designs in the composition of translational and rotational
ow: (1) at the venous anastomosis (section A), where an increase in the
number of pitches imparts a marked clock-wise rotation of the location of
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duced by the gras.
high axial velocities and secondary ows stretching/folding; and (2) down-
stream of the venous anastomosis (section B), where ROI-1 experiences, for
an increase of the number of pitches, amarked reduction in low velocity and
recirculating regions close to the wall; this as a consequence of the multiple-
vortex and the dierently stretched secondary ow patterns.
At late systole, Figure 13.9 shows that increasing the number of pitches
in helical gras, and with it, helicity intensity, leads to a marked washout
of the venous region ROI-1. Herewith, in model HDG-5, the extension of
low velocity and recirculating regions very close to the wall are markedly re-
duced.is is particularly true at section B, due to the onset of a centralized,
stabilizing vortex, opposed tomore complex secondary ows characterizing
the other models.
13.4 Discussion
To study the inuence of a helical design of an AVG as vascular access on the
hemodynamics (in particular on shear-stress related parameters), six dier-
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Figure 13.7: Axial velocity contours [m/s] and in-plane streamlines at early systole
(0.09 sec). Two dierent venous cross-sections are considered as planes of obser-
vation: (A) at the venous anastomosis, where the ow starts to bend from the gra
section towards the horizontal vein; (B) at a venous cross-section located 10mm
(about 1.7 vein diameters) downstream of the venous anastomosis.
ent computational models were created. All models were constructed para-
metrically, only changing the helical pitch in the gra. A straight conven-
tional gra was introduced and ow patterns were compared to those in ve
dierent helical designed gras (Figure 13.2).
ere is no trivial relationship between the number of helix turns in the
gra design and the investigated parameters. e design with the highest
number of helix turns, HDG-5, scores best when comparing TAWSS, OSI
and RRT. For the other designs, HDG-3 seems to score better than HDG-
1, HDG-2 and HDG-4 in terms of OSI, but scores worse than HDG-4 for
TAWSS and RRT. Hence, there is no one-on-one relation between the num-
ber of pitches in the gra and the investigated parameters quantifying dis-
turbed ow and shear stress in the region of the anastomosis.
We tested two dierent methods to quantify the WSS-based descriptors
TAWSS, OSI and RRT. Overall, both the area- and the patch-method result
in the same overall conclusions. However, a case-wise analysis reveals some
dierences in the obtained results. Where the area-method indicates that
HDG-1 and HDG-2 score comparable with the reference design SCG for all
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Figure 13.8: Axial velocity contours [m/s] and in-plane streamlines at peak systole
(0.185 sec). Two dierent venous cross-sections are considered as planes of obser-
vation: (A) at the venous anastomosis, where the ow starts to bend from the gra
section towards the horizontal vein; (B) at a venous cross-section located 10mm
(about 1.7 vein diameters) downstream of the venous anastomosis.
three parameters, the patch-method results in a worse outcome for TAWSS
and a better outcome for OSI and RRT. When looking at HDG-3 (based on
the design of an existing gra), lowTAWSS area is higher than in SCG, while
the high RRT area is comparable.e average value in the patch of TAWSS
is somewhat smaller than in the reference case, but for the OSI a strong re-
duction of the area exposed to high values is found. Hence, the oscillating
shear seems to be reduced in HDG-3. For the somewhat more helical design
HDG-4, a reduced area is exposed to low TAWSS and high RRT, but again
there is an increased area characterized by highOSI. Finally, themost helical
design HDG-5 (with a pitch of 35mm) revealed to be instrumental in reduc-
ing disturbed shear (Figures 13.3 and 13.4): in it, a relevant decrease in areas
interested by low TAWSS and high RRT was observed. is is even more
pronounced when observing the elimination of the region with a TAWSS
below 0.4 Pa for HDG-5 case. Furthermore, HDG-5 even almost eliminates
the area with OSI above 0.1.
To get more insight into the reason that makes a helical design of the
gra instrumental in suppressing disturbed shear, a quantitative analysis of
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Figure 13.9: Axial velocity contours [m/s] and in-plane streamlines at late systole
(0.34 sec). Two dierent venous cross-sections are considered as planes of obser-
vation: (A) at the venous anastomosis, where the ow starts to bend from the gra
section towards the horizontal vein; (B) at a venous cross-section located 10mm
(about 1.7 vein diameters) downstream of the venous anastomosis.
the bulk ow, in terms of its helical content, was performed. erefore the
volume-integrated value of the absolute kinetic helicity into the gra was
calculated.e absolute value of the kinetic helicity was considered because
a clockwise helical pattern can otherwise compensate a counter-clockwise
pattern when volume averages are calculated. Here we observed that an
overall increase in the helical ow patterns within the gra is associatedwith
the number of helix turns.is is due to the fact that in loosely coiled helix
pipes both torsion and bending mutually contribute to the onset of helical
ow . It should be noted that the ow is not only subject to the helical de-
sign of the gra, but to the ow split at the arterial and venous anastomosis,
to the bending from the anastomosis to the horizontal position and to the
bending of the loop gra as well.
Overall, the pressure drop over the gra (Figure 13.5; bottom) increases
with increasing helicity. e pressure drop rises from 480.2 Pa to 771.3 Pa
when comparing HDG-5 to SCG (i.e. increase of 60.6%, but only 2mmHg).
So, in absolute values, both pressure drops seem negligible in the blood ow
path from a clinical point of view (i.e. from about 100mmHg at the le
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ventricle to about 5mmHg at the right atrium). When analyzing the pressure
drop as a function of time (Figure 13.5; bottom-right), it is noticed that a
negative pressure drop occurs between 0.39 and 0.48 seconds.is negative
pressure dierence over the gra is due to the fact that the ow gets inertia
dominated because of the high-ow condition and the strong decreasing
velocity.
e uid patterns observed in Figures 13.7, 13.8 and 13.9 might be a con-
sequence of the counter-rotating, intertwined uid structures characterizing
the bulk ow in helical gras, as shown in Figure 13.6. We speculate that the
more these helical ow structures are intertwined, the more they contribute
to the ow stabilization in the downstream venous segment, thus the miti-
gation of the transitional eects and, ultimately, the disorganization of the
ow eld downstream of the anastomosis.is is in line with the well docu-
mented role played by helicity in reducing energy transport from the inertial
to the dissipation scale, thus avoiding the onset of turbulence and, ultimately,
promoting ow stabilization [265].e uid structures observed in the case
of model HDG-5 during the deceleration phase (Figures 13.9) support the
plausibility of our conviction: the presence of a centralized, predominat-
ing one-vortex secondary ow stabilizes the ow eld, hence avoiding the
breakdown of the ow in multiple vortex patterns.
As observed in Figure 13.6 to 13.9, for all HDGs, a swirl pattern present
in the gra section generates a complex ow eld in the anastomosis region.
It should be remarked that the length of the straight gra section, proximal
to the venous anastomosis, might inuence the position of the swirl at the
anastomosis site and, with it, the value of the local WSS-based descriptors.
Although the connection of the venous end of the grawith the anastomosis
was created equal for all designs, the initial choice of anastomosis inow
length and geometry might inuence the uid structures developing into
the gra and downstream of the venous anastomosis. In the future, this can
be object of further investigation.
In our study we focus our attention on the impact of the design of the
gra, in terms of disturbed shear, at the venous anastomosis and not to dis-
turbed shear into the gra.is driven-by-clinical-observation focus to the
venous anastomosismakes it complicated to furnish an interpretation of dis-
turbed shear at the anastomosis in terms of the physical nature of the ow
structures into the AVG design. A description of the physical nature of the
ow in terms of the paradigms of the uid mechanics in helical conduits
(Dean [266], Germano [267] and LM [268] numbers) can only loosely be
adopted, because of the inuence of the anastomosis (45 degree angle and
non-circular cross-section at the venous anastomosis) and the applied un-
steady ow conditions. For the sake of completeness, the mean Reynolds
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number at the inlet was 909 and in the gra 576.e mean Dean numbers
were 102, 121, 150, 195 and 273; the mean Germano numbers 100, 119, 145,
183 and 240; and the mean LM numbers 0.11, 0.10, 0.09, 0.08 and 0.06; in
cases HDG-1 to HDG-5 respectively. Whether the use of mean Reynolds,
Dean, Germano and LM numbers (mean data, along the axis of the gra)
are a helpful design tool for AVGs in a clinical relevant setup (loop gra
and unsteady ow conditions) should be investigated more in depth with a
parametric approach.
It should be noted that despite the fact that HDG-5 gives the best results
concerning the reduction of the unfavorable hemodynamics, the practical
use of this design could be questioned. In clinical practice, the AVG is im-
planted in the arm under the skin. If the gra is fabricated from expanded
polytetra-uoroethylene (ePTFE), as most gras nowadays are, the num-
ber of helix turns will, most probably, be reduced because of the tension of
the skin. In the preclinical study of Huijbregts et al. on a design similar to
HDG-3, angiographic examination showed already, in a number of cases, a
reduction of the helical geometry [76].ey suggest that this might be due
to overstretching the gra during implantation, or by elongation under ar-
terial pressure. But even when a material which can resist this stretching
would be used, the gra will still require a large space under the skin.
Although numerous authors stated that low TAWSS, high OSI and high
RRT can be linked to IH and therefore stenosis formation [75, 124, 125, 246–
250], no clear threshold values for IH formation, e.g. at the venous anasto-
mosis of an AVG, for these wall shear stress descriptors can be found. We
analyzed the results of all our studied cases using threshold values of 1 Pa
for TAWSS, 0.1 for OSI and 1 Pa−1 for RRT. To somehow limit the impact
of this arbitrary choice on the interpretation of our data, we also used, the
patch-method, dening patches by those threshold values, and analyzing
area-averaged parameters.
Our study contributes to a better understanding and quantitative anal-
ysis of the impact of novel gra designs on hemodynamics. Although he-
lical designs have been introduced in bypass gras, stents and vascular ac-
cess gras [74, 258, 269, 270], this study is the rst in-depth (computational)
analysis performed on helical designed vascular access gras in a clinically
relevant (i.e. closed-loop) conguration. Caro et al. added their pre-clinical
animal study with some basic CFD work on a single helical gra. Without
stating the used methods, they only showed a numerical helical gra in a
straight conguration, focusing on the non-symmetric ow eld in the gra
itself.e paper also reported a small experimental in-vitro study showing
the helical ow patterns in a 90ř anastomosis, by the use of ink dilution [74].
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Further numerical research in the eld of helical designed gras was only
performed in a coronary bypass conguration [256–258].
e present study has to be seen as an addition to the research area of
helical designs in gras. In our in-depth CFD analysis, it was possible to
calculate dierent WSS-descriptors, based on dierent methodologies, as
well as bulk ow parameters. Because the loop conguration and the artery
and vein anastomoses were included, clinically relevant ow patterns could
be visualized. e strength of this study is that it does not only compare
hemodynamics in non-helical and helical designed gras, but also unravels
the inuence of changing the helical pitch on the ow eld and wall shear
parameters.
13.5 Conclusion
Introducing helix turns in the design of an AVG inuences the hemody-
namics in both gra, venous anastomosis and draining vein. e genera-
tion of helical ow leads to a more complex ow eld which, with appro-
priate design parameters, may eectively reduce the area of zones exposed
to unfavorable wall shear stress conditions that are associated with an in-
creased risk of intimal hyperplasia. However, the value of the pitch in the
gra design is not (fully) proportional to the distal hemodynamics condi-
tions. It was demonstrated that the general mechanical approaches for he-
lical conduits are not sucient to describe the disturbed shear observed in
the venous anastomosis region. We showed, by introducing more realistic
conditions (unsteady ow and closed-loop conguration), that the optimal
pitch length and optimal number of helix turns in an arterio-venous gra to
reduce regions with unfavorable hemodynamics cannot be derived without
studying case by case.
166
Five
Studies on CVCs
167

C
h
a
p
t
e
r
14
Computational study of flow in a
novel CVC
T.W.I. Clark, K. Van Canneyt and P. Verdonck
Computational ow dynamics and preclinical assessment of a novel
hemodialysis catheter.
Seminars in Dialysis. 2012.
169
14. Computational study of flow in a novel CVC
14.1 Introduction
Over 420 000 Americans with end-stage renal disease receive hemodialysis
[17]. Native arterio-venous stulas are the optimal form of vascular access,
however synthetic gras and dialysis catheters remain additional important
access alternatives. Dialysis catheters are placed for acute hemodialysis and
to serve as a bridge to a permanent form of vascular access. Catheters are
also used as an access of last resort when patients have exhausted their vas-
cular anatomy for placement of a stula or gra [19].
Manufacturers of dialysis catheter design have typically emphasized
higher ow rates, and since a higher ow rate through the dialyzer can the-
oretically result in a shorter treatment time, catheters have oen been de-
signed to function at the highest possible ow rate [271]. However, an in-
crease in ow rate is oset by a higher pressure gradient over the catheter
which in turn will induce elevated shear rates [98]. Moreover, there is no
linear relation between blood ow rate and solute clearance, and it is ade-
quate solute clearance which is the goal of maintenance hemodialysis rather
than shorter treatment times [272].
Optimal dialysis catheter ow therefore requires a balance. Flow that
is too high can produce high shear rates which has the potential to cause
platelet activation and mechanical hemolysis. Flow that is too low can in-
crease blood cell residence time within the catheter lumen and promote
thrombus formation [98].
A critical parameter of dialysis catheter performance for optimal solute
clearance is the access recirculation. It is important to have the smallest pro-
portion of cleansed blood returning back to the dialyzer since higher per-
centages of recirculation can require a longer duration of hemodialysis for
target solute clearance. Inmost dialysis catheter designs, increased ow rates
and/or reversal of lines will increase catheter recirculation [273, 274].
In this study, we describe a novel hemodialysis catheter designated as
the VectorFlow catheter. is catheter has helically contoured arterial and
venous apertures to produce a spiral, three-dimensional transition in blood
cell vectors as blood enters and leaves the catheter.ese vectors are opposed
so that the admixture of dialyzed and nondialyzed blood is reduced, thereby
minimizing recirculation. Most current catheter designs have lumen aper-
tures at the catheter tips which are perpendicular to the direction of blood
ow in the superior vena cava or right atrium. Blood entering the arterial
lumen in particular is subject to a rapid change in the net vector of blood
ow, as the direction of blood ow must assume a sudden reversal in direc-
tion. e helically curved shape of the lumen apertures of the VectorFlow
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catheter also serves to minimize blood cell residence time in the catheter tip
and reduces blood cell shear stress by providing a more gradual transition
in ow velocity to blood entering and leaving the catheter.
e performance characteristics of this catheter were studied in three
settings: a simulated model using computational ow dynamics (CFD) (to
measure shear stress, blood cell residence time, Platelet Lysis Index and ca-
theter recirculation), a bench model of hemodialysis (to measure recircula-
tion at varying rates of ow), and an animalmodel (tomeasure recirculation
at varying rates of ow).e performance characteristics of this catheter are
compared to several other current dialysis catheter designs.
We will focus mainly on the CFD study and only mention shortly the
methods and results of the other two investigations (more details can be
found in Clark et al. [275]).
14.2 Material and methods
14.2.1 Computational Fluid Dynamics
Simulated 14 Fr. VectorFlow symmetrical tip and Tal Palindrome catheters
(Figure 14.1) were rendered using SolidWorks soware (Dassault Systèmes
SolidWorks, Concord, MA) and exported into Gambit soware (Ansys Inc.,
Canonsburg, PA, US). Since it is not feasible to evaluate catheter perfor-
mance within a simulated right atrial model (due to complexity of assump-
tions regarding atrial size, proportion of ow from the inferior vena cava,
and tricuspid function) these virtual catheters were placed within an 18mm
diameter and 120mm long cylinder representing the superior vena cava
(SVC) using Fluent ow simulation soware (ANSYS inc., Canonsburg, PA,
US). e computational ow dynamics model of dialysis catheter perfor-
mance previously described and validated using Particle Image Velocimetry
(PIV) byMareels et al. was used for analysis [98, 276]. Each catheter and the
SVC were meshed to obtain over 3,300,000 tetrahedral volume cells. e
tetrahedral mesh was locally rened around the catheter tip to obtain opti-
mal resolution for assessment of shear stress and to achieve grid indepen-
dence. Fluent was used to iteratively solve the continuity and momentum
equations with a nite volume method to result in a steady-state solution.
All boundaries were rigid, impermeable and with no slip at the vessel-
wall surfaces. e SVC inlet ow was established at 3 l/min, and the SVC
outlet was set to a reference pressure outlet of 0 Pa. is corresponded to
an SVC velocity of 19.6 cm/sec, in accordance with prior clinical measure-
ments of Cohen et al. [277].e blood ow through the catheter was set to
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Figure 14.1: VectorFlow symmetrical tip catheter in multiple projections (A). Note
the helical shape to the catheter tip at the arterial and venous lumens, which are
symmetrical and opposed on each side of the catheter. Representations of Vector-
Flow (B) and Palindrome (C) catheter tips within Gambit soware (ANSYS inc.,
Canonsburg, PA, USA) in preparation for computational ow dynamics.e arte-
rial inlets are shaded.
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400ml/min. Blood was modeled as a non-Newtonian uid, using the Que-
mada blood viscosity model [119]. Hematocrit was set to 40%, the plasma
viscosity to 1.3mPa.s and the blood density to 1060 kg/m3.
Shear stress and Platelet Lysis Index
Shear stress levels were calculated as the multiplication of dynamic viscosity
and strain rate. To assess platelet activation and thrombosis formation, the
Platelet Lysis Index (PLI) was calculated in the manner of Goubergrits and
Aeld [278], based on the work of Giersiepen et al. [279].e formula was
initially derived from in vitromeasurements of lactic dehydrogenase (LDH)
release from lysed human platelets and is based on the combination of the
magnitude of shear stress, τ, and exposure time to the vascular device, t:
PLI = 3.66 10−6 ⋅ t0.77 ⋅ τ3.075 (14.1)
is index allows linking high shear stress to subsequent low ow zones
via pathlines.e PLI can be used as a comparative tool in the quantitative
assessment of the arterial catheter tip design rather than as a predictive tool
of actual platelet activation. In the inlet of a catheter a minimum of 1000
pathlines were computed. Each pathline took 3000 steps of 10 microme-
ters to allow the pathline to extend past the disturbed ow in the catheter
tip zone and into the region of Poiseuillian ow further downstream the ar-
terial catheter lumen. At every point along each pathline, shear stress and
velocity magnitude values were exported. e time value was computed as
the distance between two subsequent points along a pathline divided by the
average velocity over the segment. PLI values of every step along a pathline
were summed. Subsequently, a weighted average of all pathline PLI values
was computed using the entrance velocity of a pathline as weighing factor.
As such, each pathline contributed to the PLI according to the amount of
catheter inow it represented.
Blood Residence Time
Blood cell residence time (RT) was calculated in the tip volume, 0.075ml,
by solving a specic form of the continuity equation as previously described
by Mareels et al [98]. is RT value indicates the time blood remained in
the arterial inlet volume before being drained to the arterial outlet, ie. the
‘washout time’ of blood in the arterial inlet and a proxy of the risk of catheter
tip thrombosis. It was calculated by Mareels et al. [98] that for his reference
catheter design, here described as the ‘step tip’ catheter, the average time
needed for the blood particle to pass through the tip volume was 0.015 s.
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erefore, volume percentage with RT above 0.030 seconds (twice the av-
erage in the reference case) was calculated as possible threshold for higher
risk of catheter thrombosis.
Access recirculation
Access recirculation was assessed by labeling all venous (dialyzed) blood
ow particles and calculating the particle density in the arterial lumen out-
ow versus the distal vena cava superior outow. From this, the percentage
of recirculation was calculated as the percentage of blood particles returning
through the arterial lumen compared to the blood particles brought in the
system by the venous lumen inow.
14.2.2 Bench model
An in vitro model was used to simulate caval hemodynamics for catheter
measurements. A ow circuit was created with a hollowed dialyzer to simu-
late the SVC (internal diameter 35mm) using 5% saline circulating through
Gambro dialysis tubing at maximal ow rate of 2000ml/min. e use of a
35mm SVC with 2 l/min ow gives an average velocity of 3.5 cm/s. Since the
uid used in the experiment is 5% saline, with almost 3 times lower viscos-
ity than blood, the applied Reynolds number (dimensionless factor used to
compare ow elds with dierent geometry, velocity and viscosity) of the in
vitro benchmodel is equal to the Reynolds number of the CFD calculations.
Within the center of this simulated SVC, the following catheters for re-
circulationmeasurements were introduced (more details and gures in Sec-
tion 5.3): Duraow (AngioDynamics, Latham,NY,US),Ash split-tip catheter
(Medcomp,Harleysville, PA,US),DuraMax (AngioDynamics), Centros (An-
gioDynamics), Tal-Palindrome (Covidien,Manseld,MA,US) and theVec-
torFlow symmetrical tip study catheter.
A second pump was used to provide constant ow through each dialysis
catheter. Recirculation was measured of each catheter at ow rates of 400,
500 and 600ml/min using an ultrasound-dilution technique. For asymmet-
rical tip catheters (i.e. step tip and split tip designs) lines were reversed and
measurements obtained at each ow rate to assess themaximal recirculation
of each catheter. For the VectorFlow and Tal-Palindrome catheters, the sym-
metrical tip design of these catheters is such that ‘arterial’ and ‘venous’ lumen
designation is arbitrary and so line reversal would not result in a change in
recirculation. erefore, these measurements were obtained in these two
catheters without designating the lines as ‘reversed’ or ‘forward’.
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14.2.3 In vivomodel
A single domestic swine was utilized for in vivo assessment of catheters.
e jugular vein was accessed percutaneously.e study catheters were ad-
vanced in random sequence. e following catheters were evaluated: Vec-
torFlow (symmetrical tip) catheter, VectorFlow-Split Tip catheter (which
was constructed during the course of this study but not available at the time
of the benchmodel experiments) and Tal-Palindrome. To simulate a dialysis
circuit, a pump was used with ow settings of 300, 400 and 500ml/min. At
each ow setting, catheter recirculation was measured in triplicate for the
VectorFlow, VectorFlow-Split Tip and Tal Palindrome catheters. To serve
as additional comparisons, Ash split tip and DuraMax catheters were run
in reversed line positions (to produce maximal recirculation) at 500ml/min
and recirculation measured in triplicate.
14.3 Results
14.3.1 Computational Fluid Dynamics
e results of CFD analysis of the VectorFlow and Palindrome catheters are
summarized in (Figure 14.2 and 14.3). For comparison purposes, these re-
sults are graphedwith the conventional catheter tip designs previously simu-
lated under identical conditions by Mareels et al. [98]. Both the VectorFlow
and Palindrome catheters were associated with levels of mean shear stress
similar to split tip and step tip catheter designs (Figure 14.2a). e Vector-
Flow catheter was associated with an 18% lower mean shear stress compared
to that of the Palindrome catheter, at 13.6 and 16.6 Pa, respectively.
e Platelet Lysis Index (PLI), a weighted scaling of blood particles ex-
periencing low shear stress for a long period and high shear stress for a
short period, is a metric previously developed to compare the risk of platelet
activation, platelet aggregation and thrombogenicity between vascular de-
vices [98, 272, 273]. Lower levels of PLI were seen with the VectorFlow
(PLI = 0.019) and Palindrome (PLI = 0.015) catheters as well as the step tip
design (PLI = 0.007) (Figure 14.2b). As reported previously [98], the highest
PLI was associated with the concentric catheter tip design (PLI = 0.126), fol-
lowed by the angled tip design (PLI = 0.045). Moderately high PLI was also
present with the split tip design (0.036).
e percent volume of blood owing through the catheter with a resi-
dence time (RT) exceeding 0.030 seconds was calculated.is showed that
the VectorFlow catheter design produced a percent volume of RT> 0.030 s
of 1.2%, compared to 0.9% for the Palindrome catheter and 8.3% for the con-
centric design. e highest residence time was present with the split tip
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(a)
(b)
(c)
Figure 14.2: Comparison of mean shear stress [Pa] (a), of Platelet Lysis Index
(b) and of blood Residence Time > 0.030 seconds (c) between the VectorFlow and
Palindrome study catheters, and compared with the values of split-tip, concentric,
step-tip, and angled-tip designs.
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catheter, which was associated with a 31.4% percent volume of RT> 0.030 s
(Figure 14.2c).
Recirculationwas directly compared between theVectorFlow and Palin-
drome catheters using computational ow dynamics. e calculated per-
cent of recirculation of the Palindrome catheter was 0.039%, compared to
13.6% for the step tip catheter in reversed position (with aspiration of blood
through the venous lumen). However, recirculation of the VectorFlow ca-
theter was calculated at 1.2 10−4%. Velocity streamlines entering and leaving
the catheter and a detailed view of the ow inside the arterial lumen are
shown in Figure 14.3.
Figure 14.3: VectorFlow velocity streamlines, colored by velocity magnitude (m/s).
Le: Pathlines of ow entering the arterial lumen and leaving the venous lumen.
Note lack of streamtraces leaving the venous lumen entering the arterial lumen of
the catheter (the recirculation was calculated at 1.2 10−4%).
Right: Streamtraces inside the arterial lumen.
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14.3.2 Bench model
e results of recirculationmeasurements at varying ows within the bench
model are summarized in Figure 14.4. Among each of the studied catheters,
with the exception of the VectorFlow and Palindrome catheters, higher rates
of catheter ow resulted in higher percentages of catheter recirculation. In
reversed positions, recirculation was highest with the Ash split catheter with
a mean of 29.3% at a ow rate of 600ml/min. Among the step tip catheter
designs, the DuraMax catheter was associated with the highest percentage
of mean recirculation (20.8%) at 600ml/min.e Palindrome catheter had
the lowest rate of recirculation among the remaining catheters, ranging from
means of 7.3 - 9.5%.e VectorFlow catheter had no detectable recirculation
(0%) at any ow rate. As the catheter has a symmetrical lumen design, re-
versal of lines did not inuence this result.
Figure 14.4: Comparison of catheter recirculation calculated from benchmodel of
hemodialysis.e Ash Split, DuraMax,Centros, and DuraFlow catheters were run
in reversed line position (aspirating through venous lumens).e VectorFlow and
Palindrome catheters have symmetrical lumens so that line reversal did not aect
recirculation.
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14.3.3 In vivomodel
For each catheter, recirculation was measured at each ow (with lines re-
versed tomaximize the eects of recirculation). Triplicate recirculationmea-
surements were performed at each ow rate; mean recirculation percentages
are shown in Figure 14.5.eVectorFlow catheter, concordant with the nd-
ings of computational ow dynamics and bench model measurements, was
associatedwith absence ofmeasurable recirculation (0%). Moreover, signi-
cant reductions in recirculationwere observedwith a split tip cathetermodi-
ed with VectorFlow lumens. With lines reversed, the VectorFlow-Split Tip
design was associated with a 44% decrease in recirculation at 500ml/min
ow compared to the Palindrome catheter, and a 59% reduction in recircu-
lation at 500ml/min compared to the Ash split catheter.
Figure 14.5: Comparison of catheter recirculation measured in an animal model
of hemodialysis. VectorFlow-Split, Ash Split and DuraMax catheters were run in
reversed line positions to producemaximal recirculation. (VectorFlow-Split = split-
tip catheter with arterial and venous lumens modied to resemble the VectorFlow
symmetrical tip catheter.)
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14.4 Discussion
Chronic dialysis catheters are the least optimal form of hemodialysis ac-
cess due to higher rates of infection and dysfunction [280, 281]. However,
catheters remain widely utilized as a bridge to permanent access placement
or maturation, or when other access options have been depleted. Following
the introduction of the K/DOQI guidelines by the National Kidney Foun-
dation and the Fistula First initiative by the Centers for Medicare Services
(CMS), the prevalence of stulas among hemodialysis patients increased
from 28% in 1998 to 55% in 2007 in the US. However, catheter utilization
has been relatively constant at 17-18% since 2003, in part from the increased
placement of arterio-venous stulas resulting in longer periods of catheter
use during access maturation [17].
ere remains an ongoing need to improve catheter performance and
decrease catheter-related morbidity. Current strategies to extend catheter
longevity include surface coatings with antithrombotic [282] and/or antimi-
crobial agents [283, 284], antimicrobial lock solutions [285, 286] and modi-
cations in catheter tip design to improve ow characteristics and decrease
recirculation [99, 101].
Flow inside dialysis catheter lumens is three-dimensional. Whereas ow
within straight segments of catheter lumens is aligned, the ow at the inlet
and outlet of a catheter is more complex and greatly inuenced by catheter
tip design [98, 276]. Variation in shear stress has been identied as a risk
factor for thrombogenicity through platelet activation. Clearance of blood
from the catheter tip is also considered a critical component in catheter de-
sign; catheters with higher levels of blood residence times (exceeding 0.030
seconds) in computational ow models have been considered susceptible
to thrombus formation through platelet activation and delayed washout of
blood near the wall of the catheter lumens [98, 276].
A threshold of 10 Pa of shear stress for platelet activation has been iden-
tied as being within the range of shear stress is resulting in platelet activa-
tion and aggregation, which occurs between 0.1 and 20 Pa [287]. In addi-
tion to high shear stress, areas of ow stagnation or recirculation can induce
platelet aggregation. Strony et al. [288] observed in a model of coronary
artery stenosis that platelet activation and aggregation was found to corre-
late with elevated regions of shear stress of 46 Pa and prolonged blood transit
times.
An ideal dialysis catheter, fromaowdynamics perspective, is onewhich
produces low shear stress, a low percentage of prolonged blood residence
time, and a low Platelet Lysis Index. e Platelet Lysis Index is a weighted
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scaling of blood particles experiencing low shear stress for a long expo-
sure period within a vascular device and high shear stress for a short pe-
riod within a vascular device.e PLI was initially developed by measuring
lactic dehydrogenase (LDH) release in vitro from injured platelets and has
been used in the comparison of platelet lysis amongmechanical heart valves
[273, 274] and dialysis catheters [98].
Minimal recirculation is another desirable attribute of a dialysis catheter
[19]. Recirculation might decrease the eciency of solute clearance. In this
current era of available devices for vascular access, many dialysis catheters
are capable of achieving rates of ow exceeding 500ml/min, and some dialy-
sis units (mostly in the US)may utilize catheter ow rates approaching these
levels with the intent of producing amore ecient dialysis session. Depend-
ing on the catheter design, however, this can result in decreased eciency
and dialysis adequacy through an increase in recirculation [273, 274, 289–
291]. A recent study found that 24% of patients with tunneled hemodialysis
catheters had recirculation levels exceeding 10% [292]. Dialysis providers
will oen reverse lines of dialysis catheters to achieve higher rates of ow
when ‘arterial’ lumen function is compromised; this line reversal will result
in higher recirculation.erefore, the ability to reverse lines when required
without compromising through higher recirculation would be an additional
desirable attribute of a dialysis catheter.
Using computational ow dynamics we evaluated the ow characteris-
tics of a novel hemodialysis catheter, designated the VectorFlow catheter.
e inlet and outlet of the catheter tip are designed to optimize the tran-
sition of blood ow vectors into and out of the catheter lumens through a
helical, three-dimensional pattern of blood ow (Figure 14.3). Spiral ow
is a normal phenomenon in the vascular system which reduces near wall
kinetic energy and has been observed in healthy subjects within a variety
of vascular territories including the aorta and the carotid artery [293, 294].
e spiral pattern of blood ow within the VectorFlow catheter was associ-
ated with a low level of shear stress. Compared to the Palindrome catheter,
an 18% reduction in mean shear stress was observed. Blood cell residence
times and the Platelet Lysis Index between the VectorFlow and Palindrome
catheters were similar.
From the computational ow eld, a negligible value of recirculation
was found (0.00012%). Within the bench model of hemodialysis, the Vec-
torFlow catheter was absent of any measurable recirculation as well. Since
recirculation increases with higher rates of ow, we deliberately evaluated
catheter recirculation at higher rates of ow than would be used clinically
(up to 600ml/min) to evaluate whether the VectorFlow catheter produced
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any measurable recirculation. Concordant results were seen in an animal
model of recirculationwhich also demonstrated absence of recirculation be-
tween dierent rates of ow within the catheter.
ese ndings concerning the recirculation can be attributed to the three-
dimensional pattern of ow which occurs at the tip of the catheter (Fig-
ure 14.3). At the arterial lumen inlet, where blood experiences the greatest
change in blood cell velocity and direction, a smoother transition of blood
cells can account for the reduction inmean shear stress. Absence of measur-
able recirculation can be attributed to the opposing vectors of blood entering
and leaving the catheter lumens (Figure 14.3). In contrast, the Palindrome
catheter was associated with recirculation in the in vitro and in vivomodels.
We attribute this dierence to the Palindrome catheter not having a ow-
diverting interface at the catheter tip to impart a helical, three-dimensional
pattern of blood owwith opposing vectors between the arterial and venous
lumens. However, in the computational model, an almost negligible recir-
culation (0.39%) was found for the Palindrome, as in the VectorFlow.
Because the Palindrome andVectorFlow catheter tips are symmetrical, it
is possible that clinical use of this device might be associated with a greater
degree of exibility among dialysis personnel since either lumen could be
designated as the arterial lumen. However, we also observed a signicant
reduction in recirculation when the helical shape of the catheter tip was in-
corporated into a split-tip catheter design suggesting that the benet of this
design is applicable to other catheter congurations.
Our study hasmultiple limitations. Although in clinical practice dialysis
catheters are preferentially placed in the right atrium, we utilized a straight
tube of an SVC model to enable uniform conditions in which to compare
catheter performance. Mareels et al. [276] studied the validity of the sim-
pliedmodel of a SVC (straight tube) compared to amodel of a right atrium,
three-dimensionally reconstructed fromdigital cryosection images frome
Visible Human Project (National Library of Medicine, National Institutes of
Health, Bethesda, MD, US).ey found a discrepancy between both mod-
els, in that within the realistic model of the right atrium catheter recircu-
lation seems to decrease in peak ow conditions, but was expected to in-
crease the moment the triscuspid valve closes and blood ow stagnates. To
achieve more comparable results, we chose the simplied model and be-
lieve that this choice does not compromise our global ndings. Next, our
in vitro model was larger in diameter (35mm) than a typical human supe-
rior vena cava. Furthermore, in vivo measurements were obtained in only
a single animal. Although our study received IACUC1 approval to include
1Institutional Animal Care and Use Committee
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additional animals if necessary, given that the recirculation measurements
were completely concordant with the CFD and bench model results we felt
it unethical to repeat the same experiments on additional animals. It is pos-
sible that this decision represented a Type II error and additional dierences
in catheter recirculationwould have emergedwith a larger sample size of an-
imals. However, our animal study enabled a sucient number of repeated
measurements in a single animal to detect statistically signicant dierences
between recirculation rates between the study catheters.
We also recognize that the additional hemodynamic advantages of this
catheter design (reduced catheter shear stress, blood cell residence time and
Platelet Lysis Index), in terms of lower thrombogenicity, remain to be estab-
lished with additional pre-clinical data over a longer implantation time.
14.5 Conclusion
We report a novel dialysis catheter with a symmetrical tip design and heli-
cally contoured lumens which optimize the vectors of blood entering and
leaving the catheter.ese features result in favorable levels of shear stress,
blood cell residence time and Platelet Lysis Index. Although other catheter
designs were associated with comparatively low levels of recirculation at
modest rates of blood ow, the novel catheter we describe was associated
with a complete absence of detectable recirculation. When these catheter
tip features are incorporated into a split tip catheter design, a signicant re-
duction in recirculation was also observed.
Dialysis providers are under increasing pressure to achieve optimal dial-
ysis adequacy and minimize access-related morbidity; these results serve as
encouraging pre-clinical assessment of this dialysis catheter design.
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15.1 Reversing lines: in vivo and 1-compartment kinetic modeling
15.1.1 Introduction
e use of central venous catheters (CVCs) as permanent access is discour-
aged in hemodialysis (HD) patients [22]. However, they are a life-saving
option in the growing group of HD patients who ran out of native vascular
access possibilities [295, 296]. Although the major reason to avoid CVCs is
the risk for infection, other drawbacks are the risk for thrombosis, and inad-
equate blood ows (< 300ml/min) [297]. A commonly used double lumen
catheter is the so-called ‘shotgun’ type where the venous port (i.e. the lu-
men through which the blood is returned to the patient) is positioned more
distally than the arterial port (i.e. the lumen through which the blood is
pumped to the dialyzer).e ow of these large bore double lumen catheters
can still be inadequate because of formation of a thrombus inside or a b-
rinous sheet around the catheter. ese problems can oen successfully be
solved by reversing the connection of the lines. is approach of reversing
lines is criticized, as it is presumed to increase recirculation, reported to be
between 5 and 28% [298]. Carson et al. indicated that reversing lines indeed
enhanced recirculation in dysfunctional catheters, but that instantaneous
clearance improved if blood ow increased aer reversing the lines, balanc-
ing out the loss induced by recirculation [298]. Instantaneous clearance does
however not equal total solute removal (TSR), which also depends upon the
duration of the dialysis session and the compartmental behavior of dierent
solutes.ere are so far no data on how reversing catheter lines impacts on
TSR during a dialysis session.
is study compares TSR and reduction ratios of dierent classes of ure-
mic toxins in patients (in vivo) dialyzed with a double lumen catheter con-
nected in the correct line (CL) position vs the reversed line (RL) position.
Next, we used a mathematical model to calculate how much increase in
blood ow is necessary to compensate for dierent degrees of recirculation
and obtain the same TSR with RL as compared to CL.
15.1.2 Patients and methods
In vivo study
e study was approved by the local ethics committee and written informed
consent was obtained. Each patient was dialyzed on two dierent occa-
sions using the Genius system with high-ux Fresenius FX80 dialyzers us-
ing a double lumen central venous catheter: Bard Hemoglide (n=14), Opti-
ow (n=3), Medcomp Split Stream (n=2), Pourchez Retro (n=2), and Arrow
(n=1). Patients were dialyzed during two consecutive midweek sessions of
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equal duration, once with CL and once with RL connection, in random or-
der. For each test session, blood ow (Qb) was set at the maximum speed
tolerated by the system, i.e. 350ml/min. Each patient served as his/her own
control.
Blood was sampled pre and post dialysis and a dialysate sample was
taken post dialysis from the ultraltrate collector, representative for the total
spent dialysate. As such, this allows calculation of the total solute removal
obtained during the dialysis session. Urea, creatinine, phosphorus and β2M
(β2-microglobulin) concentrations were determined from both the blood
samples as the dialysate.
e reduction ratio (RR) [%] of urea, creatinine, phosphorus, and β2M
was calculated frompre-dialysis (Cpre) andpost-dialysis concentration (Cpost)
in blood samples from the dialyzer blood inlet line:
RR = (Cpre − Cpost)
Cpre
⋅ 100 (15.1)
Based on the total spent dialysate concentration at the endof dialysis (Cd ,end)
and the total waste dialysate volume (Vd ,end), total solute removal (TSR)[mg] was calculated as:
TSR = Cd ,end ⋅ Vd ,end (15.2)
Mathematical study
A urea single-pool kinetic model was coupled with a dialyzer model to sim-
ulate solute removal in the patient and the dialyzer in dierent situations of
catheter connection and degrees of access recirculation (Figure 15.1). Ultra-
ltration and generation rate were assumed to be zero during the dialysis
session. Urea extraction ratio, ER, in the dialyzer was taken at 80%. e
extraction ratio, ER, and dialyzer clearance, K, are dened as:
ER = Cbi − Cbo
Cbi
(15.3a)
K = ER ⋅ Qb (15.3b)
with Cbi and Cbo the blood dialyzer inlet and outlet concentrations and Qb
the blood ow rate.
e time variation of the compartmental concentrations, C, can, for a
particular solute, be determined by solving the mass balance equation for
the single compartment:
d(VC)
dt
= −Qb ⋅ (Cbi − Cbo) = −K ⋅ Cbi (15.4)
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Dialyser
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Figure 15.1: Mathematical model for urea removal, consisting of a single-pool ki-
netic model of the patient coupled with a dialyzer model. Kinetic model with V the
single-pool volume [l] and C the single-pool concentration [mmol/l] correspond-
ing to the patient’s blood concentration. Dialyzer model with Qb the blood ow[ml/min], Qd the dialysate ow [ml/min], K the dialyzer clearance [ml/min], Cbi
and Cbo the blood inlet and outlet concentration [mmol/l], and Cd i and Cdo the
dialysate inlet and outlet concentration [mmol/l].
Simulations with coupled models rendered concentration proles dur-
ing dialysis: patient’s blood concentration, blood dialyzer inlet and outlet
concentrations (Cbi and Cbo), and dialysate inlet and outlet urea concentra-
tions (Cdi=0 andCdo). Herewith, Cbi was derived from the patient’s concen-
tration, C, based on Equation 15.4 and accounting for the percentage access
recirculation (R - see Figure 15.1). Cbo was calculated by:
Cbo = Cbi ⋅ (1 − ER) (15.5)
and Cdo was calculated for each time point during dialysis from the mass
balance in the dialyzer:
Cdo = Qb ⋅ Cbi − (Qb − Qu f ) ⋅ CboQd + Qu f (15.6)
which can be simplied due to our assumption of a zero ultraltration ow
(Qu f=0).
From the patient’s concentration decline during dialysis, the reduction
ratio (RR) was calculated using Equation 15.1. Total solute removal (TSR)
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was calculated according to:
TSR = end∫
begin
Cdo ⋅ Qd dt = Vd ,end ⋅ end∫
begin
Cdo dt (15.7)
with Vd ,end , the total waste dialysate volume, multiplied by the area under
the dialysate outlet curve Cdo, as derived with Equation 15.6.
For the parameter study, RR andTSRwere calculated for a normal catheter
connection with zero recirculation, and for a reversed catheter connection
with a recirculation in the range 5 to 25% and a blood ow rate in the range
150-350ml/min.
Statistical analysis
Data were analyzed using SigmaStat soware (Jandel Scientic, San Rafael,
CA, USA). Data are expressed as mean± SD.e paired t-test was used for
normally distributed samples. A p-value of <0.05 was taken the limit of sig-
nicant dierence.
15.1.3 Results
In vivo study
Twenty-two stable hemodialysis patients (18women and4men) of 75.3± 10.0
years old and 67.3± 12.0 kg were included in the study. Sixteen patients had
a dialysis session with CL and RL catheter connection, while 5 and 1 patients
could not be dialyzed with CL connection and RL connection respectively.
Furthermore, 1 patient was omitted from analysis because of technical prob-
lems. irteen patients were dialyzed with a blood ow of 350ml/min in
both conditions. Two other patients had a lower Qb in reversed connection
(250ml/min and 300ml/min, respectively).
Reduction Ratio (RR) and Total Solute Removal (TSR) for urea, creati-
nine, phosphorus, and β2M are given in Table 15.1.
Mathematical model
Figure 15.2 shows the patient’s blood concentration, blood dialyzer inlet and
outlet concentration, and dialysate outlet concentration during dialysis with
a blood ow rate of 300ml/min for a CL connection with zero recircula-
tion (upper panel) and RL connection with 15% access recirculation (lower
panel).
Table 15.2 gives the RR and TSR for dierent parameter settings of blood
ow (range 150-350ml/min) and access recirculation (range 5-25%) for the
CL and RL catheter connection.
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RR [%] TSR
Correct Reversed p-Value Correct Reversed p-Value
Urea 73± 5 71± 4 0.14 301± 112mmol 293± 104mmol 0.35
Creatinine 65± 4 63± 3 0.06 483± 426mg 465± 371mg 0.41
Phosphorus 53± 11 51± 11 0.25 498± 98mg 526± 108mg 0.56
β2M 52± 10 51± 7 0.78 72.2± 53.6mg 65.7± 39.3mg 0.95
Table 15.1: Reduction ratio (RR) and total solute removal (TSR) for urea, creatinine,
phosphorus, and β2M for correct and reversed catheter line connection in clinical
conditions.
Figure 15.3 shows a nomogram of the blood ow that is needed with RL
connection (y-axis) for dierent degrees of recirculation (range 5-25%), in
order to obtain the same amount of urea TSR as with CL connection and
zero recirculation (x-axis).
15.1.4 Discussion
is study demonstrates that connecting patients to double lumen dialy-
sis catheters in a reverse (RL) mode does not impair total solute removal
(TSR) of dierent types of uremic retention solutes in clinical practice. In the
mathematicalmodel, TSR in the RLmodewas dependent upon the obtained
blood ow in the CL connectionmode, and the presumed degree of recircu-
lation in the RL connection mode. Reversing lines is thus not problematic
in well functioning catheters. In conditions of a dysfunctional catheter, the
improvement in solute removal obtained by reversing connections depends
upon the percentage of increase in ow obtained and the degree of recircu-
lation.
Clearance in double lumen catheters might be hampered by presence of
recirculation. Carson et al. found recirculation in the correct connection
mode in well functioning catheters was 0% [298], whereas Trerotola et al.
found that it was depending upon design of the catheter, being below 5% in
the split tip vs below 10% in the shotgun design [274]. Canaud et al. used
two separate single lumen catheters, with the tips at dierent depths along
the vena cava superior, and under these conditions, recirculationwas around
10% [299].
Catheter ow can be impaired by intraluminal thrombus formation, for-
mation of brinous sheats around the catheter, or kinking [101]. Many cen-
ters have a policy to reverse the connection of the lines to increase blood
ow, a procedure that allows continuation of the dialysis session. ere is
however concern that recirculation may occur in this setting. Carson et al.
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Figure 15.2: Concentration proles during 240min dialysis with blood ow
300ml/min for a correct catheter connection with zero recirculation (upper panel)
and for a reversed catheter connection with 15% access recirculation (lower panel).
For the correct catheter connection the patient’s blood concentration is equal to the
blood dialyzer inlet concentration.
observed recirculation rates in RL mode ranging up to 25%, using a catheter
where the two tips were separated by 2.5 cm. Reversing the lines signicantly
increased recirculation from 2.9± 5 to 12± 9%, in a study, where catheter tips
were separated with 3-5 cm [300]. However, when considering the individ-
ual data points, for the majority of patients, recirculation remains equal in
the correct and reversed mode, and some outliers cause the overall dier-
ence, just as in the study by Carson et al. [298]. Recirculation in reversed
mode connection can thus be a problem in some, but not in all patients.
However, recirculation is only of relevance as far as it hampers solute
clearance and removal, the ultimate aim of dialysis. In addition, in catheters
with impaired blood ows in the correct mode, blood ows are oen higher
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Line R RR TSR TSR
connection [%] [%] [mmol] % decrease
Qb = 150ml/min
Correct 0 51 494 reference
5 52 473 4.3
10 52 451 8.7
Reversed 15 52 429 13.2
20 53 407 17.6
25 53 384 22.3
Qb = 250ml/min
Correct 0 70 672 reference
5 70 641 4.6
10 71 611 9.1
Reversed 15 71 580 13.7
20 71 549 18.3
25 72 518 23.3
Qb = 350ml/min
Correct 0 81 782 reference
5 82 747 4.5
10 82 710 9.2
Reversed 15 82 674 13.8
20 83 637 18.5
25 83 600 23.3
Table 15.2: Urea reduction ratio (RR) and total solute removal of urea (TSR) for
correct and reversed catheter connection as calculated in the mathematical model.
For the reversed connection, the results are calculated for dierent percentages of
recirculation. It is presumed that in the correct connection, no recirculation will
occur, so as a consequence, in real practice, the percentages recirculation are ac-
tually the dierence between the recirculation in the reversed and in the correct
connection mode. While no dierences were found for RR, the last column in-
dicates the percentage decrease in TSR when changing the correct connection to
reversed connection for the same blood ow Qb .
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Figure 15.3: Nomogram relating blood ows in the correct connection mode (X-
axis) to the blood ow needed in the reversed mode (Y-axis) to obtain compara-
ble total solute removal, and this for dierent degrees of recirculation in reversed
mode (5 to 25%). It is presumed that there is no recirculation in the correct con-
nection mode, so in clinical practice, one should calculate the dierence between
recirculation in the reversed and the correct mode, and use that value as reference
recirculation.
in the reversed mode, thus compensating for decreased clearance caused by
the enhanced recirculation [298]. In the latter study, adequacy of dialysis
was calculated as instantaneous clearance of urea, which might not be a rel-
evant parameter, as dierent total solute removals can be obtained during
a dialysis session, despite equal Kt/V’s or instantaneous clearances [301]. In
the current study, reduction ratios were not dierent for dierent rates of
recirculation in the reversedmode, and total solute removal in clinical prac-
tice was not dierent in the reversed or in the correct connection mode for
urea, creatinine, phosphorus or β2M. It is possible that the dierence in de-
gree of recirculation in the reversed versus correct mode was not important
in our patients, as all catheters were functioning properly.
We used a mathematical model to calculate total solute removals in dif-
ferent settings, with variable blood ow rates and degrees of recirculation in
a nomogram (Figure 15.3). At a recirculation of 15%, the blood ow should
increase from 200 and 250 (in CL) to 270 and 340ml/min (in RL), respec-
tively, values comparable to those obtained by Carson et al. [298]. However,
our nomogram allows calculation of necessary blood ow increase for dif-
ferent degrees of recirculation, which gives it a better clinical applicability
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and accuracy. Of note, as we assumed that in the correct mode, recircula-
tion is zero, one should actually use the dierence between recirculation in
the reversed and correct mode as reference. If the dierence in recircula-
tion remains below 10%, small gains in blood ow aer reversing the lines
already result in improved solute removal; however, if the dierence in re-
circulation is above 20%, substantial increases in blood ow are needed to
achieve comparable solute removals. In cases where patients are dialyzed on
reversed mode connections for a longer time, it might thus be wise to check
recirculation to determine future access policy.
15.1.5 Conclusion
In conclusion, in well functioning catheters, solute removal is equal in re-
versed and in correct connectionmode. As long as the dierence in recircu-
lation is below 10-15%, reversing the lines is a defensible practice to increase
blood ow, without the need to replace the catheter. If the dierence in re-
circulation is above 15-20%, then it would be better to replace the malfunc-
tioning catheter to avoid suboptimal dialysis.
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15.2 Single vs. double lumen CVC: 2-compartment kinetic
modeling
15.2.1 Introduction
As explained in the previous section (15.1), the use of central venous catheters
(CVCs) as permanent vascular access for hemodialysis is strongly discour-
aged, mainly due to the risk of infection and thrombosis, and the occur-
rence of inadequate blood ows. e latter problem can, for double lumen
catheters, oen be solved successfully by reversing the catheter connection,
an approach that is criticized since this might enhance access recirculation,
lowering the eciency of dialysis treatment [298]. By increasing blood ows
aer reversing the catheter connection, instantaneous dialyzer clearances
can be improved, restoring the loss of adequacy which is due to recircu-
lation [298]. In the previous section, it was found in vivo that solute re-
moval of urea, creatinine, phosphate, and beta-2-microglobulin was only
slightly inuenced during hemodialysis by reversing the catheter connec-
tion. Furthermore, from single pool urea kinetics, coupled with a math-
ematical hemodialysis model, it was calculated to what extent blood ow
must increase aer reversing the lines to compensate for recirculation and
to obtain equal total solute removal as with the correctly connected lines.
Once the degree of access recirculation has been quantied in a direct
or indirect way (i.e. by measuring ionic dialysance with normal and re-
versed catheter connection) at the patient’s bedside [302–308], the resulting
nomograms (Figure 15.3) can help the clinician to make bedside decisions
on optimal catheter application. ese ndings however do not count for
the compartmental behavior in the patient. Furthermore, such nomogram
information is still not available for single lumen (SL) catheters. When SL
CVCs are used, solute removal is hampered due to the inherent recirculation
and the lower eective blood ows that are reached due to the alternating
functioning of the two blood pumps.
Furthermore, solute removal during hemodialysis is retarded if a solute
is distributed over more than one compartment throughout the patient’s
body. Hence, even when the degree of recirculation is quantied by mea-
surements, it is not possible to simply predict the impact on dialysis ade-
quacy caused by the access recirculation. Even the previous ndings, using
a one compartmental model in Section 15.1, might have overestimated the
impact of dialyzer clearance and/or recirculation on solute removal, by not
counting for the retarded kinetics in the patient.is retardation is impor-
tant for dicult to remove solutes, like middle molecules [144, 309, 310],
but is known to be prominent as well with small and water soluble solutes
[145, 146].
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erefore, we developed a calibrated mathematical model combining
the two-compartmental kinetic behavior of dierent uremic toxins with a
hemodialysis model, including the type of vascular access. Based on this
approach, we compared total solute removal and reduction ratios with dial-
yses using a double lumen CVC either with or without reversed connection
lines, and a single lumen CVC.
15.2.2 Material and methods
In order to compare hemodialysis (HD) adequacy in case of dierent types
and modes of application of catheters, a 2-compartmental kinetic model,
simulating the solute transfer in a patient, was coupledwith a dialysismodel,
simulating the solute transfer in a hemodialyzer. Parameters, such as reduc-
tion ratios and total solute removals, were calculated for dierent solutes and
dierent catheter scenarios.
e calibrated mathematical patient/dialyzer model
e coupled mathematical patient/dialyzer model in the setting of a double
lumen (DL) catheter is shown in Figure 15.4, while that of a single lumen
(SL) catheter is shown in Figure 15.5. Solute transfer in the patient was sim-
ulated according to two-compartmental kinetics, distinguishing between a
perfused volume V1 and a non-perfused volume V2. Both volumes are char-
acterized by a homogeneous concentration and dierent inputs and outputs
such as solute generation rate G1 (in V1) and/or G2 (in V2). Furthermore, so-
lute is removed from V1 by hemodialysis with a dialyzer clearance K (Equa-
tion 15.3), and solute is transported in between both compartments, driven
by a concentration gradient, and proportional to the intercompartmental
clearance K12. Ultraltration (Qu f ) was assumed to occur in both compart-
ments, keeping the ratio between both volumes constant.
e time variation of the compartmental concentrations C1 and C2 was,
for a particular solute, determined by solving themass balance equations for
both compartments (similar to the simplied formulation in Equation 15.4):
d(V1C1)
dt
= G1 + K12 ⋅ (C2 − C1) − K ⋅ Cbi (15.8a)
d(V2C2)
dt
= G2 − K12 ⋅ (C2 − C1) (15.8b)
Blood concentration variation over the dialyzer was, for a particular so-
lute, determined by solving the mass balance equation in the dialyzer:
Cbi ⋅ Qbi + Cdi ⋅ Qdi = Cbo ⋅ Qbo + Cdo ⋅ Qdo (15.9)
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Figure 15.4: Extended mathematical model combining a kinetic model and a dial-
ysis model using a double lumen central venous catheter, with or without access
recirculation.
V1: perfused volume; V2: non-perfused volume; C1 and C2: concentration in V1
and V2; K12: intercompartmental clearance; G1 and G2: generation rate in V1 and
V2; Qb : blood ow; Qd : dialysate ow; Qu f : ultraltration ow; K: dialyzer clear-
ance; Cb i and Cbo: blood inlet and outlet concentration; Cd i and Cdo : dialysate
inlet and outlet concentration; R: access recirculation.
Cbi and Cbo are the blood inlet and outlet concentrations, and Cdi and Cdo
the dialysate inlet and outlet concentrations with respect to the dialyzer. Cdi
is zero in the normal dialysis setting.
Double lumen catheter
For a correctly connectedDL catheter inwhich no recirculation occurs (R=0
in Figure 15.4), the blood inlet concentration Cbi is equal to the concentra-
tion in the perfused compartment C1. In case of switching the catheter con-
nection, inducing access recirculation R [%], the blood inlet concentration
Cbi is diluted by cleansed blood Cbo coming from the dialyzer outlet. Deal-
ing with the time it takes for the blood to ow through the dialysis circuit,
we accounted for this time delay, TD, to calculate blood inlet concentration
Cbi at time t from the blood outlet concentration Cbo at time point (t-TD)
and the degree of recirculation R:
Cbi(t) = (1 − R) ⋅ C1(t) + R ⋅ Cbo(t − T) (15.10)
Single lumen catheter
In case of a single lumen double pump dialysis treatment (Figure 15.5), one
cycle can be subdivided in two phases: an arterial phase (subscript ap) dur-
ing which blood is pumped from the patient’s perfused compartment into
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Figure 15.5: V1: perfused volume; V2: non-perfused volume; C1 and C2: concen-
tration in V1 and V2; K12: intercompartmental clearance; G1 and G2: generation
rate in V1 and V2; Qb : blood ow; Qd : dialysate ow; Qu f : ultraltration ow; K:
dialyzer clearance; Cbi and Cbo : blood inlet and outlet concentration; Cd i and Cdo :
dialysate inlet and outlet concentration; Qap : blood ow during arterial phase; Qv p :
blood ow during venous phase.
the buer reservoir at a ow rateQap, and a venous phase (subscript vp) dur-
ing which the blood is pumped, at a ow rate Qvp from the buer reservoir
through the dialyzer and back towards the patient. Herewith, Qvp might be
set higher than Qap according to a pump ratio larger than 1 and, hence, an
eective blood ow rate of more than Qap/2 can be obtained. Within each
cycle, the blood volume in the buer reservoir (Vres) is strictly controlled in
between a minimum and maximum level, corresponding respectively to a
minimumandmaximumbuer blood volume, Vmin andVmax .is implies
that blood entering the buer reservoir during an arterial phase is mixed
with Vmin blood that was still in the buer reservoir aer the previous ve-
nous phase. Equation 15.8a should in this case be changed into Equation
15.11a for the arterial phase (with Qbi = Qap) and Equation 15.11b for the ve-
nous phase (with Qbo = Qvp - Qu f ):
d(V1C1)
dt
= G1 + K12 ⋅ (C2 − C1) − Qap ⋅ Cbi (15.11a)
d(V1C1)
dt
= G1 + K12 ⋅ (C2 − C1) + (Qvp − Qu f ) ⋅ Cbo (15.11b)
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Furthermore, the concentrations Cbi and Cbo are not constant within
one phase, since the arterial and venous phase can each be split into two
extra phases. During the arterial phase, the cleansed blood (from the pre-
vious venous phase) in the catheter volume (Vc), is rst entering the buer
reservoir, followed by uncleansed blood from the patient’s perfused com-
partment. During the venous phase, the uncleansed blood in Vc (from the
previous arterial phase) is rst owing back to the patient’s perfused com-
partment, followed by cleansed blood. During all phases, we accounted for
the number of cycles, TD, it takes for the blood to ow through the dialysis
circuit, comparable to the modeling of the DL catheter in reversed connec-
tion mode.
Studied solutes
To see the impact of the kinetic behavior on the dialysis adequacy, four so-
lutes were studied, each with a dierent kinetics during dialysis.e data of
two-compartmental calibrated kineticmodels were taken from literature for
urea and methylguanidine (MG) [146], beta-2-microglobulin (β2M) [144],
and phosphate [145]. Table 15.3 shows the molecular weight and the kinetic
parameters: pre-dialysis V1, V2, C1, and C2, generation rate G1 andG2, inter-
compartmental clearance K12, and the dialyzer extraction ratio ER, which is
dened as the relative concentration variation over the dialyzer length.
Urea MG β2M P
Reference Eloot et al.[146] Eloot et al.[146] Stiller et al.[144] Spalding et al.[145]
MW 60Da 73Da 11,800Da 31Da
V1−pre 6.4 L 8.0 L 2.56 L 13 L
V2−pre 36.3 L 94.6 L 7.44 L 27 L
C1−pre = C2−pre 24.0 mmol/l 3.7 µmol/l 33 mg/l 1.7 mmol/l
K12 822 ml/min 1025 ml/min 56.3 ml/min 300 ml/min
G1 310 mmol/24h 46 µmol/24h 0 0
G2 0 0 218 mg/24h 0
ER 0.84 0.79 0.19 0.57
Table 15.3: Kinetic parameters for urea, MG, β2M, and P.
MG: methylguanidine; β2M: beta-2-microglobulin; P: phosphate; MW: molecu-
lar weight; V1−pre : predialysis perfused volume; V2−pre : predialysis non-perfused
volume; C1−pre and C2−pre : predialysis concentration in V1 and V2; K12: intercom-
partmental clearance; G1 and G2: generation rate in V1 and V2; and ER: dialyzer
extraction ratio, dened as the relative concentration variation over the dialyzer
length.
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Studied vascular access and dialysis strategies
For the four solutes, four dierent scenarios were studied. ree are based
on the double lumen catheter: one for the normal 4 h dialysis treatment
without any recirculation at a blood ow rate of 350ml/min (DL-normal)
and one at a reduced ow rate of 250ml/min (mimicking an impaired cathe-
ter function) (DL-low ow), and a case mimicking dialysis with reversed
connections at 350ml/min (introducing e.g. 10% recirculation and a time
delay TDDL of 35s) (DL-reversed). e fourth scenario is based on single
lumen catheter dialysis treatment (SL) with an eective blood ow rate of
273ml/min and a time delay (TDSL) of 5 cycles. All treatment parameters
can be found in Table 15.4.
Next to these scenarios, extra calculations were performed on the ade-
quacy of the DL-reversed dialysis for circulations in a range of 0-50%.
DL-normal DL-reversed DL-low ow SL
Session duration [min] 240 240 240 240
Post dialysis rebound [min] 60 60 60 60
Qb [ml/min] 350 350 250 273
Qu f [L/h] 1 1 1 1
R [%] 0 10 0 inherent
Qap [ml/min] n/a n/a n/a 500
Pump ratio (Qvp/Qap) n/a n/a n/a 1.2
Vc (12Fr) [ml] n/a n/a n/a 2.9
Vmin [ml] n/a n/a n/a 10
Vmax [ml] n/a n/a n/a 55
TD n/a 35 s n/a 5 cycles
Table 15.4: Operating parameters dialyzing with a double lumen (DL) and single
lumen (SL) catheter.
DL: double lumen; SL: single lumen; Qb : blood ow; Qu f : ultraltration ow; R:
access recirculation; Qv p : blood ow during venous phase; Qap : blood ow during
arterial phase; Vc : catheter volume; Vmin : minimum buer volume; Vmax : maxi-
mum buer volume.
Simulations and adequacy parameters
e coupled mathematical patient/dialyzer model, was written in Matlab
(R2010b,eMathWorks inc., MA, US), and iteratively solved themass bal-
ance equations for a complete dialysis session of 240 minutes. e calcula-
tions were performed with a time step of 1 second for the continuous DL
catheter simulations, while this was 0.01s for the periodical SL catheter sim-
ulations in order to include all four phases during a single cycle. In order to
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be able to compare the impact of the dierent vascular access modalities on
the dialysis adequacy for dierent solutes, each with their specic kinetics,
dierent parameters were calculated.
We calculated a reduction ratio RR [%] for all studied solutes in the per-
fused (RR-C1) as well as in the non-perfused compartment (RR-C2), accord-
ing to Equation 15.1.
Due to a redistribution in the body caused by the two-compartmental
kinetic behavior of the studied solutes, a rebound eect will occur following
dialysis. To have an idea about the percentage rebound (%rebound), the
concentration in the perfused compartment was calculated 60minutes aer
the dialysis end (C1−post60), by compartmentalmodeling and setting dialyzer
clearance K equal to zero:
%rebound = (C1−post60 − C1−post)
Cpre − C1−post ⋅ 100 (15.12)
Furthermore, total solute removal (TSR) was calculated during an entire
dialysis session as the amount of solute found in the spent dialysate. From
the mass balance equation in the dialyzer, TSR at time point T can be calcu-
lated, in accordance with Equation 15.7 as:
TSR = T∫
0
Cbi ⋅ (ER ⋅ Qbi + (1 − ER) ⋅ Qu f )dt (15.13)
For the vascular access modalities deviating from the well functioning
DL catheter, the dialysis time was calculated which is additionally needed
in order to obtain the same amount of TSR as with the well functioning DL
catheter.
Finally, nomogramswere derived indicating dialysis adequacy, expressed
as TSR, as a function of blood ow for dierent degrees of recirculation.
Herewith, TSR for a well functioning DL CVC (350ml/min blood ow and
no recirculation) was taken as reference and equal to 1.
Sensitivity study
Since our calculations are based on literature data and since we performed
the analyses for a xed number of kinetic and dialysis parameters, we per-
formed a sensitivity analysis to check the impact of our parameter choice on
the dialysis adequacy. For this purpose, we took the TSR as calculated for
DL-normal as comparator, while introducing changing values for intercom-
partmental clearance (K12: ±10%), extraction ratio (ER: ±10%), and the ratio
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of compartmental volumes (V1/V2: ±10%) was calculated in a DL-normal
CVC. In the DL-reversed CVC, TSR was determined for a range of time
delay (TDDL: 0-70 s) values, and in the SL CVC, TSR was calculated for
a varying catheter volume (Vc : 2.5-3.5ml), buer reservoir volume (Vres),
minimum volume in the buer reservoir (Vmin:5-15ml), venous versus ar-
terial pump ratio (Pump ratio: 1.1-1.3), and time delay (TDSL: 0-10 cycles).
15.2.3 Results
e urea concentration decrease during 4 h dialysis and 1 h rebound in the
perfused (C1) (for all studied scenarios) and the non-perfused compartment
(C2) (for the DL-normal) is illustrated in Figure 15.6A, while the cumulative
TSR is shown in Figure 15.6B.e post dialysis urea reduction ratios are RR-
C1=73.6% and RR-C2=66.8% with the DL-normal (Table 15.5). As observed
in Table 15.6, the DL-reversed CVC only showed minor deviations (range
3.5-4.2%) of RRs compared to thewell functioningDLCVC,while deviations
are much more pronounced with the DL-low ow CVC and the SL CVC
(range 13.0-17.5%). A similar trend is followed by the %rebound and TSR.
e concentration decrease of β2M in the perfused (C1) (for all stud-
ied scenarios) and non-perfused compartment (C2) (for the DL-normal)
is shown in Figure 15.7A, while the cumulative β2M TSR is shown in Fig-
ure 15.7B.e large intercompartmental clearance K12 for β2M, compared
to that of urea (Table 15.3), causes a 4-fold larger %rebound (Table 15.5).
While an analogous trend for RR, %rebound andTSR is present for urea,
MG and P (Table 15.5), β2M is behaving dierently. With the latter, RRs
are comparable for DL-normal, DL-reversed, and SL CVC, with high devi-
ations for the DL-low ow CVC (range 21.1-43.9%)(Table 15.6). Despite the
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Figure 15.6: Urea concentration prole (panel A) and cumulative TSR (panel B)
for dierent dialysis strategies.
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dierent dialysis strategies.
low RRs for the DL-low ow CVC, TSR was found comparable to TSR with
DL-normal and DL-reversed CVC, while TSR for the SL CVC shows large
deviations (17.2%).
Table 15.6 also indicates the extra time needed to reach the same amount
of TSR aswith the 4 hdialysiswith aDL-normalCVC.With theDL-reversed,
the least extra time is needed for all studied solutes (2-17min), while this is
also minimum with the DL-low ow for β2M (16min).
Figure 15.8 shows the impact on TSR of the degree of recirculation
(0-50%) with a DL-reversed catheter. Adequacy is decreased by 10% for a
recirculation degree of 17% (MG), 26% (urea), and 30% (phosphate). Even
for a recirculation of 50%, the removal of β2M is only decreased by 5% com-
pared to the scenario with the DL-normal catheter.
RR-C1 RR-C2 %rebound TSR Time[%] [%] [%] [mmola] min
Urea 73.6 66.8 10.9 787 240
MG 51.0 38.6 24.8 0.17 240
β2M 66.3 31.0 42.2 298 240
P 68.6 52.8 14 44 240
a mg for β2M
Table 15.5: Adequacy parameters for DL-normal dialysis for dierent solutes, dif-
ferent types of vascular access.
RR: reduction ratio; TSR: total solute removal; MG: methylguanidine; β2M: beta-
2-microglobulin; P: phosphate.
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RR-C1 RR-C2 %rebound TSR Time
% reduction % reduction % reduction % reduction min
Urea
DL-low ow 15.6 17.5 -20.2 13.5 65
DL-reversed 3.5 4.2 -4.6 3.3 15
SL 13.0 14.7 -16.5 13.2 65
MG
DL-low ow 20.6 22.5 -9.7 19.1 73
DL-reversed 5.5 6.2 -2.4 5.3 17
SL 17.8 19.7 -8.5 17.9 70
β2M
DL-low ow 21.1 43.9 -25.6 4.9 16
DL-reversed 1.2 2.6 -1.4 0.6 2
SL 1.5 4.2 -2.4 17.2 75
P
DL-low ow 16.3 19.5 -12.9 14.2 63
DL-reversed 2.8 3.4 -2.1 2.7 11
SL 11.5 13.8 -8.6 14.4 67
Table 15.6: Adequacy parameters for dierent solutes, dierent types of vascular
access: % decrease and extra time versus DL-normal.
DL: double lumen; SL: single lumen; RR: reduction ratio; TSR: total solute removal;
MG: methylguanidine; β2M: beta-2-microglobulin; P: phosphate.
Figure 15.9 shows nomograms for urea (panel A), MG (B), β2M (C), and
P (D).
e results of the sensitivity study indicate that a 10% change in extrac-
tion ratio gives the largest variation in TSR (range 1-6%), whereas for all
other parameters under study, TSR variations remain below 3% (see Table
15.7).
15.2.4 Discussion
We demonstrated that, as far as this procedure results in better blood ows,
reversing the lines of double lumen-reversed central venous catheters (DL-
CVC) is the best alternative in case of dysfunctional ow in normal connec-
tion mode (as in the study of Section 15.1). is is because rather similar
total solute removals (TSR) were found with the DL-reversed as with the
DL-normal CVC, and this for all solutes under study. Also, recirculation
degrees of around 20% result in an adequacy decrease of merely 10%, which
was found to be evenmore adequate than with a double lumen catheter with
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Figure 15.8: Dialysis adequacy (in terms of Total Solute Removal) for dierent so-
lutes as a function of the degree of recirculation.
Parameter Referencevalue
Reference
treatment Range Urea MG β2M Phosphor
K12 See Table 15.3 DL-normal ± 10% <1% <2% <3% <2%
Er See Table 15.3 DL-normal ± 10% <4% <6% <1% <4%
V1/V2 See Table 15.3 DL-normal ± 10% <0.01% <0.01% <0.2% <0.01%
TDL 35 s DL-reversed 0-70 s <1% <2% <3% <3%
Vlumen 2.9 ml SL 2.5-3.5 ml <1% <1% <0.5% <1%
Vover 10 ml SL 5-15 ml <0.5% <0.5% <0.5% <0.5%
Vres 55 ml SL 50-60 ml <1% <1% <1% <1%
Pump ratio 1.2 SL 1.1-1.3 <2% <3% <1% <3%
TSL 5 cycles SL 0-10 cycles <2% <2% <1% <2%
Table 15.7: 4-hour dialysis session: Parametric study on changes in TSR
reduced ow of 250ml/min. Besides, the adequacy of a single lumen (SL)
CVC is comparable to that obtainedwith a dysfunctioningDLCVC (DL-low
ow), except for β2M for which reduction ratio (RR) is much better while
TSR is much smaller for the SL CVC.
Although CVCs are strongly discouraged as permanent access for HD,
as they are associated with higher mortality and infection rates, their use
has become unavoidable in a growing number of patients. Beside the risk of
infection, use of CVCs is also hampered by presence of impaired ow, fre-
quently leading to interruption of the dialysis session. Dierent strategies,
such as reversing the lines, continuing dialysis at lower blood ows, or even
catheter replacement, can be applied to tackle this problem. However, clear
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Figure 15.9: Nomograms for urea (panel A), MG (B), β2M (C), and P (D), relating
dialysis adequacy (TSR) for dierent blood ows and dierent degrees of access
recirculation (0-20%).e DL-normal CVC with R=0% and with Qb=350ml/min
is taken as reference with adequacy equal to 1.
evidence to support either of these options is lacking. More specically, it
is unclear in how far solute removal is hampered by access recirculation or
lower blood ows. Solute kinetics play an important role in the solute re-
moval during dialysis. From that point of view, it could be assumed that
the presence of access recirculation, induced by reversing the catheter con-
nection or by using a SL CVC, has minor impact on the removal of solutes
like β2M, with a hampered transport inside the patient, as conrmed in our
study.
We derived nomograms from the obtained TSR results, illustrating the
loss of adequacy (as denedbyTSR)whenusingDLCVCs at dierent (lower)
blood ows and/or the presence of access recirculation. ese nomograms
can be used in clinical practice to guide catheter management in individual
patients in case access recirculation is quantied [302–308]. From the ad-
equacy perspective, these graphs clearly illustrate that there is no straight-
forward relation between the degree of access recirculation and the loss of
adequacy, and that the presence of access recirculation should not be nec-
essarily considered as unacceptable. ey illustrate as well that the type of
vascular access has the least inuence on the removal of themiddlemolecule
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β2M, due to the much slower kinetic transport in the patient compared to
that of the small and water soluble solutes urea, MG, and phosphate.
Solute kinetics is also one of the reasons for the, at rst sight, contradic-
tory nding that β2M reduction ratio is much better for SL CVCs compared
to the dysfunctioning DL CVCs, while total solute removal is much lower
using SL CVCs (Figure 15.7 and Table 15.6). During hemodialysis with a SL
CVC, plasma concentrations (concentrations in the perfused compartment
C1) are decreasing at the same degree as with the DL-normal and the DL-
reversed, resulting in a high RR.is phenomenon is due to adequate β2M
removal in the hemodialyzer and the inherent access recirculation diluting
the blood dialyzer inlet concentration, in combination with the slow β2M
transport from the non-perfused towards the perfused compartment (low
intercompartmental clearance K12). However, the lower blood dialyzer inlet
concentrations lead to lower spent dialysate concentrations and, combined
with the lower average ow rate, lower TSR. With respect to the middle
molecule β2M, the SL CVC is thus a worse alternative for a dysfunctional
DL CVC when considering the dierence in TSR, a more reliable adequacy
parameter than RR [301].
Somewhat less expected, our study reveals that adequacy is not much
dierent between the DL-normal and DL-reversed CVC (with R=10% or
less) for all studied small and water soluble solutes, while adequacy was sig-
nicantly lower with the DL-low ow and SL CVC. As long as recirculation,
when reversing the connection lines, is limited to around 20%, and blood
ow can be restored, the adequacy decrease will be limited to less than 10%.
is is an important take home message, since the use of lower blood ows
(250ml/min) results already in an adequacy decrease in the range 14-20%
for urea, MG, and phosphate.
One could think that our study is suering from a major drawback, be-
ing purely based onmathematics. Validation is herewith rather dicult, not
to say impossible, since the kinetic parameters, such as distribution volume
and intercompartmental clearance, are not known in a particular patient.
We should stress however that the models used here were based on kinetic
models that were previously calibrated on patients data. Hence, our math-
ematical model can be considered as an ‘average patient on dialysis’. It also
allows us to compare dierent scenarios, i.e. double lumen, either with re-
versed connection lines or not, and single lumen CVCs in an ‘average pa-
tient’, something that is not possible to study in vivo in the same patient.
Some other weaknesses of the modeling approach can be highlighted.
First, the solute extraction ratio was considered constant for all scenarios
due to a lack of knowledge of how ER exactly changes with blood and/or
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dialysate ows. Hence, since ER should be increased for lower blood ows,
RR and TSR for low ow dialyses (i.e. DL-low ow and SL) might be slightly
higher in vivo. Second, per studied solute, the calibrated kineticmodels were
taken from literature, being serial mathematical models. However, despite
any physiological meaning, in contrast with the physiologically based paral-
lelmodels [311–313], the appliedmodels are based on patient data, describing
solute kinetics in a correct way. And third, although of limited impact when
dealing with our cross-over simulations, some other factors might play a
(rather minor) role as well in the overall recirculation, such as tubing com-
pliance, and the presence of a pre-arterial-pumpow chamber in the dialysis
circuit [314].
Furthermore, our mathematical study has some important strengths.
First, the removal of dierent types of solutes with a totally dierent ki-
netic behavior in the patient was modeled. e solutes mainly dier in
distribution volume and intercompartmental clearance, both representing
the retardation of transport from the deeper tissues towards the patients
plasma (Table 15.3). Second, the dierent solutes were modeled with a two-
compartmental model that was calibrated with clinical data, including urea
that was previously studied using single-pool kinetics (Section 15.1). ird,
our mathematical model is up till now the only available tool that allows
direct comparison between solute removal with double and single lumen
catheters on the one hand, and correct and reversed connected catheter lines
on the other hand. And fourth, the single lumen catheter model is designed
in such detail that dialysis modeling is possible with dierent stroke vol-
umes, as determined by the arterial-venous pump ratio and the buer vol-
umes.
15.2.5 Conclusion
In case of a dysfunctioning double lumen catheter during 4 h standardhemo-
dialysis, reversing the lines should be preferred above lowering the blood
ow in correct connection mode, if this practice results in higher blood
ows. Single lumen catheters are a suboptimal long term option in terms
of adequacy for patients on regular dialysis (3 times a week for 4 hours).
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15.3 Slow extended dialysis: 2-compartment kinetic modeling
15.3.1 Introduction
Extended dialysis is gaining renewed interest over the last decade, especially
since it has been associated with better outcome in observational studies
[315, 316], and with more solute removal, even with low blood ows [301].
In dialysis centers, mainly short dialysis (4 h) is performed, while extended
nocturnal hemodialysis (NHD) is more feasible in the homecare setting.
ere is however still uncertainty on the optimal blood and dialysate ows
for this extended form of dialysis. High ows induce more frequent alarms,
higher costs of water, and higher consumption of dialysate concentrates,
with the need to change containers during the night. e question under
study is whether the loss of adequacy due to lower ows in nocturnal home
hemodialysis (NHHD) versus high ows in short in-center dialysis, is com-
pensated by the longer dialysis duration.
Furthermore, in case of a gra or stula, double needle puncturing in
home dialysis is oen unpractical if patients are dialyzingwithout assistance,
and is substantially more dangerous in case of accidental needle dislodge-
ment with subsequent blood loss out of the venous needle.
Since no data are available on solute removal for single versus double
needle/lumen dialysis or for high versus low blood ows in extended dial-
ysis, we developed a mathematical model combining a two-compartment
kinetic model for dierent uremic toxins with a hemodialysis model. Here-
with, we compared total solute removal and reduction ratios in dierent set-
tings of extended NHHD versus short dialysis.
15.3.2 Material and methods
For this study, the same calibrated mathematical patient/dialyzer model was
used as in Section 15.2 and shown in Figure 15.4 (omitting the recirculation
R) and Figure 15.5. e same four solutes were studied (urea and methyl-
guanidine (MG), beta-2-microglobulin (β2M) and phosphate), with molec-
ular weight and kinetic parameters as shown in Table 15.3.
For each of the four solutes, four dierent scenarios were studied: the
standard double needle (lumen) 4 h dialysis at high owQb 350ml/min (DL-
HF-4h), and three extended 8 h dialysis sessions: two double lumen with ei-
ther high ow Qb 350ml/min (DL-HF-8h) or low ow Qb 175ml/min (DL-
LF-8h), and one single lumen (SL-8h). All treatment parameters can be
found inTable 15.8. For the SL approach, next to 12 Fr central venous catheter,
the single needle approach (Vc = 0.5ml) was considered.
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DL-HF-4h DL-HF-8h DL-LF-8h SL-8h
Session duration [min] 240 480 480 480
Post dialysis rebound [min] 60 60 60 60
Qb [ml/min] 350 350 175 273
Qu f [L/h] 1 0.5 0.5 0.5
Qap [ml/min] n/a n/a n/a 500
Pump ratio (Qvp/Qap) n/a n/a n/a 1.2
Vc (12Fr) [ml] n/a n/a n/a 2.9
Vmin [ml] n/a n/a n/a 10
Vmax [ml] n/a n/a n/a 55
Table 15.8: Operating parameters in the dierent dialysis settings.
DL: double lumen; SL: single lumen; HF: high ow; LF: low ow; Qb : blood ow;
Qu f : ultraltration ow; R: access recirculation; Qv p : blood ow during venous
phase; Qap : blood ow during arterial phase; Vc : catheter volume; Vmin : minimum
buer volume; Vmax : maximum buer volume.
15.3.3 Results
Reduction ratio (RR) and total solute removal (TSR) are presented in Table
15.9 for the four scenarios and the four solutes under study. Compared to
the 4 h hemodialysis, RR’s are equal in DL-LF-8h, higher in SL-8h, and even
more increased in DL-HF-8h mode, and this for all studied solutes.
For theDL-LF-8h and the SL-8h approach, TSRwas for all solutes higher
compared to 4 h hemodialysis (range 6-18% and 13-35%, respectively). TSR
with the SL-8h approach was even larger compared to the DL-LF-8h, except
for β2M.
By further increasing the ow during extended dialysis (from low ow
DL-LF-8h to high ow DL-HF-8h), TSR increases but is not doubled com-
pared to 4 h hemodialysis: only 7-30% higher compared to DL-LF-8h, and
even only 7-15% higher compared to SL-8h hemodialysis. For β2M, dier-
ences in TSR with DL-HF-8h are limited to only 7% (DL-LF-8h) and 11%
(SL-8h).
Finally, with the single needle approach, RR and TSR, respectively, were
only 1 and 2% higher compared to the values found with the SL CVC (data
not shown).
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RR-C1 [%] RR-C2 [%] TSR [mmola]
4 h 8 h 4 h 8 h 4 h 8 h
DL-HF DL-HF DL-LF SL DL-HF DL-HF DL-LF SL DL-HF DL-HF DL-LF SL
Urea 73.6 90.5 71.8 84.1 66.8 88.5 68.6 81.6 787 1031 851 957
(23) (-2) (14) (32) (3) (22) (31) (8) (22)
MG 51.0 70.8 47.3 61.0 38.6 63.7 41.1 54.0 0.17 0.27 0.18 0.23
(39) (-7) (20) (65) (6) (40) (59) (6) (35)
β2M 66.3 83.8 60.2 80.6 31.0 66.3 39.6 62.2 298 380 353 338
(26) (-9) (22) (114) (28) (101) (28) (18) (13)
P 68.6 87.8 68.0 81.5 52.8 81.6 60.3 74.5 44 59 47 54
(28) (-1) (19) (55) (14) (41) (34) (7) (23)
amg for β2M
Table 15.9: Adequacy parameters for dierent solutes, and dierent dialysis settings.
RR: reduction ratio; TSR: total solute removal; DL: double lumen; SL: single lumen; HF: high ow; LF: low ow; MG:
methylguanidine; β2M: beta-2-microglobulin; P: phosphate. e value between brackets is the percentage increase of the
adequacy parameter, compared to 4h DL-HF.
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15.3.4 Discusion
We demonstrated that total solute removal (TSR) during extended HD is
higher when compared to 4 h HD for all studied solutes, even with low ow
or using a single lumen approach. Although there was more solute removal
with DL-HF-8h HD as compared to DL-LF-8h HD, these dierences were
rather limited, especially for solutes which are dicult to remove, such as
β2M. Even in the 8 h single lumen HD approach, TSR was higher than with
4 h standard HD. Hence, our data demonstrate that vascular access has only
a limited impact on total solute removal during extended dialysis regimens,
especially for solutes with retarded multi-compartment behavior.
In extended slow dialysis (i.e. low blood and/or dialysate ow with DL-
LF-8hHD), the lower solute clearance is counterbalanced by a nancial ben-
et and better patient quality of life. Especially in the home dialysis setting,
the use of low dialysate and/or blood ows is of relevance, as this reduces the
frequency of alarms, and avoids the necessity to wake up during the night
to exchange dialysate concentrate bags. All this substantially adds to the
quality of sleep and thus quality of life of the patient. Furthermore, lower
dialysate ows also reduce costs related to the water consumption, again of
high relevance in the home dialysis setting, where these extra expenses in
many countries are directly on the patient’s costs.
A single needle access can be of importance for patients who dialyze
without assistance, as double needle puncturing is cumbersome under these
conditions. A single puncture also results in slower deterioration of vascu-
lar access and less access-related problems [317]. In addition, single needle
dialysis enhances safety in case of disconnection of lines. Even for patients
dialyzing with a central venous catheter as access, our ndings are relevant,
as several observational studies reported a lower incidence of complications
in single vs double lumen catheters [85, 318, 319]. Our results indicate that
these low blood and dialysate ows, even in a single needle setting (i.e. SL-
8h), can be used without jeopardizing solute removal.
It can be remarked from the present results that increasing dialysis du-
ration has most impact on TSR, with none or only limited impact on RR.
A similar trend was found previously in an in vivo cross-over study of 4, 6
and 8 hours HD [301].is seemingly discrepancy can be explained by the
fact that during (slow) 8 h dialysis, more solute can be transported from the
non-perfused into the perfused compartment where it can be removed by
dialysis. Hence, this higher TSR results in a smaller post-dialysis rebound
with 8 h dialysis, which is not necessarily reected in a higher RR.
e fact that our study is purely based on mathematics should not be
regarded as a drawback. Our simulations can be considered as being per-
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formed in an ‘average patient on dialysis’ since we used kinetic models that
were previously calibrated on patient’s data [144–146]. However, someweak-
nesses of the modeling approach should be highlighted.
First, for all scenarios, we started, per solute, from the same conditions
as indicated in Table 15.3, although several parameters could be dierent be-
tween 4 h and 8 h dialysis, and between the rst, second, and third dialy-
sis session of the week (i.e. pre-dialysis concentrations and compartment
volumes). In steady state, for instance, pre-dialysis concentrations will be
lower with 8 h dialysis, while total solute removal, which is equal to genera-
tion rate, will become equal again to that during 4 h dialysis. Over a longer
period, time averaged concentrations will be lower with extended dialysis.
e aim of our study, however, was to compare the adequacy of dierent
scenarios for a single session, such that a mathematical model based on an
‘average patient’ with same pre-dialysis conditions is a useful tool.
And second, per studied solute, the calibrated kineticmodels were taken
from literature. Herewith, phosphate modeling was performed using the
calibrated two-compartment model, although it cannot accurately describe
plasma concentrations as compared to the three- and four-compartment
models [145], i.e. the modeled concentrations decrease slower during the
rst and faster during the second half of dialysis. Since the use of more com-
plex models would need too many additional assumptions, and since we are
mainly interested in pair wise comparisons of RR and TSR between dierent
scenarios, our method seems quite defensible.
Beside these weaknesses, our mathematical study has some important
strengths as well. Dierent types of solutes were modeled with a totally
dierent kinetic behavior in the patient. Furthermore, the mathematical
modeling of SL dialysis included several details like stroke volumes, arterial-
venous pump ratio, buer volumes and recirculation.
Although the present ndings might not all be very surprising to each
clinician [319], it is worthy to see the conclusions based on mathematical
modeling, independent from the variability present in the general patient
population, and from the variability present in the starting conditions of
dierent dialysis strategies. Our data clearly shows that the loss of adequacy
due to lower ows in nocturnal home hemodialysis can be compensated by
longer dialysis duration, compared to short in-center dialysis.
15.3.5 Conclusion
Although high blood and dialysate ows still result in higher total solute
removal during extended 8 hour dialysis as compared to lower ows, the
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gain is limited, especially for solutes with more complex compartment be-
havior, such as β2M. Even when using a single lumen approach, total solute
removal is superior in extended 8 h dialysis compared to standard 4 h dialy-
sis. In view of the practical constraints of the home dialysis setting, low ow
dialysis, even with single lumen approach, is a defensible option.
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Conclusions
is is it. Aer 6 years of swimming, diving, oating and sometimes even
drowning in the biouid site of vascular accesses (VA), you can ndmy nal
conclusions hereaer. Since my PhD-work was built around the three types
of VA [arterio-venous stula (AVF), arterio-venous gra (AVG) and central
venous catheter (CVC)], not one general but several research statements will
be discussed in the following section. While the dierent studies in this
dissertation were grouped per VA type, the statements will be discussed per
study method.
16.1 CFD analysis
e main pressure drop in the AVF circuit should be over the anastomo-
sis.
In general, there is a huge absence of interest in the geometry of the cre-
ated arterio-venous anastomosis. is can be noticed by the virtual total
absence of studies regarding this topic, as well as by the lack of interest in
the geometry of the anastomosis in clinical studies dealing with AVF out-
come. Creating a too small anastomosis reduces the chance of proper s-
tula maturation. But avoiding the non-maturation by creating a (too) large
anastomosis should not result in an increased prevalence of venous hyper-
tension, cardiac overload, distal hypoperfusion or ischemia. We showed in
our study on the impact of the anastomosis size (i.e. length and width) and
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angle, that slightly changing the AVF anastomosis geometry has a large im-
pact on the blood ow and local pressure distribution, with a quadratic and
case-/patient-specic relation between ow rate and pressure drop.
During surgical creation of an AVF, as well as during complication solv-
ing interventions, should the anastomosis geometry be chosen with care,
keeping in mind the impact of the geometry on pressure drop and ow dis-
tribution. erefore, it can be stated that the main pressure drop in the
arterio-venous circuit should be over the anastomosis to avoid complica-
tions such as high pressure in the venous system, cardiac overload and distal
ischemia.
Using a helical pattern in the design of an AVG introduces a more com-
plex ow eld and reduces, but does not delete, zones with unfavorable
hemodynamic conditions.
To investigate the inuence of helicity in the gra design, a straight con-
ventional gra was compared to ve dierent helical designed gras. We
analyzed the ow eld using dierent wall shear stress descriptors as well
as the kinetic helicity in the bulk ow and the pressure drop over the gra
section. e investigated wall parameters (time-averaged wall shear stress,
oscillatory shear index and relative residence time) can be linked to an in-
creasing risk of intimal hyperplasia formation, thus stenosis formation.
It is clear from our study, that introducing helicity in the design of an
AVG changes the downstream hemodynamics and introduces a more com-
plex ow eld.ere is however no trivial relationship between the number
of helical turns and the investigated wall shear parameters. Only the very
‘swirling’ design, a pitch smaller than 6 times the gra diameter, signicantly
reduces the area with unfavorable hemodynamic conditions at the venous
anastomosis. However, in clinical practice, inserting this design under the
skin of a patient will not be obvious. So, a design with a more modest he-
licity pattern can be used to achieve more athero-protective conditions, but
the unfavorable hemodynamics will not be vanished. Furthermore, because
every gra is, irrespective of the gra design itself, subject to torsion and
bending while connected in a loop conguration between an artery and a
vein, gras should be studied case-by-case to qualify their ability to reduce
unfavorable hemodynamics.
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e VectorFlow CVC outperforms standard catheters due to the negligi-
ble recirculation.
We showed, based on kinetic modeling, that reversing the lines is a defen-
sible practice to increase blood ow in malfunctioning catheters. e Vec-
torFlow catheter, a double-D design with symmetrical tip, showed in a CFD
analysis, as well in an in vitro and in vivo investigation, a negligible recir-
culation. Note that correct and reverse line connection are equal due to the
symmetrical design of the catheter tip. So from this point of view, the Vec-
torFlow is a reliable option.
e CFD analysis had the advantage that not only a global factor as re-
circulation could be assessed, but a more in depth analysis could be per-
formed as well. An ideal dialysis catheter, from a uid-dynamic perspective,
produces low shear stresses on the uid, has a low percentage of prolonged
blood residence time (cf. clotting) and maintains a low platelet lysis index
(cf. hemolysis). e mean shear stress and platelet lysis index were only
slightly elevated (8% maximum) compared to reference case of a ‘shotgun’
design, even with a signicant higher Reynolds number (18%) in the arterial
and venous lumen.e blood residence time was only modestly elevated.
e symmetrical-tip design of theVectorFlow catheter introduces a neg-
ligible recirculation and keeps the blood (ow) parameters in a very accept-
able range. However, additional pre-clinical data are required to conrm the
increased catheter patency during long-term implantation.
16.2 Experimental assessment
e pulse wave propagation model and the high ow CFD solver, devel-
oped in the ARCH-project, are experimentally validated and can be used
for further clinical implementation.
For 1D-modeling, one cannot merely rely on patient data to determine whe-
ther the physical descriptions in themodel are complete. Conducting an ex-
perimental validation on an in vitro setup, with controllable andmeasurable
boundary conditions (e.g. no vessel adaption), is probably the best option.
For example, due to the inter-day variability of the patient’s blood pressure
(i.e. by room temperature or the tranquility of the patient), an in vitro setup
seems more ‘reliable’ when it comes to investigate the model’s fundamental
principles and the underlying physics. More over, compared to in vivo val-
idation, in vitro validation is not hampered by the search for non-invasive
measurement methods and by a limited number of accessible locations in
the circuit.
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e experimental validation of the pulsewave propagationmodel showed
that mean values of ow and pressure can be predicted adequately, but that
viscoelasticity should be introduced in the model to match the diastole or
systole values.
e pulse wave propagation model validation showed that calculating
the pressure and ow waves (with correct attenuation) is very challenging.
is knowledge makes it clear that studies relying on sensitive detection of
the reduction or magnication of the pulse pressure, cannot just rely on
computational modeling.
For new CFD-codes, one can rely, in rst instance, on the comparison
of the code against known benchmark results. However, to ensure that ow
vs. pressure drop simulations, in challenging cases, give reliable results, in
vitro assessment seems still needed. Herewith, the overall ow eld is well
described by the solver and the pressure drop values are reliable up to a
Reynolds numbers of 2000. Hence, introducing a non-linear pressure loss
coecient in the pulse wave propagationmodel, calculated by the CFD code
seems a good option to replace the pressure loss coecients based on e.g. T-
shaped ttings.
e experimental validation of themodels’ fundamental principles opens
the way for further clinical implementation and in vivo validation.
Experimental lab work needs experienced researchers.
During the experiments in the context of in vitro validation, concerning
the pulse pressure analysis stenosis detection method and in the eld of
neurosurgery [320, 321], much knowhow is gained on how in vitro uid-
mechanical experiments should be executed.
As computers get faster and computational power increases (in 2006 the
Hydraulics lab had 3 single calculation computers, at present, a cluster of
over 200 cpus is available for the bioMMeda research group), the time con-
suming experimental validation seems to vanish. But, still, in vitro valida-
tion of numerical models is very valuable.
In contrast to numerical investigations, constructing a large set of exper-
imental models and setups is not possible, while keeping cost, both money
and time, within ‘budget’. One should, either investigate time to build up
in-house knowledge on model construction or invest money in purchasing
a state-of-the-art model.
It was found in largemulticenter PIV-studies that uctuations in the ow
conditions and uid properties need to be well controlled to increase accu-
racy and reproducibility.We had the same experience when analyzing the
results of the preliminary PIV-study on a model of a kinked blood vessel
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[322, 323]. Herewith, we minimized, in our nal PIV study, uctuations on
the ow conditions by installing a 1m long sti tube proximal to the model
to obtain a symmetric inow and even checked the correctness of the as-
sumed velocity prole. Furthermore, we closely monitored the uid tem-
perature and consequently adapted andmeasured the viscosity, to minimize
uid property uctuations.
To conclude, I want to point out that experimental work needs an ex-
perienced investigator. During the rst construction of models and setups,
a lack of skills may lead to leakages on multiple (unexpected) locations, air
bubbles in the circuit, and inating and/or bursting silicon models (by mis-
judgment of clamps or valves), such that pressure and ow data will make
crazy antics. However, aer obtained the necessary experience, collecting
data from a well controllable setup (as a validation for example), provides
most certainly a great sense of accomplishment.
16.3 Diagnostic tools
Pulsepressure analysis at the arterial needle canbeused todetect stenoses
in early stage.
e disadvantage of current stenoses detection methods, based on pressure
drop or ow reduction, is the fact that they can only ‘trace’ stenoses with a
diameter reduction of about 70% (≈90% area reduction).
Our developed pulse pressure analysis (PPA) method, however, can de-
tect stenoses with a 50% and even a 25% diameter reduction.is detection
in early stage can help the clinicians in the patient-specic stula patency
management. e PPA method is even independent of the ow and heart
rate.
For use in clinical practice, the full pressure prole should be acquired
and analyzed.is technique is feasible since most of the dialysis machines
nowadays have arterial line pressure sensors reportingmeanpressures. How-
ever, a longitudinal study should reveal whether stenoses can be detected in
early stage only by, for example, weekly registration of the arterial needle
pulse pressure.
Standard pulsed wave Doppler ultrasound measurements cannot pro-
vide reliable blood ow rates.
We performed a theoretical study based on patient-specic data, both pre
and post arterio-venous stula creation, integrating computational uid dy-
namics calculations with an ultrasound simulator. We found that, when an-
alyzing the simulated pulsed wave Doppler (PWD) spectrum in the brachial
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and radial artery, the velocity component in the direction of the ultrasound
(US) beam, in a centered, small, sample volume, can be captured accurately
provided that the velocity is derived using the mean of the pulsed wave
Doppler spectrum rather than the outer envelope contour. However, when
deriving the nal blood ow rate based on these measurements, a high de-
gree of inaccuracy occurs. We found that two factors induce this inaccuracy.
First, the angle-correction of the velocity in the direction of the US-
beam towards the velocity in the longitudinal direction is largely inuenced
by the radial velocity components in the complex ow eld.
Second, the largest error is introduced when the velocity in one point
(e.g. in the center of the vessel, 0D) has to be transferred to the cross-
sectional mean velocity (2D) without any knowledge on the ow prole: i.e.
is the prole symmetrical, with its maximum velocity in the center and is
the shape of the prole parabolic, at or something in between like Wom-
ersley ow? It cannot be predicted in advance, even not for the low ow
pre-operative cases.
In our study case, ow at the brachial artery (pre- and postoperative) and
pre-operatively at the radial artery was best estimated assuming a parabolic
ow prole. For the post-operative radial artery acquisition, the most com-
plex ow pattern occurred and assuming a plug ow prole resulted in the
lowest bias.
One might expect that the use of the larger sample volume (e.g. over the
full diameter of the vessel, 1D) should provide the most accurate estimate of
the volume ow (2D). Interestingly, our data indicated that this was not sys-
tematically the case, probably because this method is challenged by the fact
that velocities near the vessel wall are dicult to measure, even in straight
vessel segments.
16.4 Kinetic modeling
Reversing connection lines is the best alternative for dysfunctional dou-
ble lumen CVCs during standard (4 h) dialysis.
In case of a dysfunctional double lumen CVC, two options can be taken: i.e.
lowering blood ow, or reversing the lines simultaneously and thereby in-
creasing blood ow. First, we found during an in vivo study, including 22
patients, that reversing the lines in a well-functioning double lumen CVC
did not inuence the solute removal of four generally studied solutes. Since
reversing the catheter linesmight increase recirculation (suction of cleansed
blood back to the dialyzer) in a standard ‘shotgun’-type CVC, a mathemat-
ical study, combining single pool modeling with a dialyzer model, was per-
formed to determine dialysis adequacy based on urea removal. e study
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revealed that the total solute removal (TSR) of urea was only reduced by
9.2% (at blood ow rate, Qb, of 350ml/min) when the recirculation was be-
low 10%.
To better describe the retarded solute transport in the patient’s body, a
more complex 2-compartment kinetic model was combined with a dialyzer
model. Dialysis adequacy was checked for 4 dierent solutes in 4 dierent
access types. We found a reduction of urea-TSR of only 3.3% when intro-
ducing 10% recirculation (Qb 350ml/min). For a solute with a hampered
transport within the patient (like β2M), an enormous recirculation of 47%
only reduces solute removal with 5%.
rough the 2-compartment kinetic modeling, we revealed that double
lumen reversed connection (introducing recirculation) with a high blood
ow rate, should be preferred above the correct line connection (negligi-
ble recirculation) with a lowered ow. Single lumen CVC dialysis seemed a
suboptimal option in regular 4 h dialysis.
Low-ow dialysis with double lumen CVC, or dialysis with single lumen
CVC or single needle with an AVF, are considerable alternatives during
extended (8 h) dialysis.
Due to the available time during 8 h dialysis, solute kinetics in the patient
play an important role as compared to the dialyzer clearance. erefore, 2-
compartment kinetic modeling was performed for 4 solutes and 4 dierent
cases.
We found the obvious fact that solute removal was higher when, for the
full length of the dialysis, a high ow (as in regular dialysis) wasmaintained.
However, solute removal with 8 h was not doubled compared to the 4 h dial-
ysis (increase of 28-51%).
One should keep in mind that when searching for the optimal parame-
ters for extended (nocturnal) dialysis, especially in the homecare setting, ex-
tra boundary conditions play a role compared to a regular dialysis treatment
(4 h in dialysis center). First, the quality of life is inuenced by the patient’s
quality of sleep. erefore avoiding the necessity of waking up during the
night to change concentrate bags, by reducing the blood and dialysate ow
rate, is preferable.is reduction in ow rates also reduces the costs of water,
which is in home-dialysis mostly covered by the patients themselves. Since
solute removal in low ow (175 instead of 350ml/min) dialysis is comparable
with that in regular daytime dialysis, low-owdialysis is a worth considering
alternative.
With a single lumen catheter, an increase in solute removal with 8 h dial-
ysis (13-35%) was present compared to the regular 4 h dialysis. Finally, with
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a single needle punctured in an AVF, solute removal even increases a few
percentages compared to the results for the single lumen CVC dialysis.is
last option was studied because in the homecare setting, patients oen di-
alyze (relying on their arterio-venous stula as preferable vascular access)
without assistance and a single needle puncturing might be preferable.is
because double needle puncturing is cumbersome and single needle punc-
turing increases safety, due to a decreased frequency of line disconnection.
us, single needle/lumen hemodialysis seems to be the best option in the
home setting, keeping a good balance between dialysis adequacy, practical
use, quality of life, and nancial burden.
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Abbreviations
APD Automatic peritoneal dialysis
ARCH Patient-specic image-based computationalmod-
eling for improvement of short- and long-term
outcomeof vascular access in patients onhemodial-
ysis therapy
ATP Adenosine triphosphate
AVF Arterio-venous stula
AVG Arterio-venous gra
CAPD Continuous ambulatory peritoneal dialysis
CFD Computational uid dynamics
CKD Chronic kidney disease
CSA Cross-sectional area [m2]
CT Computed tomography
CVC Central venous catheter
DA Distal artery
DL Double lumen
DOPPS Dialysis outcomes and practice patterns study
DRIL Distal revascularisation-interval ligation
EBPG European best practice guidelines
EPO Erythropoietin
ePTFE Expanded PTFE
ER Extraction ratio [%]
ESRD End-stage renal disease
FDA Food and drug administration
FSI Fluid structure interaction
HD Hemodialysis
NKF-K/DOQI National kidney foundation - kidney disease out-
comes quality initiative
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LNH Local normalized helicity
LVH Le ventrical hyperthropy
MR Magnetic resonance
NHD Nocturnal hemodialysis
NHHD Nocturnal home hemodialysis
OSI Oscillatory shear index
PA Proximal artery
PAI Proximalisation of the arterial inow
PD Peritoneal dialysis
PIV Particle image velocimetry
PLI Platelet lysis index
PRF Pulse repetition frequency
PTA Percutaneous transluminal angioplasty
PTFE Polytetrauoroethylene
PV Proximal vein
PWD Pulsed wave Doppler
Qdp Flow rate versus pressure drop
RBC Red blood cell
RF Radiofrequency
ROI Region of interest
RR Reduction ratio [%]
RRT Relative residence time
RRT Renal replacement therapy
RT Residence time
RUDI Revision using distal inow
SL Single lumen
SLF Spiral laminar ow
SMAHT Small amplitude helical technology
TAWSS Time-averaged wall shear stress
TD Time delay
TSR Total solute removal
Tx Renal transplantation
US Ultrasound
VA Vascular access
WSS Wall shear stress
Symbols
a Acceleration vector [m/s2]
A Angle [○]
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C Compliance [m2/Pa]
C1/C2 Concentration in the perfused / non-perfused
compartment [g/l or mol/l]
Cbi/Cbo Blood concentration at the dialyzer inlet / outlet
[g/l or mol/l]
Cdi/Cdo Dialysate concentration at the dialyzer inlet / out-
let [g/l or mol/l]
Cpost/Cpost60 Blood concentration post dialysis / 60min aer
dialysis [g/l or mol/l]
Cpre Blood concentration pre dialysis [g/l or mol/l]
D Distensibility [Pa−1]
ex , ey and ez x,y and z-component of the unity vector e
Eu Euler number []
F Force vector [N]
g Gravity vector [m/s2]
G1/G2 Solute generation rate in the perfused / non-per-
fused compartment [g/min or mol/min]
H Hematocrit [%]
H Helicity [m/s2]
Hk Kinetic helicity density [1/(m2⋅s2)]
K Dialyzer clearance [ml/min]
K12 Intercompartmental clearance [ml/min]
L Length [m]
µ Dynamic viscosity [Pa⋅s]
µp Plasma dynamic viscosity [Pa⋅s]
ν Kinematic viscosity [m2/s]
n Normal vector on a surface
ω Vorticity [1/s]
p Pressure [Pa]
Q Flow rate [m3/s or ml/min]
Qap/Qvp Blood pump ow rate during the arterial / venous
phase [ml/min]
Qbi/Qbo Blood ow rate at the dialyzer inlet / outlet
[ml/min]
Qdi/Qdo Dialysate ow rate at the dialyzer inlet / outlet
[ml/min]
Qu f Ultraltration ow rate [ml/min]
ρ Mass density [kg/m3]
R Access recirculation [%]
R Radius [m]
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Rp Pheripheral resistance [Pa⋅s/m3]
Re Reynolds number []
τ Shear stress [N/m2]
τ0 Critical shear stress [N/m2]
T Time period [s]
t Time [s, min or h]
u, v and w x,y and z-component of the velocity vector v [m/s]
v Velocity vector [m/s]
V1/V2 Perfused / non-perfused volume [l]
Vc Catheter volume [ml]
Vmin/Vmax Minimum /maximumvolume in the buer reser-
voir [ml]
Vres Volume of the buer reservoir [ml]
W Width [m]
Z0 Characteristic impedance [Pa⋅s/m3]
Operators
∆ Dierence
δ Partial derivative
D Substantial derivative ( DDt = δδt + u δδx + v δδy +w δδz)
d Derivative∇ Nabla (∇ = ex δδx + ey δδy + ez δδz)
Subscripts
0 At mean pressure
ai Arterial inlet
ao Arterial outlet
avg Average
vo Venous outlet
d Distal
dia Diastolic
DL Double lumen
max Maximal
p Proximal
SL Single lumen
v Venous
Superscripts
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Units
cm Centimeter
Fr French needle gauge
h Hour
kg Kilogram
l Liter
µm Micrometer
m Meter
min Minute
ml Milliliter
mm Millimeter
mmHg Millimeters of mercury
N Newton
Pa Pascal
s Second
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